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ABSTRACT 
One hundred and fifty -one Bacteroides isolates were collected 
from a variety of clinical samples (wound, swabs, vaginal swabs and 
blood cultures) and from the cervix of women attending a colposcopy 
clinic. 
A method for the isolation of plasmid DNA from Bacteroides 
species was developed and provided a simple and reproducible 
technique for the analysis of the plasmid content of the isolates. 
The strains were divided into three groups, the B. fragilis group, 
the melaninogenicus /oralis group and the asaccharolytic group. The 
incidence of plasmids in each group was determined. 
Forty per cent of the strains were found to have plasmids but 
there was great variation in the plasmid distribution within each 
group. Sixy -one percent of the B. fragilis strains had plasmids as 
opposed to 23% of the asaccharolytic Bacteroides, and 10% of the 
melaninogenicus /oralis strains. Plasmids ranging in size from 1.1 to 
108 MegaDaltons (MDa) were detected but most of the plasmids were 
less than 10 MDa. Seventy -nine percent of the plasmid- containing 
strains had more than one plasmid. 
The susceptibility of the isolates to chloramphenicol, 
clindamycin, metronidazole, erythromycin, imipenem, moxalactam, 
cefoxitin, cefotetan, cefotaxime, cefuroxime, penicillin and 
nalidixic acid was investigated. Chloramphenicol was the most active 
non -beta -lactam antibiotic. Six percent of the strains were 
resistant to clindamycin and metronidazole resistance, though rare, 
VI 
was observed in 2% of the strains. Among the beta -lactam 
antibiotics, imipenem, though not in use in the United Kingdom was 
found to have excellent activity against the Bacteroides. Moxalactam 
and cefoxitin were also very active with less than 1% of the strains 
displaying resistance. Various levels of resistance, ranging from 
4 to 50% were found amongst the three Bacteroides groups. There was 
evidence of species variation in antimicrobial susceptibility. 
Attempts were made to correlate plasmid presence with observed 
antibiotic resistance and capsule variation within the strains. 
Transferable macrolide -lincosamide -streptogramin (MLS) resistance 
determinants were not identified and observed MLS resistance could 
not be cured. However, a possible correlation was found between 
plasmid content and resistance to cefoxitin but plasmid content was 
not found to alter the resistance pattern of strains to nalidixic 
acid. Capsule variation was found to depend on altered gene 
expression and not on the presence or absence of plasmids. 
Of 
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A. THE IMPORTANCE OF BACTEROIDES IN HUMAN ANAEROBIC INFECTIONS 
1. Anatomical Distribution of Bacteroides Species 
Bacteroides are obligately anaerobic, non spore -forming, non - 
motile, Gram -negative rods. Studies of various anatomical sites 
together with improved anaerobic techniques have given more knowledge 
of the normal anaerobic flora and of their importance in human 
infections. A complex anaerobic flora is to be found in the 
gastrointestinal tract, the female genital tract, the mouth and the 
upper respiratory tract. 
1.1 Bacteroides in the Gastrointestinal Tract 
Ninety to ninety -five per cent of the bacteria in the large 
intestine are obligate anaerobes, while the remainder are coliform or 
other facultative bacteria. Species belonging to the Bacteroides 
fragilis group form the predominant flora, being present in the range 
of 1 x 1010 to 5 x 1010 organisms per gram of faeces (Moore et al., 
1969; Stiffler et al., 1974; Guiney and Davis, 1975; Tinnell and 
Macrina, 1976; Mancini and Behme, 1977; Duerden, 1980b; Rotimi 
et al., 1981). Some members of this group can occur as opportunist. 
pathogens. 
Bacteroides vulgatus and Bacteroides distasonis are the most 
prevalent members of the Bacteroides fragilis group in the normal 
flora. However, Bacteroides fragilis, a minor component of the 
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group, is the major isolate in clinical conditions. It is 
responsible for more than 60% of all anaerobic infections in humans 
(Gorbach and Bartlett, 1974a and b; Nastro and Finegold, 1972; 
Mancini and Behme, 1977; Welch et al., 1979; Wallace et al., 1981; 
Smith et al., 1982). Infections with this organism occur when 
predisposing events such as intraabdominal pathology and 
gastrointestinal or gastro -urinary surgery lead to a breakdown of the 
normal anatomic barriers (Stiffler et al., 1974; Wallace et al., 
1981). 
1.2 Bacteroides in the Female Genital Tract 
Reports differ as to the prevalence of the Bacteroidaceae in the 
genital tract. Bacteroides of the melaninogenicus /oralis group have 
been recently recognised as frequent members of the normal microflora 
of the lower genital tract (Taylor et al., 1982; Tabaqchali et al., 
1983). Of these Bacteroides bivius and disiens are the most common 
isolates (Duerden, 1980; Evaldson et al., 1982; Larsen and Galask, 
1982; Hill and Ayers, 1985). 
Although Bacteroides fragilis has been isolated from women with 
a variety of genital tract infections, the Bacteroides fragilis group 
is not part of the normal commensal flora of the vagina (Bartlett 
et al., 1977; Duerden, 1980; Larsen and Galask, 1982; Taylor 
et al., 1982; Spiegel et al., 1980). 
Bacteroides fragilis is present at this site in less than ten 
per cent of healthy women. It has been suggested that its apparent 
disproportionate prevalence in genital tract infections is due either 
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to its presence in low numbers in the vagina or to intermittent 
contamination of the vagina from the anus. Subsequent multiplication 
and invasion could then occur when facilitated by local conditions 
(Bartlett et al., 1977; Levison et al., 1977). 
1.3 Bacteroides in the Mouth and Upper Respiratory Tract 
Bacteroides species other than those of the Bacteroides fragilis 
group are usually found in the mouth and upper respiratory tract 
(Gorbach and Bartlett, 1974b; Duerden, 1980b; Evaldson et al., 
1982). They are a minor component of the flora of the healthy 
gingiva but are isolated in increased numbers during gingivitis 
(Newman, 1979; Evaldson et al., 1982). Bacteroides gingivalis forms 
25 -50% of the cultivable flora in advanced periodontitis and is also 
present in acute periodontitis (Newman, 1979; Evaldson et al., 
1982). The predominant Bacteroides in juvenile periodontitis are 
members of the melaninogenicus /oralis group and there is an absence 
of Bacteroides gingivalis (Evaldson et al., 1982). 
B. PLASMIDS IN BACTEROIDES 
1.1 Properties of Plasmid DNA and Incidence in Bacteria 
Plasmids are stable extrachromosomal genetic elements which 
usually exist in the cell as closed, circular deoxyribonucleic acid 
(DNA) molecules. They replicate autonomously and are known to confer 
a variety of phenotypic properties of both clinical and ecological 
significance. Such traits include resistance to antibiotics and 
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heavy metals (Helinsky, 1973; Summers and Lewis, 1973), toxin 
production including enterotoxins (Gyles et al., 1974), exfoliative 
toxins (Warren et al., 1975) and haemolysins (Goebel et al., 1974; 
Jacob et al., 1975), surface antigens (Bak et al., 1972), 
bacteriocins and hydrocarbon catabolism (Macrina and Balbinder, 1973; 
Jacob et al., 1975), production of sex factors for conjugation 
(Pemberton and Clark, 1973) and the use of organic compounds such as 
camphor and napthalene (Dunn and Gunsalus, 1973). 
Because of the importance of several of these characteristics to 
human disease and microbial ecology, plasmids have been sought and 
found in a wide variety of bacteria including Pseudomonas (Keil and 
Williams, 1985; Sharabadi et al., 1975; Takahashi and Nagano, 
1984), Bacillus (Lovett,1973), Staphylococcus (Takahashi and Nagano, 
1984) and most genera of the Enterobacteriaceae (Goebel et al., 1974; 
Takahashi and Nagano, 1984). The ecological niche of the 
Bacteroides, their potentially important role in human intestinal 
pathology and their importance as opportunistic pathogens, have made 
members of this genus the subject of much current investigation. 
1.2 The Incidence of Plasmids in Bacteroides 
Plasmids have been demonstrated in most representatives of the 
Bacteroides fragilis group in the fragilis species as well as other 
species. Young and Mayer (1979) in their analysis of 62 strains of 
Bacteroides isolates found that only 46% possessed plasmids. This 
figure was similar to that of Riley and Mee (1984) who examined 50 
isolates, but is somewhat higher than the 26% found by Wallace et al. 
(1981) who studied 32 random Bacteroides isolates. Stiffler et al. 
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(1974) found plasmids in three of four clinical isolates of 
Bacteroides. Most strains of Bacteroides examined carried a multiple 
plasmid population. Of 40 plasmid- containing strains examined by 11 
groups of workers 26 (65%) contained more than one plasmid band. 
1.3 The Size Range of Plasmids in Bacteroides 
The overall size range of plasmids isolated from Bacteroides 
species was between 2.0 and 58 megadaltons (MDa), with the most 
commonly found plasmids having molecular masses of less than 10MDa. 
Wallace et al. (1981) found three distinct sets of plasmids of sizes 
2.0, 3.0 and 5.0MDa, while Young and Mayer (1979) found that 26 of 
their 29 plasmid- containing strains had plasmids with molecular 
weights of less than 10MDa. In their study of 50 Bacteroides 
strains, Riley and Mee (1984) found. plasmids of 9.8MDa and less in 18 
of 20 plasmid- containing strains. Plasmids with molecular masses of 
greater than 10Md have been found in Bacteroides fragilis by Stiffler 
et al. (1974), Guiney and Davis (1975), Welch et al. (1981), Guiney 
et al. (1984), and Smith and Macrina (1984). Riley and Mee (1981) 
found a plasmid greater than 10MDa in Bacteroides distasonis, while 
Tinnell and Macrina (1976) and Rotimi et al. (1981) found plasmids 
greater than 10MDa in Bacteroides thetaiotaomicron. Martinez -Duarez 
et al. (1985) isolated a 23.7MDa plasmid from a strain of Bacteroides 
uniformis. 
This size range of plasmids in Bacteroides is rather small by 
comparison with aerobes such as Pseudomonas and facultative 
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anaerobes such as Escherichia coli from which plasmids over 80MDa 
have been isolated (Takahashi and Nagano, 1984) (Table 1.1). 
C. ANTIBIOTIC THERAPY OF BACTEROIDES INFECTIONS 
The term antibiotic /antimicrobial agent is used throughout this 
thesis to include synthetic chemotherapeutic agents as well as true 
antibiotic substances produced by micro -organisms. 
1. Therapeutic Problems of Bacteroides Infections 
Infections with Bacteroides pose many therapeutic problems 
because of their resistance to commonly used antimicrobial agents. 
Some classes of antibiotics such as the aminoglycosides are known to 
be inactive against these species (Watt, 1979; Bryan and Kwan, 1981; 
Wexler and Finegold, 1987). Other classes such as the tetracyclines 
are becoming increasingly ineffective due to the emergence and spread of 
resistant strains. Use is recommended only where laboratory tests 
demonstrate susceptibility of the isolates (Nastro and Finegold, 
1972; Chow et al., 1975; Sutter and Finegold, 1976; Brown and 
Waatti, 1980; Snydman et al., 1980; Cuchural et al., 1981; 
Phillips et al., 1981). 
Clindamycin (Cc) and chloramphenicol (Cm) were traditionally 
used for the treatment of bacteroides infections. The unique 
antimicrobial activity of metronidazole (Mz) has only recently been 
recognised. An increased awareness of the importance of anaerobic 
bacteria in infections has emphasised the need for new antimicrobial 
agents. In recent years considerable effort has gone into the 
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TABLE 1.1 
Molecular masses (Mr) of plasmids detected in various clinical 
isolates 
Strain tested Mr of plasmids detected (MDa) 
Escherichia coli CU06711 83, 
72, 
44 
42, 2.7 E. coli CU09232 
Citrobacter freundii CU17160 100, 3.9, 2.0 
C. freundii CU13222 120, 48 
Enterobacter cloacae CU06407 100, 83, 48, 2.6, 2.0 
E. aerogenes CU13116 120, 100, 21, 2.7 
Serratia marcescens CU16741 100, 63, 42, 20, 2.3 
Klebsiella pneumoniae CU03092 100, 68 
K. pneumoniae CU06351 60, 32, 2.5 
Proteus vulgaris CU08806 100, 83, 2.6, 2.0 
Morganella morganii CU23232 36, 28 
Providencia rettgeri CU21322 115, 90 
Pseudomonas aeruginosa CU13325 85, 45, 3.5, 3.3 
P. aeruginosa CU20304 117, 54, 16 
Haemophilus influenzae FM0634 43 
Staphylococcus aureus FM0333 38, 11, 2.1 
Data of Takahashi and Nagano (1984) 
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development of beta -lactam antibiotics which show improved activity 
by virtue of resistance to beta -lactamases produced by many species 
of aerobic and anaerobic bacteria. 
2. Non -Beta Lactam Antibiotics with Activity Against Bacteroides 
2.1 Metronidazole 
Metronidazole is a synthetic derivative of the nitroamidazoles, 
a group of heterocyclic compounds based on a 5- membered nucleus (Fig 
1.1a). It was originally introduced for the treatment of 
trichomoniasis but has gained widespread use for both the prophylaxis 
and treatment of anaerobic infections (Baines, 1978; Eykyn and 
Phillips, 1978). 
Metronidazole is selectively active against obligate anaerobes 
and clinical experience has shown it to be highly effective against 
Bacteroides (Nastro and Finegold, 1972; Sutter and Finegold, 1976; 
Cuchural et al., 1981; Ohm -Smith et al., 1982). Nitro compounds 
have, however, been reported to be weakly mutagenic and carcinogenic 
(Finegold, 1977; Roe, 1977) and fears have been expressed about the 
saftey of metronidazole (Anon, 1975). Investigations have shown that 
theoretical 
while there is aArisk associated with its usage metronidazole is one 
the safest nitro compounds for the treatment of anaerobic infections 


















Structures of some non -beta lactam antibiotics with activity against 
Bacteroides 
9 
Figure 1.1 (continued) 
(d) Chloramphenicol 
H i HCOCHCl2 
Ç- i -CH2OH 
OH H 
10 
2.1.1 Mode of Action of Metronidazole 
The mode of action of this bacteriocidal drug is not clear. It 
was thought to involve reduction by nitroreductases to an 
uncharacterised, unstable intermediate which interacted with DNA and 
prevented further replication (Edwards et al., 1973; Chrystal 
et al., 1980). However, Narikawa (1986) showed that the 
nitroreductase activity of bacteria may not directly influence 
metronidazole susceptibility but may affect drug uptake. 
Evidence that pyruvate ferredoxin oxidoreductase activity is the 
major factor in metronidazole susceptibility was presented by O'Brien 
and Morris (1972). This was later confirmed by several workers 
including Britz (1981) and Narikawa (1986). In 1983 the subject was 
reviewed by Mueller who put forward the hypothesis shown in Fig 1.2. 
2.1.2 Resistance to Metronidazole 
In the UK resistance to metronidazole is rare and few reports 
have been substantiated (Ingham et al., 1978; Rotimi et al., 1979; 
Eme et al., 1983). However, in France 12% of the clinical isolates 
investigated by Acar et al. (1981) were resistant to 8 mg /1 of 
metronidazole. In South Africa 21% of Bacteroides fragilis were 
reported by Appelbaum and Chatterton (1978) to be resistant to 16 
mg /1 metronidazole; and in the USA resistance to 100 mg /1 
metronidazole in 17% of Bacteroides species was reported by Chow 






















Inactive end products 
1 
Inactive end products 
i 
Scheme of action of metronidazole on an anaerobic microorganism: 
a, passage through the cell membrane; b, reductive activation; 
c, interaction with intracellular targets; d, release of inactive 
end products (Mueller, 1983). 
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Apparent resistance may be due to two factors. Testing under 
conditions of inadequate anaerobiosis may inhibit the action of 
metronidazole (Muller and Lindmark, 1976; Milne et al., 1978; Tally 
et al., 1978). Ingham et al. (1981) found that the rate of killing 
by metronidazole was directly related to the p02 of the surrounding 
medium. This explained the observed, increased bacteriocidal 
activity on Bacteroides in the presence of E. coli described by 
Chrystal et al. (1980). Resistant strains may be microaerophillic 
organisms which have been wrongly classified as obligate anaerobes (B 
Watt, personal communication). 
2.2 Chloramphenicol 
Chloramphenicol is a bacteriostatic agent which inhibits protein 
synthesis (Garrod et al., 1981). It is a broad spectrum antibiotic 
with marked activity against the Bacteroides (Sutter et al., 1973; 
Sutter and Finegold, 1976; Kaye et al., 1980; Snydman et al., 1980; 
Cuchural et al., 1981; Phillips et al., 1981; Ohm -Smith et al., 
1982). With the large scale emergence of tetracycline- resistant 
strains, chloramphenicol replaced tetracycline as the initial agent 
for therapy of bacteroides infections (Bodner et al., 1970; Tally 
et al., 1979). However, it may produce dangerous 
bone marrow depression or aplasia (Garrod et al., 1981). As a 
result, at present one of its limited uses is in the treatment of 
serious infections caused by Bacteroides fragilís. 
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2.2.1 Resistance to Chloramphenicol 
Chloramphenicol resistance in Bacteroides species is a very rare 
occurrence (Phillips et al., 1981; Martinez -Suarez et al., 1985). 
Of 1,266 isolates examined by Brown and Waatti (1980) only 25 (2%) 
were found to be resistant. Resistance may be due to impermeability 
or to enzymic degradation (Nagai and Mitsuhashi, 1972; Shaw, 1975). 
The molecule can be attacked at a number of different points by 
bacterial enzymes and the degradation products have no antibacterial 
activity. Chloramphenicol nitroreductase inactivates chloramphenicol 
by reducing the p -nitro group at position 6 of the benzene ring 
( Britz and Wilkinson, 1978b; Tally and Malamy, 1984). More 
frequently inactivation of chloramphenicol is due to acetylation by 
chloramphenicol acetyltransferase (CAT) (Britz and Wilkinson, 1978b; 
Britz, 1981; Martinez -Suarez, 1985). This enzyme utilises acetyl - 
coenzyme A as an acyl donor and produces a 3- monoacetoxy derivative 
of chloramphenicol as the major product. 
CAT enzymes have been detected in Bacteroides fragilis and 
Bacteroides uniformis (Britz and Wilkinson, 1978b; Britz, 1981; 
Martinez -Suarez, 1985). They were similar to CAT type II from 
enterobacteria but were nevertheless considered to be distinct. 
Properties of the CAT enzyme from Bacteroides fragilis are outlined 
in Table 1.2. Both the K 
m 
(affinity for chloramphenicol) and 
specific activity were lower than the CAT from Bacteroides uniformis. 
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TABLE 1.2 
Properties of chloramphenicol acetyltransferase from B. fragilis 
(1) pH optimum for assay of 7.8 
(2) Molecular mass of 89,000 daltons 
(3) Acidic protein (binds to DEAE gels) 
(4) Major product is Cm -3- acetate, some Cm -1 acetate 
(5) Stable to heating at 75 °C for 10 min 
(6) Constitutively synthesized 
(7) Specific activity (post heating 70 °C, 10 min): 0.03umol /min /mg 
protein 
(8) Km for Cm about 5uM 
(9) Sensitive to inhibition by DTNB and p- chloromercuribenzoate 
(10) Unstable during storage 
Data of Britz and Wilkinson (1978b) 
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2.3 The Macrolide -Lincosamide Group 
The macrolides are a large group of antibiotics with similar 
properties. They consist of a macrocyclic lactone ring to which 
sugars are attached. Erythromycin is the most widely used. The 
lincosamides are derivatives of lincomycin, an antibiotic isolated 
from a strain of Streptomyces lincolnensis (Lewis et al., 1962). The 
most widely used and most active of these drugs is clindamycin. 
2.3.1 Erythromycin 
The structure of erythromycin is shown in Fig 1.1b. This drug 
has a narrow spectrum of activity being mainly active against Gram - 
positive species. It has, however, some activity against the 
Bacteroides and was in the past recommended with lincomycin as the 
drug of choice for severe infections due to Bacteroides fragilis 
(Finegold et al., 1966; Ingham et al., 1968). Both were, however, 
replaced by clindamycin which was shown to be more active in vitro 
(Ingham et al., 1970; Finegold et al., 1972; Nastro and Finegold, 
1972). 
Erythromycin is primarily bacteriostatic but may be 
bacteriocidal in higher concentrations (Garrod et al., 1981). Its 
mode of action is similar to that of clindamycin. Side effects are 
rare but the usefulness of this antibiotic has been reduced by the 
emergence of bacterial resistance (Sutter et al., 1973). 
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2.3.2 Clindamycin 
Clindamycin was produced by 7- chloro substitution of the 7 (R) 
hydroxyl group of lincomycin and is available as a hydrochloride 
salt, a phosphate or an ester. Clindamycin is a primarily 
bacteriostatic agent which inhibits protein synthesis (Garrod et al., 
1981). It prevents the synthesis of bacterial peptides by 
acting specifically on the 50S sub -unit of the bacterial ribosome, 
possibly affecting the process of peptide chain initiation 
(Cundliffe, 1969; Reuesser, 1975). 
Clindamycin shows excellent activity against most anaerobic 
pathogens (Nastro and Finegold, 1972; Sutter et al., 1973; Sutter 
and Finegold, 1976; Kaye et al., 1980; Snydman et al., 1980; Ohm - 
Smith et al., 1982; Van der Auwera et al., 1987). It has been 
recommended as the drug of choice for treatment of anaerobic 
infections because of its therapeutic efficacy, ease of 
administration and lack of resistance (Tally et al., 1979; Reig 
et al., 1984). The value of clindamycin has, however, been reduced 
by the development of bacterial resistance and the occurrence of 
pseudomembranous colitis in some patients treated with the drug 
(Gorbach and Bartlett, 1974; Finegold, 1977; Finegold 1979). 
2.3.3 Resistance to Clindamycin and Erythromycin 
Resistance to clindamycin can be low level (5 -20 mg /1) or high 
level ( >160 mg /1) (Rahman, 1978; Salakai et al., 1976; Yee et al., 
1982; Guiney et al., 1983), and may be the result of two different 
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mechanisms of resistance in Bacteroides species (Guiney et al., 
1983). 
High level resistance to clindamycin in anaerobic bacteria is 
usually associated with resistance to erythromycin and the 
streptogramins and is known collectively as macrolide, lincosamide, 
streptogramin (MLS) resistance (Privatera et al., 1981; Guiney 
et al., 1983). This type of resistance is mediated by methylation of 
the adenine residues of the 23S ribosomal RNA. The resulting reduced 
affinity between the MLS antibiotic and the 50S ribosomal sub -unit 
prevents binding and protein synthesis is not affected (Lai and 
Weisblum, 1971; Rasmussen et al., 1986). Low level resistance is 
less prevalent among the Bacteroides. Strains exhibiting this type 
of resistance show variable cross -resistance to lincomycin and 
erythromycin (Guiney et al., 1983). 
The first report of clindamycin resistance in the Bacteroides 
fragilis group appeared in 1976 (Salakai et al., 1976). Resistance 
though uncommon a few years ago has been increasing ( Salakai et al., 
1976; Acar et al., 1981). There is wide variation in the literature 
as to the prevalence of resistant strains. Phillips et al. (1981) 
found 2% of Bacteroides strains isolated from clinical material in a 
London hosptial were resistant to clindamycin. Brown and Waatti 
(1980) found 5% of 1,266 isolates in Detroit were resistant. This 
was similar to the 7% resistance observed by Cuchural, et al. (1981) 
in isolates from Boston, but all were much less than the 20% 
resistance observed by Acar et al. (1981) during investigation of 717 
isolates in France. 
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Bacteroides fragilis is known to acquire resistance to 
clindamycin and erythromycin during prolonged treatment or after in 
vitro exposure to these drugs (Soriano, 1981; Soriano et al., 1980). 
Variation may be due to specific epidemiological factors or to local 
usage of the macrolide -lincosamide antibiotics. 
2.4 The Beta -Lactam Antibiotics 
The beta -lactam antibiotics include the penicillins, the 
cephalosporins, the cefamycins and the thienamycins. All contain the 
fused beta -lactam ring system (Fig 1.3a). 
2.4.1 The Penicillins 
Penicillin (Pn) is one of the natural products of the mould 
Penicillium chrysogenum. It is active against select Gram -postive 
and Gram -negative organisms. The nucleus of the penicillin molecule 
is 6- amino -penicillanic acid (Fig 1.3b). Substitution has produced a 
variety of antibiotics which have different properties (Fig 1.3c). 
They are either acid or penicillinase resistant with broad or narrow 
spectra of antimicrobial activity. All penicillins are bacteriocidal 
to actively growing cells. They inhibit the transpeptidase step in 
cell -wall peptidoglycan synthesis (Garrod et al., 1981). 
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(a) The beta lactam ring 
(b) 6- amino -penicillanic acid 
(c) Penicillin G 
(d) 7- aminocephalosporanic acid 
Figure 1.3 
O H 
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Relationship of the penicillins and cephalosporins to the beta -lactam 
ring.R represents substituents. 
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2.4.2 The Cephalosporins 
The cephalosporins are synthetic derivatives of cephalosporin C, 
an antibiotic produced by the mould Cephalosporium acremonium. The 
basic nucleus is 7- aminocephalosporanic acid (Fig 1.3d) (Garrod 
et al., 1981). It consists of a dehydrothiazolidine ring fused with 
a four -membered beta -lactam ring. Modification of the nucleus by 
substitution at a number of places can affect the antibacterial 
activity and pharmacological properties of these compounds (Fig 1.4a) 
(Neu, 1981). 
All cephalosporins are bacteriocidal with a broad spectrum of 
activity. They inhibit cell -wall synthesis in Gram -positive cocci 
and Gram -negative bacilli by a mechanism similar to that of the 
penicllins. 
2.4.3 Classification of the Cephalosporins 
Cephalosporins for human clinical use are sub -divided into five 
groups on the basis of the method of administration and beta- 
lactamase resistance (Fig 1.5). Cefuroxime (CXM) and cefotaxime 
((HR745) CTX) are both broad spectrum cephalosporins active against a 
wide range of Gram positive and Gram negative organisms. While both 
are resistant to beta -lactamase, cefuroxime, a 'second generation' 
cephalosporin, is less resistant than cefotaxime a 'third generation' 
cephalosporin (O'Callaghan et al., 1976; King et al., 1980; Jones 
and Thornsberry, 1982; Neu, 1982). Both have a methoxyaminoside 
group (Fig 1.6). 
*More recent classifications take account of the anti -pseudomonas 
activity of these antimicrobial agents. 
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COOH 
a Basic nucleus of the cephalosporins (cephem nucleus) with R 
(representing substituents) at positions in which major 
modifications are possible. Substitutions at position 3 and /or 
the acyl side chain alter antibacterial and pharmacological 
properties. Substitutions at or near position 7 affect 




b Structure of the cefamycins (cephem nucleus). 
COOH 
c Structure of the thienamycins (carbapenem nucleus). 
Figure 1.4 












beta -lactamase beta -lactamase 
sensitive resistant 
Figure 1.5 
Classification of cephalosporins for human clinical use (O'Callaghan, 
1979). 
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Structures of selected cephalosporins 
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2.4.4 The Cefamycins 
The cefamycins are derivatives of the naturally occurring 
cefamycin C. They are alpha -methoxy cephalosporins which have a 
methoxy group substituted at position 7 of the beta -lactam ring (Fig 
1.4b). Cefoxitin (CFX), cefotetan (CTN) and moxalactam (MOX) (Fig 
1.7) are all semi -synthetic cefamycins with broad spectrum activity, 
favourable pharmacokinetic properties and are resistant to beta - 
lactamases (Darland and Birnbaum, 1977; Fu and Neu, 1981; Ayers 
et al., 1982). Cefotetan is unusual in that tautomeric changes 
produce small amounts of a tautomer with similar antimicrobial 
activity (Iwanami et al., 1980). Moxalactam is unique in that oxygen 
replaces sulphur in the 6- membered ring of the conventional cephem 
nucleus (Fass, 1979). 
2.4.5 The Thienamycins 
The thienamycins are derivatives of thienamycin, a beta -lactam 
antibiotic produced by the soil organism Streptomyces cattleya (Kahan 
et al., 1983). Thienamycin is the first representative of a unique 
and diverse class of naturally occurring and synthetic beta -lactam 
antibiotics, the carbapenems. They differ from the penicillins and 
cephalosporins by the structure of the secondary ring which does not 
contain sulphur and by the presence of a 6- alpha -hydroxyethyl side 
chain and by the presence of unsaturation of the 5- membered ring (Fig 
1.4c). 
N-formimidoyl thienamycin (Imipenem, MK0787) is an amidine 
derivative of thienamycin (Fig 1.8a). Unlike thienamycin it is 
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(b) Imipenem (MK0787) 
Figure 1.8 
Structures of thienamycin and imipenem. 
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chemically stable in concentrated solution (Leanza et al., 1979) and 
stable within the range of pH 6 -8 (Borobio et al., 1985). Its 
antibacterial properties are superior to thienamycin (Kahan et al., 
1983). Both are resistant to beta -lactamases due to the unusual 
trans -conformation of the hydroxyethyl side chain (Cassidy, 1981). 
2.5 Resistance to Beta -Lactam Antibiotics in Gram Negative Bacteria 
The activity of beta -lactam antibiotics against bacterial 
species seems to depend on three main properties: first, the ability 
of the compound to inhibit peptidoglycan synthesis in the cytoplasmic 
membrane; second, its ability to penetrate the permeability barrier 
afforded by the outer membrane of the Gram -negative bacterial 
envelope to reach its target; and third, the compound must be 
resistant to any beta -lactamases produced by the organisms. 
2.5.1 Penicillin Binding Proteins of Bacteroides 
The targets of beta -lactam antibiotics are a number of proteins 
located in the bacterial cytoplasmic membrane. These proteins are 
penicillin- sensitive enzymes which bind penicillin irreversibly to 
the bacterial membranes. They are referred to as penicillin binding 
proteins (PBPs) and their cytoplasmic membrane location indicates 
involvement in the catalysis of the terminal stages of peptidoglycan 
synthesis (Spratt, 1977). 
PBPs have been detected in several genera of both Gram -negative 
and Gram -positive bacteria (Spratt, 1975, 1977; Nolan and 
Hildebrandt, 1979; Zimmerman, 1980; Georgopapadakou et al., 1980, 
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1983). They have been extensively studied in E. coli for which 
essential PBPs have been identified and their functions elucidated 
(Spratt, 1977; Suzuki et al., 1978; Tamura et al., 1980). In 
recent years there have been investigations into the properties of 
PBPs in Bacteroides (Botta et al., 1983; Georgopapadakou et al., 
1983; Otsuki et al., 1983; Piddock and Wise, 1986). 
There is conflicting information in the literature on the number 
of PBPs in Bacteroides and their molecular masses (Georgeopapadakou 
et al., 1983; Otsuki et al., 1983). Piddock and Wise (1986) 
reported the presence of three major PBPs in Bacteroides fragilis, 
PBP 1, 2 and 3. They observed that PBP 1 could be resolved into a 
doublet or triplet. An additional PBP, PBP 4, which was found in 
single isolates of Bacteroides vulgatus, Bacteroides ovatus and 
Bacteroides thetaiotamicron could be detected occasionally in 
Bacteroides fragilis under special conditions. Bacteroides vulgatus 
was also found to have a PBP 5. The molecular masses of the PBPs 
ranged between 38,000 and 82,000 with the highest molecular mass 
being that of PBP 1. 
Botta et al. (1983) detected only 3 PBPs in two clinical 
isolates of Bacteroides fragilis with molecular masses ranging 
between 53,000 and 76,000. De La Rosa et al. (1982) showed that 
changes in the growth state of E. coli cells resulted in modification 
of the PBPs. Differences in methodology may therefore account for 
the discrepancies. Botta et al. (1983) examined cells in the log 
phase while Piddock and Wise (1986) examined cells in the late log to 
early stationary phase. It is also possible that more subtle 
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differences such as growth media, gel composition or oxygen lability 
of PBPs could explain the contradictory results. 
Investigation of the affinities of the PBPs by Piddock and Wise 
(1986) showed that the higher molecular mass PBPs were involved in 
binding at concentrations approximating the minimum inhibitory 
concentrations (MICs). For most compounds the primary target was PBP 
2 followed by PBP 1. Differences in bias shown by the remaining 
compounds were thought to reflect the availability of particular PBPs 
in vivo. 
These workers postulated that for the genus Bacteroides, the 
killing targets for most beta -lactam antibiotics were PBPs 1 and 2. 
A correlation was found between the binding to PBP 1 and the response 
of spheroplasting and lysis. It was therefore deduced that the 
components of PBP 1 were enzymes involved in cell elongation. The 
binding of PBP 2 was correlated with the morphological response of 
filamentation. Piddock and Wise (1986) further deduced that PBP 2 
was involved in septation and PBP 3 in the maintenance of cell shape. 
In addition, compounds that bound to PBP 1 were found to kill more 
rapidly than compounds that bound to PBP 2 and PBP 3. 
Morphological changes in the cells could not be correlated with 
the binding to PBPs 4 and 5. These compounds may be similar to the 
'dispensable' PBPs of E. coli which are non -essential for shape 
maintenance and cell division (Mutahashi et al., 1977). 
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2.5.2 Beta -Lactamase Activity of Bacteroides 
Beta -lactamases are enzymes which hydrolyse the beta -lactam ring 
of beta -lactam antibiotics (Fig 1.9). Several authors have 
established a correlation between the resistance of a number of 
species of Bacteroides to beta -lactam antibiotics and the production 
of beta -lactamases. 
Beta -lactam activity in Bacteroides was first described by 
Garrod (1955). Since then several investigators have reported the 
presence of beta -lactamases in varying percentages of strains of the 
Bacteroides fragilis group. These percentages range from 50 to 95% 
and possibly reflect differences in methodology (Weinrich and Del 
Bene, 1976; Darland and Birnbaum, 1977; Olsson et al., 1977; Gabay 
et al., 1981; Nord and Olsson -Liljequist, 1981; Eley and Greenwood, 
1986). Beta -lactamase activity has also been detected in Bacteroides 
of the melaninogenicus /oralis group (Pinkus et al., 1968; Hackman 
and Wilkins, 1976; Salyers et al., 1977). 
Characterisation of B- lactamases in Bacteroides Species 
The beta -lactamases of Bacteroides are a new class of enzymes. 
They do not fit into the existing classification scheme worked out 
for aerobic Gram -negative rods by Richmond and Sykes (1973) (Olsson 
et al., 1976; Maskell et al., 1984). 
Substrate Profile 
The Bacteroides fragilis group produces more than one type of 




































Beta -lactam hydrolysis of the beta -lactam bond in (a) the penicillin 
molecule to form the biologically inactive penicilloic acid, (b) the 
cephalosporin molecule to form the inactive, unstable cephalosporoic 
acid which gives rise to substrate dependent products (Richmond and 
Sykes, 1973). R and R1 indicate substituents. 
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with a minimal amount of activity against penicillin (Anderson and 
Sykes, 1973; Britz and Wilkinson, 1978; Leung and Williams, 1978; 
Gabay et al., 1981; Timewell et al., 1981b; Maskell et al., 1984). 
However, some enzymes have been shown to be active against the 
cefamycins and thienamycins (Sato et al., 1980; Yotsuji et al., 
1983; Eley and Greenwood, 1986a and b). The beta -lactamase activity 
of the non fragilis group appear to differ from the fragilis group. 
Beta -lactamases of the melaninogenicus /oralis group have 
predominantly penicillinase activity (Murray and Rosenblatt, 1977; 
Salyers et al., 1977; Timewell et al., 1981a). 
Recently, an enzyme with high penicillinase activity was 
described in Bacteroides fragilis (Yotsuji et al., 1983). 
Cell Localisation, Inducibility and Inhibitioñ 
The beta- lactamases of Bacteroides are membrane associated and 
constitutively produced (Olsson et al., 1976; Darland and Birnbaum, 
1977; Britz and Wilkinson, 1978; Sherrill and McCarthy, 1979). 
Their activity is highly dependent upon culture age. Synthesis 
occurs during exponential growth, reaching a maximum in mid -to -late 
log phase. Rapid decline in activity occurs during the stationary 
phase (Olsson et al., 1976; Darland and Birnbaum, 1977; Britz and 
Wilkinson, 1978). 
The enzymes produced by the Bacteroides fragilis group are 
usually susceptible to most of the common inhibitors, cloxacillin, p- 
chloromercuribenzoate, clavulanic acid, sublactam and 6 -B- 
iodopenicillanic acid (Wise et al., 1980; Nord and Olsson- 
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Liljequist, 1981; Smith et al., 1982; Maskell et al., 1984). 
However, enzymes resistant to one or more of these inhibitors have 
been reported (Yotsuji et al., 1983; Eley and Greenwood, 1986a and 
b). Enzymes produced by the melaninogenicus /oralis group are 
inhibited by clavulanic acid but not by cloxacillin or p- 
chloromercuribenzoate (Wust and Wilkins, 1978; Timewell et al., 
1981a). 
Molecular Weights 
Three ranges of molecular masses have been reported for the 
beta -lactamases of Bacteroides fragilis. Values between 20,000 and 
30,000 were reported by Britz and Wilkinson (1978) and Yotsuji et al. 
(1983); between 30,000 and 40,000 by Olsson et al. (1976), Sato 
et al. (1980) and Simpson et al. (1982); and greater than 40,000 by 
Olsson et al. (1976). Timewell et al. (1981) reported molecular 
masses of between 30,000 and 40,000 for Bacteroides bivius and 
Bacteroides asaccharolyticus. 
Isoelectric Focusing 
Beta -lactamases from the Bacteroides focus in the acid range. A 
single pattern of bands consisting of a main band and several 
secondary bands is usually produced. There is evidence that species - 
specific beta -lactamases are produced by the members of the 
Bacteroides fragilis group (Leung and Williams, 1978; Nord and 
Olsson -Liljequist, 1981; Timewell et al., 1981a and b). 
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Most of the beta -lactamases from Bacteroides fragilis produce a 
main band which focuses at an isoelectric point (pI) of 4.9 (Olsson 
et al., 1976; Leung and Williams, 1978; Dornbusch et al., 1980; 
Timewell et al., 1981a; Maskell et al., 1984; Eley and Greenwood, 
1986b). However, pIs between 4.2 and 5.6 have been reported (Olsson 
et al., 1976; Tally et al., 1979; Timewell et al., 1981; Simpson 
et al., 1982; Eley and Greenwood, 1986a and b). Enzymes from the 
remainder of the Bacteroides fragilis group focus between 4.0 and 5.6 
(Leung and Williams, 1978; Tally et al., 1979; Dornbusch et al., 
1980; Olsson -Liljequist et al., 1980; Timewell et al., 1981a; 
Maskell et al., 1984; Eley and Greenwood, 1986a). 
Variation in the reported pIs may be due to the presence of more 
than one type of beta -lactamase (Phillips and Shannon, 1982; Simpson 
et al., 1982), or to different pIs being reported for the same enzyme 
(Phillips and Shannon, 1982). Phillips and Shannon (1982) suggest 
the use of standard enzyme preparations, reference to which should 
standardise results. 
Cell Membrane Permeability Barriers 
Gram -negative bacteria have a complex outer cell envelope with 
pores through which molecules with appropriate charge and shape, 
weighing less than 600 daltons can pass (Fig 1.10). Alterations in 
cell permeability can result in reduced susceptibility to all 
antibiotics which use the hydrophilic pathway to gain access to the 
periplasm (Livermore and Pitt, 1986). Work with permeability mutants 
of Pseudomonas and E. coli has provided direct evidence that the cell 
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Figure 1.10 
Structure of the cell envelope of a typical Gram -negative bacterium. 
(from Hancock and Poxton, 1988) 
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lactam antibiotics from their target enzymes (Richmond et al., 1976; 
Zimmermann and Rosselet, 1977; Zimmermann, 1980; Godfrey et al., 
1984). Indirect evidence on the importance of membrane 
impermeability in the resistance of Bacteroides to beta -lactamase 
antibiotics has been provided by a number of workers (Olsson et al., 
1979; Dornbusch et al., 1980). 
2.6 Difficulties in Integrating Antimicrobial Susceptibility Data 
Presented in the Literature 
The intepretation of data on the MICs of Bacteroides species 
contained in the literature is difficult. There are differences in 
methodology and presentation of results. Table 1.3 shows the MIC for 
50 per cent (MIC50) and 90 per cent (MIC90) of the Bacteroides 
species tested against eleven reference antibiotics. The Bacteroides 
fragilis group includes Bacteroides vulgatus, Bacteroides distasonis, 
Bacteroides ovatus, Bacteroides thetaiotaomicron and Bacteroides 
uniformis. MIC data for species of this group is incomplete. In the 
literature several authors have presented results for Bacteroides 
fragilis and one or more of the other species separately and then 
grouped the rest as the Bacteroides fragilis group. 
The literature values for the achievable serum levels (maximum 
concentration obtainable in serum after normal dosages) of 
antibiotics vary. The concentrations presented in Table 1.3 are 
according to Watt (1979), Rolfe and Finegold (1981) and Queener 
et al. (1986). Despite the fact that the achievable serum level for 
penicillin is 20 mg /1 (Watt, 1979) several authors have interpreted 
MIC values of >2 -4 mg /1 as indicative of resistance to this 
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TABLE 1.3 
The Minimum Inhibitory Concentration1 of Eleven Reference Antibiotics 
to Bacteroides Species. 










Chloramphenicol (16)2 153 <5.3 7.3 
Clindamycin (8) 504 0.26 1.6 
Erythromycin (3) 122 >6.2<12.5 >25.0 
Metronidazole (16) 323 0.67 1.1 
Imipenem (32) 189 0.18 0.60 
Moxalactam (32) 244 1.3 8.8 
Cefoxitin (32) 968 <8.0 <22.9 
Cefotetan (32) 278 7.0 38.0 
Cefotaxime (16) 165 <13.1 <60.9 
Cefuroxime (32) 55 8.0 64.0 
Penicillin G (20) 198 <15.0 <30.1 
1 Results prepared from references cited in the text. 
2 Peak serum levels mg /l. 
*These data should be interpreted with caution as they represent the 
findings of many different workers with non -standardised methods. The 
serum levels indicated by various authors are open to various 
interpretations and the original references should be consulted. 
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TABLE 1.3 (continued) 










Chloramphenicol (16)1 10 6.3 6.3 
Clindamycin (8) 69 1.1 6.6 
Erythromycin (3) ND2. ND ND 
Metronidazole (16) 69 1.0 2.0 
Imipenem (32) 13 0.5 1.0 
Moxalactam (32) 45 25.4 50.8 
Cefoxitin (32) . 85 18.8 38.7 
Cefotetan (32) 47 40.3 >64.0 
Cefotaxime (16) 55 64.0 >128.0 
Cefuroxime (32) 13 64.0 >128.0 
Penicillin G (20) 33 22.6 32.0 
1 Peak serum levels mg /1. 
2 ND = Not determined. 
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TABLE 1.3 (continued) 
(c) Bacteroides distasonis 
Antibiotic 
Number Geometric mean MIC 
of 
Isolates MIC50 MIC90 
(mg /1) (mg /1) 
Chloramphenicol (16)1 ND2 ND ND 
Clindamycin (8) 44 1.0 2.0 
Erythromycin (3) ND ND ND 
Metronidazole (16) 34 0.63 2.0 
Imipenem (32) 19 0.5 2.0 
Moxalactam (32) 33 11.3 64.0 
Cefoxitin (32) 47 20.2 53.8 
Cefotetan (32) 28 32.0 >45.3 
Cefotaxime (16) 23 11.3 64.0 
Cefuroxime (32) ND ND ND 
Penicillin G (20) 14 16.0 2.0 
1 Peak serum levels mg /l. 
2 ND = Not determined. 
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TABLE 1.3 (continued) 
(d) Bacteroides ovatus 
Antibiotic 
Number Geometric mean MIC 
of 
Isolates MIC50 MIC90 
(mg /1) (mg /1) 
Chloramphenicol (16)1 ND2 ND ND 
Clindamycin (8) 20 0.63 1.6 
Erythromycin (3) ND ND ND 
Metronidazole (16) 20 0.25 1.0 
Imipenem (32) ND ND ND 
Moxalactam (32) 19 ND ND 
Cefoxitin (32) 23 20.0 40.0 
Cefotetan (32) 20 >32.0 >32.0 
Cefotaxime (16) 19 64.0 128.0 
Cefuroxime (32) ND ND ND 
Penicillin G (20) 16 ND ND 
1 Peak serum levels mg /1. 
2 ND = Not determined. 
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TABLE 1.3 (continued) 
(e) Bacteroides vulgatus 
Antibiotic 
Number Geometric mean MIC 
of 
Isolates MIC50 MIC90 
(mg /1) (mg /1) 
Chloramphenicol (16)1 ND2 ND ND 
Clindamycin (8) 10 0.008 0.12 
Erythromycin (3) ND 0.12 2.0 
Metronidazole (16) 10 0.12 2.0 
Imipenem (32) ND ND ND 
Moxalactam (32) 11 0.25 0.5 
Cefoxitin (32) 11 0.5 1.0 
Cefotetan (32) 10 0.25 2.0 
Cefotaxime (16) 11 0.12 16.0 
Cefuroxime (32) ND ND ND 
Penicillin G (20) 10 1.0 2.0 
1 Peak serum levels mg /1. 
2 ND = Not determined. 
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TABLE 1.3 (continued) 










Chloramphenicol (16)2 173 <6.0 7.5 
Clindamycin (8) 381 <0.30 1.4 
Erythromycin (3) 34 >4<8 >16<32 
Metronidazole (16) 177 0.45 1.6 
Imipenem (32) 133 0.3 0.88 
Moxalactam (32) 155 2.6 12.8 
Cefoxitin (32) 416 <5.8 20.0 
Cefotetan (32) 70 9.2 >24.7 
Cefotaxime (16) 15 <7.1 48.0 
Cefuroxime (32) 8 20.2 64.0 
Penicillin G (20) 28 <6.5 18.1 
1 Includes ALL species òf this group. 
2 Peak serum levels mg /l. 
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TABLE 1.3 (continued) 










Chloramphenicol (16)1 77 0.95 2.2 
Clindamycin (8) 138 <0.30 0.13 
Erythromycin (3) 9 >0.1<0.5 0.5 
Metronidazole (16) 122 <0.35 1.6 
Imipenem (32) 52 0.03 0.16 
Moxalactam (32) 87 0.5 9.2 
Cefoxitin (32) 153 0.65 4.2 
Cefotetan (32) 73 0.79 2.0 
Cefotaxime (16) 70 0.49 10.1 
Cefuroxime (32) ND2 ND ND 
Penicillin G (20) 39 1.4 22.6 
1 Peak serum levels mg /1. 
2 ND = Not determined. 
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TABLE 1.3 (continued) 
(h) Bacteroides bivius/disiens 
Antibiotic 
Number Geometric mean MIC 
of 
Isolates MIC50 MIC90 
(mg /1) (mg /1) 
Chloramphenicol (16)1 76 1.9 4.0 
Clindamycin (8) 103 0.07 0.08 
Erythromycin (3) ND2 ND ND 
Metronidazole (16) 95 1.3 2.0 
Imipenem (32) 31 0.03 0.06 
Moxalactam (32) 31 2.0 11.3 
Cefoxitin (32) 103 <1.1 <6.6 
Cefotetan (32) 5.6 16.0 
Cefotaxime (16) 42 1.6 11.3 
Cefuroxime (32) ND ND ND 
Penicillin G (20) 57 5.7 <32.0 
1 Peak serum levels mg /l. 
2 ND = Not determined. 
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TABLE 1.3 (continued) 
(i) Bacteroides species 
Antibiotic 
Number Geometric mean MIC 
of 
Isolates MIC50 MIC90 
(mg /1) (mg /1) 
Chloramphenicol (16)1 67 <2.7 >3.7 
Clindamycin (8) 121 <0.21 1.2 
Erythromycin (3) 50 >0.5<1 >2<4 
Metronidazole (16) 60 <0.66 >2.0 
Imipenem (32) 42 0.13 5.1 
Moxalactam (32) 42 1.0 >64 
Cefoxitin (32) 121 <2.7 26.1 
Cefotetan (32) 41 5.0 26.5 
Cefotaxime (16) 30 1.4 256.0 
Cefuroxime (32) ND2 ND ND 
Penicillin G (20) 11 1.0 20.0 
1 
Peak serum levels mg /l. 
2 ND = Not determined. 
*These data were obtained from reports in which Bacteroides species 
were unclassified and did not belong to the groups recorded earlier in 
this table. 
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antibiotic (Brown and Waatti, 1980). In this review resistance to 
penicillin is interpreted as MIC values of >20 mg /1. 
2.7 Comparative Efficacy of Antibiotics Used in the Treatment of 
Bacteroides Infections 
All the non -beta -lactam antibiotics except erythromycin have 
been shown to be active against the Bacteroides (Table 1.3). 
Clindamycin, chloramphenicol, metronidazole and imipenem showed 
consistently high activity against all species. Results in the 
literature indicate that these antibiotics are the most effective of 
all the reference antibiotics for the treatment of Bacteroides 
infections. 
Members of the Bacteroides fragilis group possess intrinsic 
resistance to penicillin (Tally et al., 1979; Acar et al., 1981). 
However, since most beta -lactamase enzymes produced by this group 
have minimal penicillinase activity resistance is possibly due to 
another resistance mechanism. Resistance in Bacteroides of the 
melaninogenicus group (Bacteroides bivius, disiens, intermedius and 
asaccharolyticus) is due in part to the production of penicillinase 
enzymes. Of the reference antibiotics (antibiotics with activity 
against Bacteroides tested during this study) penicillin was the 
least active with this group. 
The newer cephalosporins (of the second and third generation) 
have been reported to have broader spectra of antimicrobial activity 
than the older agents and to be more resistant to hydrolysis by beta - 
lactamases (Fu and Neu, 1978; Jorgensen et al., 1980; Collatz 
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et al., 1984). Despite their greater resistance to the beta - 
lactamases of aerobes,. cefotaxime and cefuroxime are still 
susceptible to the beta -lactamases of the Bacteroides fragilis group 
(O'Callaghan et al., 1976; King et al., 1980; Rolfe and Finegold, 
1981). Relative hydrolysis rates of 58 and 73 per cent for 
cefuroxime and 28 to 54 per cent for cefotaxime have been reported by 
King et al. (1980), Schrinner et al. (1980) and Fu and Neu (1981). 
These rates indicate that cefotaxime should be more active than 
cefuroxime against the Bacteroides fragilis group. The results in 
table 1.3 show that their activities are similar and cefuroxime is 
slightly more active with some species. Resistance to beta -lactamase 
is therefore not the only mechanism of resistance to the 
cephalosporins. 
There is variation in the literature regarding the relative 
activities of the cefamycins. In general the activities of cefoxitin 
and cefotetan are more similar to each other than to that of 
moxalactam. All cefamycins have been shown to be inhibitors of beta - 
lactamase activity (Olsson et al., 1976; Darland and Birnbaum, 
1977). Their activity is therefore independent of inoculum size 
(Fass, 1979; King et al., 1980) and the presence of beta -lactam 
inhibitors (Wise et al., 1982; Piddock and Wise, 1987). 
Moxalactam has been shown to be superior to cefoxitin in beta - 
lactamase inhibition (Fu and Neu, 1981). It has been suggested that 
this may be due to the presence of the carboxyl group at position 10 
(Fig 1.7) since this group appears to confer similar beta -lactamase 
stability and inhibitory activity to carbenicillin (Fu and Neu, 
1981). The increased beta -lactamase inhibition may be responsible 
48 
for the increased activity of moxalactam, as compared to cefoxitin, 
against some species of the Bacteroides fragilis group. 
Cefoxitin shows greater activity against Bacteroides 
thetaiotaomicron than moxalactam. Evidence that this was due to the 
differential susceptibility of, or access to the relevant penicillin 
binding proteins was provided by Eley and Greenwood (1984). Recently 
novel beta -lactamases conferring resistance to the cefamycins have 
been found in Bacteroides fragilis (Cuchural et al., 1983; Yotsuji 
et al., 1983; Eley and Greenwood, 1986b). In most Bacteroides 
strains, however, the likely mechanism of resistance is reduced drug 
uptake or reduced affinity of drugs for the target enzymes. 
Imipenem is the most active beta -lactam drug against 
Bacteroides. Studies have shown it to be resistant to degradation by 
the beta -lactamases of these species (Borobio et al., 1981; Hanslo 
et al., 1981; Richmond, 1981; Rolfe and Finegold, 1981; Tally and 
Jacobus, 1983). There is moderate affinity between the enzymes and 
the drug but no detectable hydrolysis occurs (Labia et al., 1986). 
Imipenem has been shown to be highly efficient at penetrating 
Gram -negative cells (Williams et al., 1986). It may therefore retain 
inhibitory activity against less permeable organisms. Piddock and 
Wise (1986) reported that compounds that bound to PBP 1 kill more 
rapidly than compounds that bound to PBP 2 and 3. They noted that 
beta -lactamase compounds that kill quickly by binding to PBP 1 are 
most effective in antimicrobial susceptibility studies in vitro. 
Imipenem and the cefamycins have been shown to fall into this 
category (Nolan and Jude, 1983; Piddock and Wise, 1986). 
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2.8 Bacteroides Species Variation in Antimicrobial Susceptibility 
Patterns 
Speciation of the Bacteroides fragilis group is necessary before 
determination of the MICs (Rolfe and Finegold, 1981; Eley and 
Greenwood, 1984). Table 1.3 shows that the antibiotic susceptibility 
patterns differ within this group. In general Bacteroides 
thetaiotaomicron and Bacteroides distasonis are the most resistant, 
while Bacteroides vulgatus is the most sensitive. 
The relative activities of the reference antibiotics also differ 
between the species. The overall trends in antimicrobial 
susceptibility for the group as a whole is therefore not necessarily 
representative of the trends within a particular species. Within the 
non -fragilis group there are distinct patterns of antimicrobial 
susceptibility which differ from those of the members of the fragilis 
group. 
D. ANTIBIOTIC RESISTANCE TRANSFER IN BACTEROIDES 
1. Possible Significance of Antibiotic Resistance in Bacteroides 
It has been noted that the genus Bacteroides may represent a 
significant repository of clinically important plasmids (Stiffler 
et al., 1974; Guiney and Davis, 1975; Del Bene et al., 1976; 
Tinnell and Macrina, 1976; Shoemaker and Salyers, 1987). In the 
colon the Bacteroides are in intimate contact with facultative, Gram - 
negative rods such as E. coli, in which the occurrence and importance 
of transferable drug resistance has been well documented (Goebel 
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et al., 1974; Gyles et al., 1974; Macrina et al., 1974; Thayer, 
1979; Takahashi and Nagano, 1984). No function has been established 
for most of the plasmids isolated from Bacteroides and they have 
therefore been classified as cryptic (Stiffler et al., 1974; Tinnell 
and Macrina, 1976; Wallace et al., 1981; Mays et al., 1982; Riley 
and Mee, 1984). Several attempts have been made to correlate the 
presence of plasmids with specific phenotypic properties which may be 
important in the expression of antibiotic resistance and virulence 
(Riley and Mee, 1984; Beul et al., 1985). A correlation has been 
established between antibiotic resistance and plasmid presence in 
Bacteroides. 
1.1 Relationship between Plasmid Presence and Antibiotic Resistance 
in Bacteroides 
The existence of Bacteroides plasmid -borne resistance to the 
macrolide -lincosamide group of antibiotics has been demonstrated. 
Tally et al. (1979, 1982) isolated a 25.6MDa plasmid designated 
pBFTM10 from Bacteroides fragilis TMP10 which conferred resistance to 
clindamycin and erythromycin. A plasmid designated pCPI which is 
similar to pBFTM10 was isolated by Guiney et al. (1984). Smith and 
Macrina (1984) isolated a 51.3MDa plasmid, pBI136 from Bacteroides 
fragilis IB106; and Rotimi et al. (1981) isolated a 46MDa plasmid 
from a strain of Bacteroides fragilis (M2178). All conferred 
resistance to clindamycin and erythromycin. 
Plasmad- mediated resistance to the M -L antibiotics has been 




plasmid designated pBF4 (also called pIP410) isolated from 
Bacteroides fragilis V479 -1 by Welch et al. (1979) confers resistance 
to clindamycin, erythromycin and tetracycline (Privatera et al., 
1979; Welch and Macrina, 1981; Shoemaker et al., 1985). Rotimi 
et al. (1981) also isolated from a Bacteroides fragilis strain (M490) 
a plasmid of between 46 and 62MDa which conferred resistance to 
erythromycin, tetracycline and chloramphenicol. In addition, these 
authors (Rotimi et al., 1981) isolated a 38MDa plasmid which 
conferred resistance solely to tetracycline from a Bacteroides 
fragilis strain (W3139), and a 46MDa plasmid which conferred 
resistance to tetracycline and chloramphenicol from a strain of 
Bacteroides thetaíotaomicron (C4/3). 
2. Methods of Antibiotic Resistance Transfer in Bacteroides 
It is quite common for plasmids carrying genetic information to 
confer conjugal donor ability on the cells in which they reside 
(Tinnell and Macrina, 1976). This low frequency transfer is not 
impeded by anaerobic conditions and may be intrageneric or 
intergeneric (Stallions and Curtiss III, 1972; Guiney and Davis, 
1978). The genetic basis for the spread of antibiotic resistance in 
Bacteroides species is not well understood. It is the subject of 
much current investigation. Antibiotic resistance transfer has been 
demonstrated in Bacteroides and can be plasmid or non -plasmid 
associated. 
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2.1 Plasmid- Associated Transfer of Antibiotic Resistance in 
Bacteroides 
Plasmid- associated transfer has been demonstrated by several 
groups of workers (Mancini and Behme, 1977; Privatera et al., 1979; 
Tally et al., 1979, 1982; Welch et al., 1979; Young and Mayer, 
1979; Rotimi et al., 1981; Welch and Macrina, 1981; Smith and 
Macrina, 1984; Martinez- Suarez, 1985). The process has been 
investigated. 
2.1.1 Mechanism of Transfer 
Genetic information can be transferred between bacteria by 
conjugation, transduction or transformation. The transfer process 
was insensitive to DNAase and this rules out transformation as the 
mode of genetic exchange. Donor cell filtrates or chloroform- treated 
donor cell supernatants were not able to mediate resistance transfer 
so that a transduction mechanism is unlikely. In addition, close 
cell -to -cell contact appeared to be necessary (Privatera et al., 
1979; Tally et al., 1979, 1982; Welch et al., 1979; Rotimi et al., 
1981). These observations have led to the conclusion that the 
process of transfer is by conjugation. 
Successful transfers were obtained by the use of filter mating 
techniques (Welch et al., 1979; Tally et al., 1979; Rotimi et al., 
1981), by the mixing of broth cultures on agar surfaces (Privatera 
et al., 1979), or by centrifugation techniques (Rotimi et al., 1981). 
Rotimi et al. (1981) were unable to demonstrate transfer in simple 
mixed liquid cultures. They argued that the formation of stable 
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mating pairs may require external support which would be necessary if 
the sex pili were particularly fragile or if conjugation required an 
alteration of the cell surfaces. 
2.1.2 Frequency of Transfer 
The frequency of transfer per donor cell varied between 10 -2 and 
10 -9. Welch et al. (1979) observed greatly increased frequency of 
transfer in intraspecies matings as compared with interspecies 
mating. Similar results were obtained by Rotimi et al. (1981). 
Welch et al. (1979) concluded that this indicated the existence of a 
host restriction - modification system in Bacteroides. This could be 
the factor responsible for the failure of Rotimi et al. (1981) to 
transfer resistance plasmids from Bacteroides fragilis to Bacteroides 
melaninogenicus and Bacteroides asaccharolyticus. 
However, Tally et al. (1979) noted that only certain 
transcipients were able to transfer at high frequency. They observed 
a similar variation in transfer frequencies (between 10 -2 and 10 -9) 
during plasmid transfer between strains of Bacteroides fragilis. A 
possible explanation is the postulate of Welch et al. (1979) that 
there may be interstrain differences in surface receptors needed for 
plasmid transmission or differences in the ability of plasmids to 
replicate or be expressed in a given host strain. 
2.1.3 Plasmid Characterisation 
Four self -transmissible conjugative plasmids which confer MLS 
resistance in Bacteroides have been extensively studied (Welch and 
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Macrina, 1981; Tally et al., 1982; Guiney et al., 1984; Smith, 
1985). Restriction endonuclease mapping of pBF4 (also called pIP410) 
and pBFTM10 have localised the MLS resistance determinant (MLSr) to a 
3.8 and 4.0Kb EcoRl -D fragment respectively. DNA homology studies 
using Southern blots have demonstrated homology between these 
fragments as well as the 4.0Kb EcoRI -B fragment of pCP1 (plasmid 
similar to pBFTM10) implicated in clindamycin resistance (Welch and 
Macrina, 1981; Shimell et al., 1982; Tally et al., 1982; Guiney 
et al., 1984). 
The MLSr determinants on these plasmids hybridise with a 10.1Kb 
segment of pBI136. However, significant differences occur in the 
size and restriction enzymes recognition sites as well as the genetic 
properties .of this segment (Smith, 1985). The homologous sequences 
on pBI136 are found on a 7.2Kb EcoRI -C and a 2.9 EcoRI -G fragment. 
Neither of these fragments express tetracycline resistance when 
cloned into E. coli as has been demonstrated with the EcoRI -D 
fragment from pBF4 and the EcoRI -B fragment from pCP1 (Guiney et al., 
1984; Smith, 1985). 
The region of pBI136 implicated in MLS resistance resides on an 
8.4Kb fragment which consists of two directly repeated sequences 
(DRS) of 1.2Kó and an intervening sequence of 6.0Kó (Smith, 1985). A 
DRS has been shown to flank both sides of the MLS resistance 
determinant of pBF4 and pBFTM10 (Shimell et al., 1982; Guiney 
et al., 1984). This DRS is a 0.5 -1Kb segment of DNA and has been 
shown to be common to all four plasmids (Smith, 1985; Rasmussen 
et al., 1987). The plasmids vary in size and restriction 
endonuclease cleavage pattern. With the exception of the MLSr 
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determinants they bear no detectable homology (Shimell et al., 1982; 
Marsh et al., 1983; Guiney et al., 1984; Smith, 1985). 
The Host Range of Antibiotic Resistance Plasmids 
Early work with resistance plasmids in Bacteroides indicated 
that the conjugative host range was limited to the Bacteroides 
fragílis group (Del Bene et al., 1976; Privatera et al., 1979; 
Welch et al., 1979). The work of Anderson (1979) presented evidence 
that inhibition of conjugation of E. coli with Bacteroides was due to 
the suppression of growth of E. coli in mixed culture. Three groups 
of workers reported plasmid- mediated transfer of antibiotic 
resistance from Bacteroides to E. coli (Mancini and Behme, 1977; 
Young and Mayer, 1979; Rotimi et al., 1981) but the plasmids 
remained uncharacterised. (The report of Guiney and Davis [1979] on 
Bacteroídes to E. coli plasmid transfer is no longer relevant as 
Bacteroides ochraceus has been renamed Capnocytophaga ochraceus.) 
Similarly, successful transfer of antibiotic resistance from E. coli 
to Bacteroides had been reported by Burt and Woods (1976). Heat 
treatment of the anaerobes by these workers was thought to have 
inhibited restriction systems and allowed tranfer but the genetic 
elements involved were not identified. 
However, more recent work has shown that the MLSr determinant 
and the flanking DR sequences on pBF4, pBFTM10 and pBI136 undergo 
transposition in both E. coli and Bacteroides species. They have 
been designated transposons Tn4351, Tn4400 and Tn4551 respectively 
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(Robillard et al., 1985; Shoemaker et al., 1985; Smith and Spiegel, 
1987). Tn4351 has been the most extensively studied. 
Rasmussen et al. (1986) investigated the nucleotide sequence of 
the MLSr gene of Tn4351 which they designated ermF. They 
demonstrated similarities between the amino acid composition from 
this gene and those of erm genes isolated from six Gram -positive 
bacteria. These results supported the hypothesis that resistance 
mechanisms in pathogenic bacteria may have originated in antibiotic - 
producing microorganisms (Walker and Walker, 1970; Benveniste and 
Davies, 1973). 
The DR sequences which flank the MLSr genes of Tn4351 and Tn4400 
have been shown to be insertion sequences (Robillard et al., 1985; 
Ras et al., 1987). Evidence that the same is true for the DRS of 
Tn4551 has been presented by Smith and Spiegel (1987). The upstream 
insertion sequence of ermF which promotes transposition of Tn4351 in 
E. coli has been designated IS4351 (Rasmussen et al., 1987). The 
moles percentages G + C content of IS4351 was shown by these workers 
to be similar to that of Bacteroides chromosomal DNA. In addition, 
they found copies of this sequence in the chromosome of a strain of 
Bacteroides fragilis. DNA homology has been demonstrated between 
IS4351 and the DR sequences of Tn4400 and Tn4451 (Shimell et al., 
1982; Smith and Gonda, 1985). These results led to the postulate by 
Rasmussen et al. (1987) that the insertion sequences of the three 
transposons are of Bacteroides origin, similarity being due to the 
widespread dissemination of a single element on Bacteroides plasmids. 
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2.1.5 Expression of Antibiotic Resistance Phenotypes 
Several groups of workers have shown that antibiotic resistance 
genes which confer resistance on Bacteroides species do not confer 
resistance on E. coli and vice versa. The CcrErmr determinants from 
the MLS resistance plasmids pBF4 and pBFTM10 are not conferred to 
susceptible strains of E. coli. In addition, a tetracycline 
resistance determinant designated *Tcr which resides on these 
plasmids is expressed in E. coli but not in Bacteroides (Guiney 
et al., 1984; Robillard et al., 1985; Shoemaker et al., 1985; 
Shoemaker et al., 1986). To date there are no known antibiotic 
resistance determinants which are expressed in both E. coli and 
Bacteroides species. 
The evidence suggests that these phenotypic differences are due 
to differences in plasmid replication and gene expressiön. Broad 
host range IncP and IncQ plasmids from E. coli were shown to be 
unable to replicate in Bacteroides. Similarly, naturally occurring 
Bacteroides plasmids were unable to replicate in E. coli (Guiney 
et al., 1984; Shoemaker et al., 1985, 1986a, 1986b). A relationship 
between gene expression and growth conditions was established by 
Guiney et al. (1984). They showed that expression of the *Tc 
determinant was dependent upon growth in the presence of oxygen. 
2.2 Non -Plasmid Associated Transfer of Antibiotic Resistance in 
Bacteroides 
r 
Non -plasmid associated transfer of clindamycin and tetracycline 
resistance has been reported in Bacteroides (Macrina et al., 1981; 
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Mays et al., 1982). Resistance was transferred from a strain of 
Bacteroides fragilis (V503), which had a 3.7Md plasmid (pVA503), to a 
plasmidless strain of Bacteroides uniformis (V528). The clindamycin 
resistance determinant of the conjugative plasmid pBF4 shared 
homology with pVA503. However, the transfer of drug resistance 
seemed independent of the transfer of pVA503. Transfer occurred by a 
conjugation -like process and the location of the determinants may be 
chromosomal. Non -plasmid -mediated transfer of resistance to 
clindamycin and tetracycline was also reported by Guiney et al. 
(1983). Homology was demonstrated between a 4.8Md EcoRI fragment of 
pBF4 and the whole -cell DNA of the transfer proficient Bacteroides 
fragilis strain. Transfer of tetracycline resistance in the absence 
of plasmid DNA was reported by Privatera et al. (1981) and Rashtchian 
et al. (1982). 
Several attempts to demonstrate transferable resistance to beta - 
lactam antibiotics have proved unsuccessful (Anderson and Sykes, 
1973; Del Bene et al., 1979; Olsson -Liljequist et al., 1980). 
However, Rashtchian et al. (1982) successfully transferred cefoxitin 
resistance from a multiple plasmid- containing strain of Bacteroides 
thetaiotamicron to other Bacteroides strains from the Bacteroides 
fragilis group. Plasmid DNA was not detected in all cefoxitin- 
resistant transconjugants. This indicates a non -plasmid transfer 
mechanism or the presence of an episomé which may integrate into the 
chromosome. 
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E. Virulence Mechanisms in Bacteroides 
The ability of a pathogen to establish itself in a host is 
dependent on it overcoming the natural defence mechanisms of the host 
which would prevent colonization and multiplication. The attachment 
of bacteria to mucosal epithelial cells is a prerequisite for the 
establishment of indigenous flora as well as pathogens. Pilus -like 
threads and capsular polysaccharide have been implicated in the 
Bacteroides (Onderdonk et al., 1977; Babb and Cummins, 1978; Burt 
et al., 1978; Woo et al., 1979; Lambe et al., 1984; Riley and Mee, 
1984; Patrick et al., 1986). 
Capsules have been associated with the virulence of a number of 
bacteria (Robbins et al., 1980). The capsule of some members of the 
Bacteroides fragilis group has been identified as a possible 
virulence factor. Several groups of workers have demonstrated 
increased resistance to phagocytosis and opsonophagocytic killing by 
neutrophils in encapsulated strains of Bacteroides fragilis (Connolly 
et al., 1984; Riley and Mee, 1984; Patrick et al., 1984). 
The capsular polysaccharide of Bacteroides fragilis has been 
shown to potentiate abscess production ( Ohderdonk et al., 1977) while 
that of Bacteroides thetaiotaomicron has been shown to confer 
resistance to a strain -specific phage (Burt et al., 1978). An 
unidentified component of the outer membrane of the Bacteroides 
fragilis group is known to inhibit the chemotaxis of 
polymorphonuclear neutrophils towards the bacterial cells (Adamu and 
Sperry, 1981). Inhibition of phagocytosis has similarly been 
demonstrated in the melaninogenicus /oralis and asaccharolytic groups 
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(Ingham et al., 1978, 1981; Okuda and Takazoe, 1973; Socransky and 
Gibbons, 1965; Sundquist et al., 1979). 
Pathogenic bacteria may produce enzymes that are able to cleave 
plasma proteins involved in the host defences (Muller and Werner, 
1970; Werner and Muller, 1971; Carlsson et al., 1984; Sundquist 
et al., 1985). They may also release substances which cause 
consumption of serum complement (Sundquist et al., 1984, 1985). 
Sundquist et al. (1985) provided evidence that these mechanisms were 
responsible for the observed inhibition of phagocytosis. They also 
demonstrated degradation of host plasma protein inhibitors which may 
be active against bacterial cells; and the degradation of haem- 
binding plasma proteins to products which may support microbial 
growth. The production of catalase and superoxidedismutase, 
observed by Gregory et al. (1977) and Wilkins et al. (1978), may 




ISOLATION AND IDENTIFICATION OF BACTEROIDES FOR 
THE ESTABLISHMENTT OF A BACTEROIDES CULTURE COLLECTION 
INTRODUCTION 
The acquisition of strains of Bacteroides was a prerequisite for 
subsequent investigations. Strains were collected from several 
sites. These included the female genital tract, blood cultures and 
wound infections. All strains were positively identified as 
Bacteroides. 
There have been numerous reports describing the normal flora of 
the female genital tract (Bartlett et al., 1977; Brown, 1982; 
Duerden, 1980; Gorbach et al., 1973; Hill et al., 1985; Larsen and 
Galask, 1982; Lindler et al., 1978; Ohm and Galask, 1975; Osborne 
et al., 1979; Watt et al., 1981). The microflora of the cervix was 
investigated with the aim of drawing general conclusions on the 
distribution of Bacteroides species while providing strains for 
further study. The Anatube Type II anaerobic transport system 
(developed in Belgium) was assessed for efficiency of transportation 
of anaerobic samples. 
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MATERIALS AND METHODS 
Source of Strains 
Bacterial strains were obtained from numerous sources. Strains 
designated MW were clinical isolates of Bacteroides supplied by Dr 
Brian Watt of the City Hospital, Edinburgh. MH strains were isolated 
from specimens processed by the diagnostic laboratories of the Royal 
Infirmary of Edinburgh. They were mainly from vaginal swabs (both 
high and low) with a small proportion from wound infections and blood 
cultures. NCTC strains were obtained from the National Collection of 
Type Cultures, Colindale Avenue, London. Strains designated MPRL 
were obtained from the culture collection of the Microbial 
Pathogenicity Research Laboratory of the Bacteriology Department, 
University of Edinburgh. MG strains were isolated from the cervix. 
Isolation of Bacterial Strains from the Cervix 
Samples were collected from the cervix of women attending the 
colposcopy clinic at the Elsie Inglis Hospital in Edinburgh. The 
women were undergoing examination as a result of abnormal cervical 
smears. They had no record of infection although in some cases there 
were signs of inflammation. All sampling was done at the time of 
speculum examination with the aid of a colposcope directed 
microscope. The surface investigated was the transformation zone 
between the endo and ecto cervix. No contact was made with other 
surfaces. The Anatube Type II system for the collection and 
transportation of anaerobic samples was used (Figs 2.1 and 2.2). All 
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Swabs were expressed in 1 ml pre- reduced diluent (saline or 
nutrient broth). Serial 10 -fold dilutions (0.1 ml) up to 10 -9 were 
spread -plated on to non -selective agar (combined blood agar as 
outlined for identification tests) and on Bacteroides selective agar 
(combined blood agar with kanamycin 75 mg /1 and vancomycin 2.5 mg /1). 
Plating was in triplicate with one set for aerobic and another for 
anaerobic incubation. Aerobic plates were incubated in air at 37 °C 
for 48 h. Anaerobic plates were incubated in an anaerobic atmosphere 
(as for identification tests) for five days. 
After incubation the number of colonies was counted and colonies 
representative of each colony type were picked from both aerobic and 
anaerobic plates. They were sub -cultured on blood agar. Gram 
staining reaction, cell morphology and colony morphology were noted. 
Strains were initially stored on blood agar with weekly sub -culture 
to maintain viability. They were later stored at -70 °C (as explained 
for culture methods). 
Characterisation of Bacterial Strains 
All bacterial strains were Gram -stained and tested for their 
ability to grow aerobically on blood agar (BA). Anaerobic, Gram - 
negative rods were characterised by the method of Brown et al. 
(1988). 
Growth Media 
Liquid media were of two types, a modification of Robertson's 
cooked meat broth [(CMB) Cruickshank, 1968, modified by Watt, 1973)] 
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and proteose peptone yeast extract medium (PPY). The PPY contained 
2% proteose peptone, 1% yeast extract and 0.5% sodium chloride. It 
was supplemented with final concentrations of haemin 5 mg /1, 
menadione 1 mg /1, cysteine hydrochloride 0.075% (w /v) and sodium 
carbonate 0.04% [(w /v) Deacon et al., 1978]. 
All solid media were prepared with Columbia agar base (Oxoid). 
Blood agar contained 5% outdated human blood or horse blood. Lysed 
blood agar (LBA) contained 5% saponin lysed blood, while combined 
blood agar (CBA) contained 4% whole blood and 1% freeze -thawed lysed 
blood. It was supplemented with menadione to a final concentration 
of 1 mg /l. Egg yolk agar (EYA) contained 0.25% sodium succinate, 
0.25% yeast extract and 5% (v /v) egg yolk emulsion. It was 
supplemented with menadione and haemin to final concentrations of 1 
g/1 and 5 mg /1 respectively (Duerden et al., 1976). Solid media for 
tolerance tests were prepared in the same way as EYA with the egg 
yolk being replaced with dye solution or rehydrated bile of the 
required concentration. 
Culture Methods 
Stock cultures were prepared by the modified method of White and 
Sands (1985). Strains were grown in 8 - 10 ml PPY for 24 - 72 h and 
the cells pelleted by centrifugation at 4000 g for 20 min in a bench 
centrifuge. Cells were resuspended in 1 ml pre- reduced PPY 
containing 10% (v /v) glycerol. The suspension was then used to coat 
sterile glass beads in cryogenic tubes with excess fluid being 
removed and discarded. Culture- coated beads were stored at -70 °C. 
Before sub -culture cryogenic tubes were removed and placed in a 
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paraffin block which had also been stored at -70 °C (to prevent 
thawing of unrequired beads). Individual beads were then aseptically 
removed as required into pre- reduced broth media while the paraffin 
block and beads for continued storage were returned to -70 °C storage 
facility. 
For identification tests the inoculum was a single bead. This 
was sub -cultured directly into 20 ml PPY or in the case of more 
fastidious strains, into 1 ml CMB which then served as the inoculum 
for the 20 ml PPY. Broth cultures were incubated for 24 - 48 h or 
until there was visible growth. Cultures of fast -growing strains 
that gave very turbid growth after 24 h incubation were diluted 1:10 
in PPY before use. Incubation was at 37 °C in an atmosphere of H2 90% 
and CO2 10% in anaerobic jars (Collee et al., 1972) or of H2 10%, CO2 
10% and 80% in an anaerobic cabinet (Forma Systems Anaerobic Work 
Station). 
Identification Tests 
Identification was in two stages. Preliminary tests (Table 2.1) 
separated isolates into one of four groups, the Bacteroides fragilis 
group, the Bacteroides melaninogenícus /oralis group, the 
asaccharolytic Bacteroides and the Fusobacterium /Leptotrichia 
buccalis group. This was followed by secondary tests (Table 2.2) to 
determine the species of each strain. Gas - liquid chromatography was 
used in the identification of Fusobacterium strains and where 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Secondary Tests for the Identification of Anaerobic Gram -negative Rods 
Bacteroides Bacteroides Asaccharolytic Fusobacterium/ 
fragilis melaninogenicus / Bacteroides Leptotrichia 
group oralis group group buccalis group 
Indole Indole Indole Indole 
Aesculin Aesculin Aesculin 
hydrolysis hydrolysis hydrolysis 
Carbohydrate 
fermentation 
Pigment Pigment Pigment 
Sucrose Gelatinase 
Rhamnose Carbohydrate Nitrate Carbohydrate 
fermentation reduction fermentation 
Trehalose Lactose Urease Glucose 






1 Method of Brown et al. (1988) 
Gas -liquid Chromatography = GLC 
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Tests were performed in broth (tube tests) as well as on solid 
media (plate tests). Plate tests included antibiotic resistance 
tests, tolerance tests, pigment production and lipase production. In 
all cases the inoculum for these tests was 0.03 ml of PPY culture or 
dilution in PPY. This was spread over the surface of the plate or 
streaked out as required. 
Tube tests were performed in Wasserman (WR) tubes (75 mm x 12 
mm) containing 100 pl of appropriate liquid substrate, or a charcoal 
gelatin disk in CMB. The inoculum was 1 ml of culture or diluted 
culture. These tests included carbohydrate fermentation, nitrate 
reduction, urease production, gelatinase production and aesculin 
hydrolysis. The final concentration of substrates were as follows: 
fermentation tests, 1% (w /v) substrate; aesculin hydrolysis, 0.2% 
(w /v) aesculin; nitrate reduction, 200 mg /1 potassium nitrate; 
urease production, 1% (w /v) urea. 
Antibiotic Resistance Tests 
Resistance to three antibiotics was tested by the disk -diffusion 
method. Disks containing neomycin 1000 ug, kanamycin 1000 ug and 
penicillin 2 international units were added to strains spread on to 
blood agar. After incubation the diameters of zones of inhibition 
were measured. Strains were considered sensitive if the zone 




The ability of strains to produce black or brown pigmented 
colonies was investigated on LBA and CBA. Streaked cultures were 
examined after incubation for 2 days with observations repeated daily 
for up to 7 days. 
Lipase Production 
Lipase production was tested on EYA. Strains were streaked out 
and examined daily up to four days for the formation of an 
irridescent layer around the colonies and development of restricted 
opacity in the medium. 
Nitrate Reduction 
The reduction of nitrate to nitrite was tested in the presence 
of potassium nitrate. Nitrite was detected by the production of a 
deep red colour on the addition of 0.25 ml of Nitrate Solution A and 
0.25 ml of Nitrate Solution B (Sutter and Finegold, 1975). 
Urease Production 
Urease activity in the presence of urea was detected by an 
indicator (0.1% bromothymol blue pH 7.0) colour change. The raising 
of the pH by ammonia, the end -product of urea metabolism, resulted 
in a colour change from green to blue. 
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Gelatinase Production 
The production of gelatinase was tested by the digestion of a 
charcoal -gelatin disk in CMB (Duerden et al., 1976). Incubation was 
for up to 2 weeks with observations at 1, 2, 7 and 14 days. 
Aesculin Hydrolysis 
Aesculin hydrolysis was tested in the presence of 0.2% aesculin. 
After incubation, a black discoloration in the presence of 0.25 ml of 
a 1% w/v aqueous solution of ferric ammonium citrate indicated 
hydrolysis. 
Tolerance Tests 
Each strain was streaked on to a series of three plates 
containing (i) no dye or bile salts (control), (ii) sodium 
taurocholate 0.5 %, (iii) gentian violet 1 in 100,000. After 
incubation growth in the presence of the bile salts and sodium 
taurocholate was compared with growth on the control plate. Growth 
was considered inhibited if it was less than that on the control 
plate,(as determined by visual inspection). 
Bile Stimulation 
Growth in PPY containing 1% (w /v) glucose (PPYG) was compared 
with growth in the presence of PPYG containing 2% (v /v) ox -bile. 
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Indole Production 
Indole production was tested in PPY broth culture (1 ml) that 
was transferred to a sterile WR tube at the time of inoculation of 
the other identification tests. The presence of indole was detected 
by the development of a pink colour after extraction into toluene 
(0.25 ml, with shaking) and addition of Ehrlich's Reagent (0.25 ml). 
Carbohydrate Fermentation 
Growth in the presence of carbohydrates was compared to that of 
growth in a carbohydrate -free control. Culture turbidity was 
recorded on a scale of trace (growth just visible) and 1 to 4. 
Increases or decreases in turbidity relative to the control were 
noted as a possible indication of fermentation.* 0.1% bromothymol 
blue indicator (pH 7) was used to determine acid production due to 
fermentation. The test was considered positive for fermentation when 
the colour of the indicator remained dark green in the control but 
turned yellow in the carbohydrate- containing culture. Where 
equivocal results were obtained the pH was read with a meter. 
Fermentation was considered positive if the pH of the test 
carbohydrate was > 0.5 pH units below the carbohydrate -free control 
culture. 
Gas -Liquid Chromatography (GLC) 
The fatty acid end products of metabolism of selected strains 
were analysed on a Supelco SP1220 (15 %) and H3PO4 (1%) on 100 - 120 
mesh Chromosorb 101 in 1.5 m x 4 mm i/d glass columns in a Pye Unicam 
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*Caution: The pH change was regarded as the important measurement. 
104 chromatograph fitted with dual FID detectors. The operating 
conditions were: oven temperature, 148 °C isothermal; carrier gas 
(Oxygen Free Nitrogen) 35 ml /min; hydrogen, 35 ml /min; compressed 
air, 525 ml /min; attenuation 5 x 102. 
Samples for analysis were prepared by the modified method of 
Deacon et al. (1978). Broth cultures (2 ml) in 1% glucose.(w /v) in 
PPY (PPYG) were acidified with five drops (0.15 ml) of 50% (v /v) 
sulphuric acid and centrifuged at 1900 g for 15 min. The supernatant 
was decanted and stored at 4 °C in Bijou bottles. 
Acidified supernatant was used directly in the case of volatile 
fatty acids. Non -volatile fatty acids were first converted to their 
volatile methyl esters. Methanol (2 ml) and 50% (v /v) sulphuric acid 
(0.4 ml) were added to acidified supernatant (1 ml) and the mixture 
left to stand overnight at room temperature. Distilled water (1 ml) 
and chloroform (0.5 ml) were added and the contents of the tube mixed 
by inversion. The lower chloroform layer was used for analysis. 
Before use the column was 'cleared' with water for the analysis 
of the volatile fatty acids and with chloroform for the analysis of 
the non -volatile fatty acids. Sterile acidified PPYG was passed 
through the column to enable correction of peak heights of the test 
samples. Combined acid standards were used to establish peak heights 
and relative retention times of fatty acids within the column: 0.01 
M acetic, propionic, isobutyric, n- butyric, ísovaleric, n- valeric, 
isocaproic and n- caproic acids for the volatile fatty acids, and the 
methyl esters of 0.04 M lactic, and 0.01 M succinic and phenylacetic 
acids for the non -volatile fatty acids. 
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Test samples were loaded and run for 10 min to obtain volatile 
fatty acid profiles, and 20 min for non -volatile fatty acid profiles. 
All loading was by injection of 1 )11 quantities from a 5 ul (SGE) 
syringe. Identification of peaks corresponding to the different 
acids was made by measurement of the relative retention times using 
the formula: 
Peak height Peak height of 
Acid of test - PPYG control Concentration of 






A total of 151 organisms collected from the various sources were 
identified to species level (Appendix 1). The distribution of the 
strains between the three Bacteroides groups is summarised in Table 
2.3. 
Isolation of Organisms from the Cervix 
The micro -organisms recovered from individual cervical samples 
are shown in Table 2.4. The total count varied from 103 to 108 
organisms per sample. All samples contained mixed populations of 
aerobic and anaerobic micro -organisms with the percentage of 
anaerobes varying from less than one per cent to greater than ninety 
nine per cent. Wide variation in the presence of anaerobic Gram - 
negative rods was also observed. They were present in 21 of 25 
patients (84 %) and were absent from four (16%). When present they 
accounted for more than fifteen per cent of the total flora in 
thirteen patients (61.9%) and as less than ten percent of the total 
flora in eight patients (38.1%). 
Most of the cervical isolates were not identified to species 
level. A large number of slow -growing strains were lost during 
subculture and storage. Of twenty nine isolates identified to the 
species level, seven belonged to the B. fragilis group, three to the 
B. melaninogenicus /oralis group, and sixteen to the asaccharolytic 
Bacteroides. Three of the strains belonged to the genus 
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TABLE 2.3 








B. fragilis group 88 58.2 
B. fragilis species 57 37.7 
Other B. fragilis species 31 20.5 
B. melaninogenicus /oralis group 41 27.2 
Asaccharolytic group 22 14.6 
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TABLE 2.4 
















1 1.6 x 104 2.0 x 103 11.1 - 
2 0.4 x 104 1.4 x 10 97.4 
3 9.7 x 105 1.1 x 106 99.1 33.0 
4 1.6 x 105 4.2 x 102 96.3 19.3 
5 1.2 x 103 0.9 x 103 0.1 
6 7.2 x 103 0.1 x 105 1.5 <1.0 
7 9.5 x 102 3.9 x 10 96.5 78.9 
8 9.1 x 10 3.4 x 10 
6 
4.4 
9 1.2 x 107 4.4 x 106 27.8 15.0 
10 3.4 x 105 6.3 x 108 99.9 15.2 
11 2.9 x 103 6.3 x 105 99.6 2.3 
12 5.9 x 105 5.2 x 106 89.8 28.9 
13 2.0 x 106 7.8 x 107 97.5 22.2 
14 <10 3.0 x 103 99.9 2.2 
16 1.1 x 103 8.1 x 104 98.7 <1.0 
17 8.9 x 105 4.0 x 106 81.9 49.9 
18 2.7 x 107 9.5 x 107 78.0 5.9 
19 6.3 x 103 1.3 x 108 99.9 99.2 
20 5.0 x 106 7.7 x 107 93.9 86.5 
21 6.0 x 103 1.2 x 108 99.9 20.0 
22 2.0 x 106 1.9 x 108 99.0 86.4 
23 1.6 x 102 8.4 x 106 99.9 <1.0 
24 3.2 x 104 8.7 x 107 2.7 - 
25 1.3 x 107 9.3 x 107 87.6 53.1 
*The counts represent the number of bacteria recovered from a swab 
expressed into lml pre- reduced diluent (see page 66). 
79 
Fusobacterium. Members of the B. fragilis group were isolated from 




Early studies of the genital tract led to Doderleins concept 
that the vaginal flora was essentially homogeneous and consisted 
mainly of lactobacilli. This theory remained widely accepted until 
the 1970's despite the isolation of anaerobes from the genital tract 
as early as the 1920's (Harris and Brown, 1929). The increased 
understanding of the complexity of this flora has been facilitated by 
the application of improved techniques for the isolation and 
identification of obligately anaerobic bacteria. 
A major problem in the recovery of anaerobic bacteria has been 
improper collection and transporation of specimens. Many fastidious 
organisms are extremely sensitive to oxygen and exposure to air 
should therefore be minimised. Transport media should maintain both 
aerobic and anaerobic organisms. It should be non -selective, non - 
bactericidal and have a low redox potential and minimal 
susceptibility to oxidation (Syed et al., 1972). This requirement 
for an ideal system has led to the development of commercial 
transport systems (Chow et al., 1975). 
The Belgian anaerobic transport system under evaluation was 
found to be efficient for the transportation of samples. The 
percentage of identifiable cultures of strict anaerobes was in some 
cases up to 99 %, indicating good survival conditions. This system 
has been used in a large scale study of the anaerobic flora of the 
oral cavity of sheep in which excellent results are also being 
obtained (McCourtie and Poxton, personal communication). 
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The microbial population of the female genital tract is 
dependent on the hormonal, anatomical, physiological and 
immunological status of individuals (Bartlett et al., 1977; Brown, 
1982; Golperud et al., 1976; Larsen, 1982; Thadepalli et al., 
1978). It is impossible to state precise figures for the prevalence 
of any organism in the genital tract due to differences in 
methodology, of the reports in the literature. 
The majority of investigations reported in the literature have 
concentrated on the microflora of the vagina. Differences in anatomy 
and physiology of the cervix and vagina result in distinctive 
microbial populations (Bartlett et al., 1978; Hill et al., 1985). 
The flora of the cervix is known to be complex with several species 
of varying oxygen tolerance (Golperud et al., 1976; Gorbach et al., 
1973; Ohm and Galask, 1975; Thadepalli et al., 1978). This 
investigation has confirmed the multibacterial nature of the 
microflora of the endocervix. 
Anaerobes form a significant proportion of the endogenous flora 
of the cervix (Gorbach et al., 1973; Ohm and Galask, 1975). 
Variation in their percentage composition, such as that observed 
within this study, has been shown to exist between individuals as 
well as within individuals sampled over a period of time (Golperud 
et al., 1976; Gorbach et al., 1973; Ohm and Galask, 1975). Gorbach 
et al. (1973) found mixed aerobic and anaerobic flora in 70% of 
individuals with Bacteroides being present in 57%. Sanders et al. 
found Bacteroides in 65% of healthy women. Ohm and Galask (1975) 
found anaerobic Gram -negative rods in 29% of women while 86% of their 
total sample population had mixed aerobic and anaerobic flora. All 
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patients examined during this study had mixed flora and 84% had 
strains of anaerobic, Gram -negative rods. 
Despite the loss of anaerobes before the completion of 
identification procedures it was possible to infer that the majority 
of Bacteroides strains isolated from the cervix were not from the 
B. fragilis group. B. fragilis itself is only rarely isolated from 
the genital tract of healthy women (Bartlett et al., 1977, 1978; 
Larson, 1982; Levison et al., 1976; Duerden 1980). In this study 
it was isolated from only one individual. This patient was not 
recorded as showing signs of inflammation. 
The percentage of B. fragilis group isolates from the cervix was 
found to be 17% and four per cent, respectively, by Gorbach et al. 
(1973) and Ohm et al. (1975). The results of this study (12%) are 
the A number of women carry 
non -identifiable Bacteroides species in the vagina (Hill et al., 
1980). Similar strains were isolated from the cervix. Fusobacterium 
strains, in agreement with the results of other workers, were 
isolated much less frequently than Bacteroides strains (Bartlett 
et al., 1977; Hill et al., 1985; Levison et al., 1977). 
The final Bacteroides culture collection was composed of strains 
from all three Bacteroides groups. This was considered appropriate 
for representative studies of the genus. 
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CHAPTER 3 
PLASMID DNA ANALYSIS OF BACTEROIDES SPECIES 
INTRODUCTION 
The presence of plasmids in bacteroides is well established. 
However, because of the pathogenic role of B. fragilis, work has been 
centred around an examination of the fragilis group strains (Guiney 
and Davis, 1975; Rotami et al., 1981; 
et al., 1979; Young and Mayer, 1979). 
Wallace et al., 1981; Welch 
To our knowledge there is no 
published data on the incidence of plasmids in Bacteroides of the 
melaninogenicus /oralis and asaccharolytic groups. The aims of this 
study were firstly, the development of a plasmid isolation technique 
suitable for Bacteroides species and secondly; the determination of 
the incidence of plasmids in strains representative of the three 
Bacteroides groups. 
(a) Development of a Method for the Isolation and Visualisation of 
Plasmids in Bacteroides species. 
The ideal method was required to be fast and simple (as large 
numbers of strains were to be screened), producing accurate and 
reproducible results. Several methods were considered but as 
resistance to digestion by lysozyme has been reported for B. fragilis 
cells (Werner, 1981) methods involving lysozyme were initially 
avoided. 
The Method of Kado and Lui (1981) 
The method of Kado and Lui [(1981) Fig 3.1)] was first 
attempted. This method was developed for the isolation of plasmids 
from several aerobic and facultatively anaerobic 
species, including 
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3 ml 0/N broth culture 
(OD 0.8 at 600 nm) 
Pellet cells at 
5,700 rpm, 4 °C, 7 min 
Resuspend in 1 ml buffer E 
(40 mM Tris -acetate, 2 mM sodium 
EDTA pH 7.9 with glacial acetic acid) 
[100 ml 0/N broth culture]* 
[2,500 g, 20 min room 
temperature] 
Add 2 ml of lysing solution 
(3% SDS and 50 mM Tris pH 12.6) 
and mix by gentle agitation 
Heat 50 - 65 °C, [60 °C, 5 min] 
20 min 
Emulsify lysate with 2 volumes phenol - 
chloroform solution 
(1 : 1 v /v) 
Break emulsion 
6,000 rpm, 15 min 4 °C temperature] 
[2,500 g, 30 min room 
25 ul upper aqueous phase + 10 ul 
tracking dye (0.25% bromocresol purple 
in 50% glycerol - 0.05 M Tris- acetate 
(pH 7.9) 
I 
Horizontal gel (0.7% agarose) [70 V, 24 h] 
12 u /cm - 2 h 




The plasmid isolation technique of Kado and Lui (1981) 
Modifications made to the technique during this study 
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E. coli. Modifications (shown in parenthesis) were made to the 
published procedure. 
The total volume of culture (3 ml) was found to be insufficient 
and was increased to 100 ml. Available Sorvall tubes were not phenol 
resistant therefore, centrifugation was in a bench centrifuge with 
modifications in the gravitational force, time and temperature of the 
run. 
The conditions for lysis covered a wide temperature range (50 - 
65 °C for 20 min). The effect of different temperatures and times on 
the isolation of DNA from bacteroides was investigated. In the 
absence of plasmid- containing strains the effect of variation on the 
chromosomal DNA of an oral strain of Bacteroides (isolated from the 
gums of a healthy individual) was investigated. The procedure was 
conducted at four temperatures (50, 55, 60 and 65 °C) with four time 
intervals (5, 10, 15 and 20 min) at each temperature. 
It was found that at 65 °C the chromosomal DNA bands obtained 
were very faint or absent. At 60 °C the chromosomal bands were 
clearly visible but faint after a period of 20 mins. At 55 and 50 °C 
the chromosomal bands were present but decreased in intensity with 
increasing time. It was decided that lysis should be at 60 °C for 5 
min. 
The plasmid profiles of 10 Bacteroides fragilis group strains 
(clinical isolates from the diagnostic laboratories of 
the Royal 
Infirmary of Edinburgh), designated Ti to T10 were 
investigated. 
Viscous lysates were obtained from some of the 
cultures, while with 
others, cell suspensions remained turbid 
and lysis appeared to be 
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minimal. Plasmids were not observed in any of the strains and DNA 
from cultures with viscous lysates appeared as streaks in the gel. 
It was decided that the method of Kado and Lui (1981) was unsuitable 
for the isolation of plasmids from bacteroides. However due to the 
simplicity of the technique and the lysozyme -free method of lysis it 
was decided that the closely related plasmid isolation technique of 
Plazinski et al. (1983) should be the next investigated. 
The Method of Plazinski et al., (1983) 
The method of Plazinski et al. (1983) was a modification of that 
of Kado and Lui (1981) (Fig 3.2). It included a washing step for the 
bacterial cells and utilised the lysing solution of Kado and Lui 
(1981) with modifications in the lysing procedure. The plasmid 
profiles of the 10 Bacteroides fragilis group strains designated Ti 
to T10 were investigated. 
Plasmids were observed in three of the strains tested (Fig 3.3). 
However viscous lysates were produced by eight strains and as before 
this resulted in streaks of DNA on the gel. The effects of aerobic 
and anaerobic conditions on the method of preparation were 
investigated. Duplicate samples were prepared, one on the bench and 
the other in an anaerobic cabinet (Forma Workstation, Model 1028) but 
no difference was found in the plasmid profile or the quality of 
the 
plasmid preparations. It 
could be done on the bench. 
of Kado and Lui (1981) and 
was concluded that future preparations 
However it was decided that the methods 
Plazinski et al. (1983) though suitable 
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1010 cells from 0/N broth culture 
pellet cells at 5,7000 rpm 
4 °C, 7.min 
Resuspend and wash in 0.5 ml TAE buffer 
[100 ml 0/N broth culture]* 
[2,500 g 20 min, room 
temperature] 
[40 mM Tris, 5 mM 
ETDA disodium salt 
Add 2 ml lysing 
1981) and mix by 
65 °C, 
sodium acetate, 1 mM 
(pH 7.8)] 
solution (Kado and Lui, 
gentle agitation 
1 h then cool at [60 °C, 5 min] 
room temperature, 5 min 
Add, with 
(pH 7.0) 
shaking, 0.25 ml of 2 M Tris 
and 5 ml phenol -chloroform 
solution 1 : 1 v/v 
Centrifuge 7,500 rpm 
15 min, 0 °C 
[3,989 g, 
temperature] 
30 min room 
70 -140 ul upper aqueous phase + 
tracking dye [50% glycerol, 50mM 
Tris acetate (pH 7.8) 0.125% 
bromophenol blue] 
Horizontal gel, 44 V for 1 h then 
120 V, 10 - 12 h, 4 °C 
Stain with ethidium bromide 
(1 ug /ml), 60 min 
Destain in TAE buffer containing 
1 mM MgSO4, 30 min 
[3 ul upper aqueous phase + 
10 ul tracking dye (Kado and 
Lui, 1981] 
[0.7% agarose, 70 V for 24 
hr] 
[Stain in E + Br 0.5 ug /ml 
30 min (Kado and Lui, 1981) 
and observe directly on a 
transilluminator] 
Figure 3.2 
The plasmid isolation technique of Plazinski et al. (1983) 
* 





ure 3.3 Agarose gel (0.7%) showing plasmids isolated from Bacteroides 
by the modified method of Plazinski et al. (1983). 
Electrophoresis was at 70 V for 24 h, at 4 °C. 
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for Gram -negative aerobes and facultative anaerobes, were not very 
suitable for Bacteroides. 
The failure of these methods prompted an examination of methods 
developed specifically for isolation of plasmids for Bacteroides 
species. Despite the use of lysozyme in these methods it was decided 
that they should be attempted. The method of Myers et al. (1976) was 
considered but later rejected as too time -consuming and involved. 
The method of Tinnell and Macrina (1976) was then examined. 
The Method of Tinnell and Macrina (1976) 
This method is outlined in Fig 3.4. Basic modifications were 
considered necessary. Thymidine labelling of the cells was not 
required so the first two steps were omitted. The method required 
was one for simple screening of crude lysates of Bacteroides and 
purification on caesium chloride - ethidium bromide gradients was 
therefore inappropriate. The method of Tinnell and Macrina (1976) 
was combined with that of Guerry et al. (1973), in which lysates 
incubated overnight were cleared of cell debris and a large 
percentage of chromosomal DNA and plasmids subsequently separated on 
sucrose gradients. The sucrose gradients were avoided by treatment 
of the samples by the method of Kado and Lui (1981) after clearing 
of 
the lysates. 
Results and Discussion 
The modified method of Tinnell and Macrina 
(1976) used initially 
for the isolation of plasmids from 
Bacteroides is outlined in 
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Early log phase broth culture 
(OD - 0.2 at 660 nm) 
Add [3H] thymidine to final concentration 
10 u Ci /ml 
Incubate at 37 °C 
Mid log phase broth culture 
[(Final volume 30 ml) absorbance 
at 660 nm " 0.6 - 0.8] 
15,000 g, 4 °C, 15 min 
Suspend in 30 ml TES buffer 
[0.05 M NaC1, 0.05 M Tris and 
0.005 M EDTA pH 8] 
Repeat washing step 
Resuspend in 0.9 ml RES buffer containing 
lysozyme 1 mg /ml and sucrose 100 mg /ml 
0.9 ml of 2% SDS in 0.01 M Tris pH 9 
Add 5 M NaC1 to give final concentration 1 M NaC1 
Store 0/N 4 °C 
Centrifuge 34,000 g, 0 °C, 30 mins 
Caesium chloride - ethidium bromide 
density gradient 
Figure 3.4 
The plasmid isolation technique of Tinnell and Macrina 
(1976) 
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Fig 3.5. Plasmid profiles of the strains were much cleaner than those 
obtained with the previous methods (Fig 3.6). High molecular weight 
plasmids (plasmids running behind the chromosomal band) were observed 
for the first time. It was therefore decided that this method would 
be the one used for plasmid analysis of the strains, with 
improvements made where necessary to increase efficiency. 
(i) Modification in culture volume 
The volume of broth culture was reduced from 100 ml to 50 ml as 
the cleared lysate obtained from this reduced amount was adequate. 
The cell pellet was no longer divided and there was no duplication of 
subsequent steps. 
(ii) Variation of the tracking dye 
Variation of the tracking dye was considered as a possible means 
of increasing the sharpness of the plasmid bands. The effect of the 
bromocresol purple dye (Kado and Lui, 1981) was compared with that of 
bromophenol blue [0.25% bromophenol blue, 0.25% xylene cyanol, 15% 
(Ficoll type 400) in water (Maniatis et al. 1982)]. Samples were run 
in duplicate with 35 pl plasmid solution plus 10 pl of either 
bromocresol purple or bromophenol blue tracking dye. The plasmid 
bands from samples run with bromocresol purple were found to be 
sharper than those run with bromophenol blue. Bromocresol purple was 
therefore retained as the tracking dye. 
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100 ml broth culture 
15,000 g, 4 °C, 15 mins 
Resuspend pellet in 30 ml 
TES buffer (0.05 M NaC1, 0.05 M Tris 
and 0.005 M EDTA pH 8) and wash 
Resuspend pellet in 20 ml TES buffer and 
divide in two. Wash as above and treat 
each pellet separately as outlined below 
Add 0.9 ml TES buffer containing lysozyme 
(1 mg /ml) and sucrose (100 mg /ml) 
37 °C, 35 min then ice, 5 
min 
0.9 ml 2 SDS in 0.01 M Tris pH 9 
5 M NaC1 (0.45 ml) to make 1 M NaC1 
4 °C, overnight 
Centrifuge 17,000 g, 30 min, 4 °C 
35 pl supernatant + 10 pl tracking dye 
(0.25% bromocresol purple in 50% glycerol - 0.05M 
Tris- acetate, pH 7.9) 
Horizontal gel (0.7% agarose) 
40 V, 24 h, 4 °C 
Stain with ethidium bromide 0.5 pg /ml, 30 min 
Transilluminator 
Figure 3.5 
The modified method of Tinnell and Macrina (1976) 
for the isolation 
of plasmids from Bacteroides species. 
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HROMOSOMAL 
DNA 
Figure 3.6 Agarose gel (0.7 %) showing plasmids isolated from Bacteroides 
by the modified method of Tinnell and Macrina (1976). 
Electrophoresis was at 40 V for 24 h, at 4 °C. 
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(iii) Modifications to the staining technique 
The method of staining employed involved the incorporation of 
ethidium bromide into the DNA after separation in the agarose gel 
(Kado and Lui, 1981). However the bands were often faint after 
staining for the recommended time (30 min). Prolonged exposure to 
the ethidium bromide solution (1 - 2 h) slightly improved the 
visibility of the bands but with the added disadvantage of increased 
background haze. It was decided to investigate the staining 
technique of Maniatis et al. (1982) (in which the ethidium bromide 
was incorporated into the gel) and to compare this with the method of 
Kado and Lui (1981). 
Agarose was dissolved in TES buffer ((1,000 ml) by heating on a 
water -bath) and cooled to approximately 55 °C. A filter -sterilised 
solution of ethidium bromide (500 ug /ml) was added (final 
concentration ethidium bromide 1 pg /ml) and two gels poured. Two 
other gels were poured, as before, without ethidium bromide. Gels 
with and without ethidium bromide were loaded with duplicate samples. 
After electrophoresis gels with ethidium bromide were viewed directly 
on the transilluminator while those without ethidium bromide were 
stained as previously described. 
Results 
The results of the comparison of the staining techniques are 
shown in Figs 3.7 and 3.8. There was a marked difference in the 
effectiveness of both techniques. An increased number of DNA bands 
was visible when staining was by the method of Maniatis et al. 
95 
Figures 3.7 - 3.8 
Agarose gels (0.6 %) showing the results of alternative staining 
techniques for the visualization of plasmid DNA isolated from 
Bacteroides species by the modified method of Tinnell and Macrina 
(1976). 
(i) Ethidium bromide added to gel (final concentration 1 
ug /ml) prior to pouring and electrophoresis. 
(ií) Gel stained for 30 min in ethidium bromide solution 
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(1982). This method therefore replaced the method of Kado and Lui 
(1981). 
(iv) Modification of the electrophoresis buffer 
The high ionic concentration of the TES buffer resulted in low 
voltages with very high currents. A current of 80 mA was obtained 
with 40 V and migration distances of plasmids were low after 
electrophoresis for 24 h. Increasing the voltage to 70 V resulted in 
currents in excess of 100 mA and disassociation of the buffer (during 
the 24 h run) with dissolution of the gel in the region of the 
electrodes. Disassociation of the buffer was also observed with 
increased duration of electrophoresis (36 - 48 h) at 40 V. 
Two modifications of the TES buffer were attempted: (i) sodium 
chloride was omitted as it was thought to be necessary only for the 
precipitation of chromosomal DNA; (ii) the buffer was diluted 1 : 2 
(with distilled water) to investigate the need for a high ionic 
concentration of the electrophoresis buffer. In both cases the 
voltage:current ratio decreased but the stability of the high 
molecular weight plasmids was affected (some bands were lost) and 
there was a decrease in the resolution of the bands. 
Tris -acetate buffer [0.04M Tris -acetate, 0.002 M EDTA, pH8.0 
( Maniatis et al. 1982)] and Tris -borate buffer [0.089 M Tris, 0.0089 
M boric acid, 0.0025 M EDTA, pH 8.0 (Myers et al. 1976)] were 
investigated. Low currents were obtainable with high voltages but 
the plasmid bands were diffuse. Excellent results were however 
obtained with the Tris -borate buffer [(TBE) 0.89 M Tris -acid, 0.089 M 
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boric acid, 0.002 M EDTA, pH 8.0) of Maniatis et al. (1982). It 
combined high voltages and low currents and gave good resolution of 
the plasmid bands. The electrophoresis buffer was changed to TBE. 
(v) Variation in Agarose Concentration 
Variation in the agarose concentration of the gels was 
investigated in an attempt to increase the migration distance of the 
plasmids. Due to the low voltages obtainable with the TES buffer and 
the restrictions on running time, it was decided to reduce the 
agarose concentration of the gels from 0.7% to 0.5 %. However the 
lower agarose concentration resulted in a decrease in the resolution 
of the bands. When 0.6% agarose was investigated the migration 
distance of the plasmids was found to have increased without a 
corresponding decrease in the sharpness of the bands. 
After the change of buffer from TES to TBE, 1% gels 
investigated to ensure that large plasmids were not being left in the 
wells (as suggested by artefacts in the wells seen under ultra -violet 
illumination). Large plasmids were not detected but the relative 
mobilities of the plasmids were decreased. The agarose concentration 
was therefore standardised at 0.6%. 
Final Method for the Isolation of Plasmid DNA from Bacteroides 
Species 
The final method for the isolation of plasmid DNA was a 
modification of the method of Tinnell and Macrina (1976) (Fig 3.9). 
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50 ml broth culture 
15,000 g, 4 °C, 15 min 
Resuspend pellet in 50 ml 
TES buffer and wash 
15,000 g, 4 °C, 15 min 
Resuspend pellet in 10 ml 
TES buffer and wash 
15,000.g, 4 °C, 15 min 
Resuspend pellet in 0.9 ml TES buffer 
containing lysozyme 
1 mg /ml and sucrose, 100 mg /ml 
37 °C, 35 min then ice, 5 
min 
0.9 ml 2 SDS in 0.01 M Tris pH 9.0 
5 M NaC1 (0.43 ml) to make 1 M 
4 °C, overnight 
Centrifuge 17,000 g, 30 min, 4 °C 
35 ul supernatant + 10 ul tracking dye 
Run on horizontal gels 
(0.6% agarose with 
ethidium bromide 1 ug /ml) 




Final plasmid isolation technique - the modified method 
of Tinnell and Macrina (1976) for the isolation of plasmids from 
Bacteroides species. 
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(i) Preparation of crude lysates containing plasmid DNA 
Cells were grown anaerobically in 50 ml of PPY at 37 °C (18 - 
48 h) to an OD at 600 nm of 0.6 - 0.8. They were pelleted by 
centrifugation at 15,000 g, at 4 °C for 15 min. The cell pellet was 
suspended and washed in 30 ml of TES buffer [0.05 MCaC1, 0.05 M Tris 
and 0.5 mM EDTA (ethylenediaminetetraacetic acid, di- sodium), pH 8.0 
(Tinnell and Macrina 1976)]. The washing step was repeated in 10 ml 
of TES buffer and then the cells were suspended in 0.9 ml TES buffer 
containing lysozyme (1 mg /ml) and sucrose (100 mg /ml). They were 
incubated at 37 °C for 35 mins and then cooled in an ice bath for 5 
min. Lysis was effected by the addition of 0.9 ml of 2% SDS in 0.01 
M Tris acetate pH 9.0. After lysis 5 MNaC1 (0.45 ml) was added with 
gentle mixing to give a final concentration of 1 MNaCl. The lysate 
was incubated overnight at 4 °C and then cleared of cell debris and a 
large proportion of chromosomal DNA by centrifugation at 17,000 g, at 
4 °C for 30 min. Aliquots of cleared lysate were stored in sterile 
Eppendorf tubes at -20 °C until required. 
(ii) Visualisation of plasmid DNA 
Plasmid DNA (35 il) from cleared lysates was visualised after 
electrophoresis in 0.6% agarose. Tracking dye (10 ul) consisting of 
0.25% bromocresol purple in glycerol: 0.05 M Tris- acetate (pH 7.9) 
(1:1 v /v) (Kado and Lui, 1981) was added by means of a Gilson pipette 
(with sterile tip) to the DNA sample in a sterile Eppendorf tube. 
The agarose was dissolved in 500 ml Tris- borate (TBE) buffer [(0.089 
M Tris- borate, 0.089 M boric acid, 0.002 M EDTA pH 8.0) Maniatis 
et al, 1982]. Ethidium bromide solution [(500 ug /ml) filter 
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sterilised] was added to the cooled agarose (approximate temperature, 
55 °C) just before pouring of the gels, to give a final ethidium 
bromide concentration of 1 Jig/mi. 
All electrophoresis was performed at 4 °C on horizontal gel 
apparatus (Fig 3.10). The dimensions of the gels were 19 x 20 cm. 
Gels were submerged in TBE buffer with a minimum of excess buffer 
covering the surface and 45 ul of sample (35 ul plasmid DNA solution 
+ 10 ul tracking dye) was loaded into each well. Electrophoresis was 
at 100 V for 10 min (to run the samples into the gel) and then at 75 
V for 20 - 24 h. The gels were then illuminated by a short wave UV 
transilluminator and photographed using Polaroid type 665 film or 
Kodak type 4147 film with a Wratten number 22 filter. 
Storage of Buffers 
All buffers and ethidium bromide stock solution were stored at 
4 °C. The tracking dye was stored at room temperature. Buffers were 
made as concentrated stock solutions (10 x working concentration). 
Immediately before use they were diluted and the pH adjusted as 
required. 
(b) Incidence of Plasmid DNA in Bacteroídes species 
Materials and Methods 
Bacterial strains 
All strains in the Bacteroides culture collection were examined 
with the exception of MPRL 528, MPRL 610 and MPRL 628. 
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Figure 3.10 
Horizontal gel apparatus used for agarose gel electrophoresis of 
plasmid DNA preparations, 
(i) Apparatus assembled for use showing: 
(a) Power pack (Vokham SAE 2761) 
(b) Gel tank 
(c) Gel tray 
(d) Slots for gel combs and spacers 
(e) Gel tank cover 
(ii) Gel comb designed to facilitate alternative method of well 
formation. Teeth at the extreme ends have extensions 
which raise the comb from the gel tray to allow formation 
of the bottom of the wells (modified from Maniatis et al. 
(1982) where teeth were the same length and coverslips 










Horizontal gel apparatus used for agarose gel electrophoresis 
of 
plasmad DNA preparations. 
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Plasmid Isolation and Visualisation 
Plasmids were isolated and visualised by the modified method of 
Tinnell and Macrina (1976). 
Preparation of Purified Plasmid DNA 
Plasmid DNA in cleared cell lysates from 500 -1000 ml broth 
cultures was purified by dye- buoyant density centrifugation by the 
modified method of Clewell and Helinski (1970). Centrifugation was 
performed on a Beckman model L2 -65B ultracentrifuge in an SW -40 
horizontal rotor at 150,000 g and 15 °C for 95 hours or on a Sorvall 
OTD 65B ultracentrifuge in a fixed angle (Kontron 70.38) rotor at 
210,000 g, and 15 °C for 23 hrs. 
Each polyallomer centrifuge tube contained 7.5 g caesium 
chloride, 6 ml of sample in TES buffer (4.5 ml sample + 1.5 ml TES) 
and 1.5 ml of a 1 mg /ml solution of ethidium bromide in TES. When 
smaller tubes were used, all amounts were proportionally reduced. 
The contents of the tubes were overlaid with light mineral oil. 
After centrifugation the lower fluorescent band of these 
gradients was visualised with a long wave ultra -violet source. It 
was removed by side puncture with a needle followed by either 
aspiration into a syringe or by dripping into a clean tube. Ethidium 
bromide was removed by extraction with water saturated butanol. 
Equal volumes of butan -1 -ol saturated with water were added with 
agitation (shaking or vigorous pipetting). The upper, pink, 
alcoholic phase was removed and the extraction repeated until this 
phase remained colourless after agitation. Plasmid DNA (contained in 
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the lower aqueous phase) was dialysed against TES buffer (2 litres) 
overnight with one change in buffer or for 4 - 8 h with two changes 
in buffer. It was then concentrated by precipitation with ethanol 
(modified method of Maniatis et al. 1982). 
Two volumes of ethanol and one tenth of a volume of 2M sodium 
acetate were added to DNA solution in sterile Eppendorf tubes. The 
tubes were centrifuged at 4 °C in an Eppendorf centrifuge (10,000 g). 
The supernatant was discarded and the tubes inverted on a layer of 
absorbent paper until dry. DNA from each tube was resuspended in 10 
ul TES buffer. Purified plasmid DNA samples, for each strain, were 
pooled and stored separately at -20 °C until required. 
Determination of Molecular Mass of Plasmid DNA 
The molecular weight mass of plasmid DNA was determined by the 
relative migration of plasmids in the test strains to plasmids of 
known molecular mass in the standard strains V479 -1 and MH 44 (Fig 
3.11). Migration distances were measured directly, with dividers and 
a ruler, from photographs of the gel. The distance measured was that 
from the bottom of the well to the leading edge of the plasmid bands. 
Determination of Molecular Mass of Plasmids of Standard Strains 
The standard strain B. fragilis V479 was known to have a single 
plasmid of molecular mass 27 MDa (Welch et al., 1979). The molecular 
















Agarose gel (0.6 %) showing the plasmid profiles of the reference 
strains B. fragilis MH44 and B. fragilis V479. Numbers show 
molecular weight of plasmids in MDa. 
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electrophoresis of purified plasmid DNA using an E. coli strain V517 
as a reference strain. V517 was known to contain eight plasmids 
ranging in molecular mass from 1.4 to 32 MDa (Macrina et al., 1978). 
A double logarithmic plot of relative migration (x axis) against the 
molecular mass Mr (y axis) of the plasmids of V517 was made (modified 
method of Myers et al., 1976). The distance migrated by one of the 
plasmids of V517 was arbitrarily selected as 100% migration. A 
straight line plot was obtained from which the molecular masses of 























Typical logarithmic plot obtained for standard strain (B. fragilis 
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RESULTS 
The plasmid profiles of strains in the Bacteroides culture 
collection are shown in Fig 3.13. The incidence of plasmids in each 
group is shown in Tables 3.1 and 3.2, and the incidence in each 
strain is shown in Appendix 2 but there was variation between the 
groups. The B. fragilis group had the widest range, but while the 
melaninogenicus /oralis group had a much smaller percentage of 
plasmad- containing strains than the asaccharolytic group the size 
range of plasmids in this group was more extensive than that of the 
asaccharolytic group. The percentage of plasmid- containing strains 
in the B. fragilis group (60.5%) was much greater than the percentage 
of plasmid- containing strains in the melaninogenicus / oralis and 
asaccharolytic groups, 10.0% and 22.7% respectively. The overall 
size range of plasmids was 1.1 MDa to 108 MDa. 
Most of the plasmids isolated had a molecular mass of <10 MDa 




































































































LE 3.1 The Incidence of Plasffii.ds in Bacteroides Species 
Bacteroides Number of strains Number of strains Size range of 





fragilis (86) 52 (60.5) 42 (48.8) 1.1 - 108 
melaninogenicus/ 4 (10) 1 (2.5) 1.75 - 32 
oralis (40) 
asaccharolytic (22) 5 (22.7) 5 (22.7) 1.7 - 5.7 
1 Number of strains in each group 
2 Percentage of strains 
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TABLE 3.2 The Size Distribution of Plasmids in Bacteroides Species 
Bacteroides 
group 
Percentage of strains with plasmids 
of molecular mass (MDa) 
<10 LO - 20 >20 




7.5 - 2.5 
asaccharolytic (22) 22.7 
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DISCUSSION 
The determination of plasmid distribution in the genus 
Bacteroides was a prerequisite for the identification of plasmid - 
encoded virulence factors. The use of agarose gel electrophoresis 
for the detection and characterisation of bacterial extrachromosomal 
DNA (plasmids) has been well established. The results of this study 
emphasise the advantages of a technique developed specifically for 
the genus of the strains under investigation. Best results were 
obtained after modification of a method developed for Bacteroides 
SPP. The methods of Kado and Lui (1981) and Plazinski et al. (1983), 
though shown to give excellent results with E. coli and agrobacteria 
(S. Amyes and W. McLaughlin, personal communication), were found to 
be unsuitable for the isolation of plasmids from Bacteroides. 
Despite the report of Werner (1981), lysozyme was found to be an 
effective agent in the promotion of lysis in Bacteroides. 
One of the limitations of the agarose gel electrophoresis method 
of detection of plasmid DNA is that it does not permit discrimination 
between open circular (OC) and covalently closed circular (CCC) DNA, 
(Myers et al., 1976). Macrina et al. (1978) reported the 
accumulation of small amounts of open circular molecules after 
prolonged storage at 4 °C or following repeated freezing and thawing 
of the samples. During this study samples were stored at -20 °C. 
Repeated freezing and thawing was avoided as it was found to destroy 
large plasmids. With the increased sensitivity of the staining 
technique OC molecules were recognised as very faint bands which were 
inconsistently present in uncharacterised strains or as additional 
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bands (usually faint) in DNA samples from strains of known plasmid 
content. 
The molecular mass of plasmid DNA can be determined by its 
migration relative to plasmid DNA of known molecular mass (Myers 
et al., 1976). The multiple plasmid containing strain, E. coli V517 
was reported to be a convenient single source of plasmíd DNA of 
varying molecular sizes (Macrina et al., 1978). However the amount 
of plasmid DNA may vary between samples. The developed plasmid 
isolation technique was found to be more efficient at isolating 
plasmids from Bacteroides than from E. colí. The eight plasmids of 
V517 could not be visualised consistently after isolation procedures. 
It was therefore decided that the plasmids of a multiple plasmid- 
containing strain of Bacteroides, MH44, should be calibrated with 
reference to V517 and used with V479 as the standard strains. 
Some of the results of this study confirm those of other 
workers. Most of the plasmid- containing strains had multiple plasmid 
populations (Riley and Mee, 1984; Young and Mayer, 1979) and most 
common plasmid sizes (10 MDa) were in keeping with published results 
(Riley and Mee, 1984; Wallace et al., 1981; Young and Mayer, 1979). 
However the overall size range of plasmids, 1.1 to 108 MDa, was 
greater that that reported in the literature. Plasmids with 
molecular mass of greater than 60 MDa have not previously been 
reported. The percentage of Bacteroides isolates with plasmids was 
greater than that reported in the literature. This may have been due 
to the increased sensitivity of the staining technique. Bands which 
would otherwise have remained undetected were visualised when 
ethidium bromide was incorporated into the gel as opposed to staining 
127 
after electrophoresis. The discrepancy could have resulted from the 
detection of low copy number plasmids which would by other staining 
methods produce very faint or undetectable bands. 
The plasmid incidence of the melaninogenicus /oralis and 
asaccharolytic strains was markedly less than that of the B. Fragilis 
group strains. As the latter group are more often associated with 
infection this may indicate an as yet unestablished role of plasmids 
in the virulence of Bacteroides. 
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CHAPTER 4 
ANTIMICROBIAL SUSCEPTIBILITIES OF BACTEROIDES SPECIES 
INTRODUCTION 
The importance of anaerobes in human clinical infections has 
been increasingly recognised in the last decade. Improved 
methodology has resulted in an increased frequency of isolation from 
infections (Chow and Guze, 1974; Finegold, 1977). Changing 
antibiotic resistance patterns and the development of new drugs have 
necessitated the continual updating of antimicrobial susceptibility 
data. 
The purpose of this study was two -fold. Firstly, it was 
designed to examine the in vitro activity of a wide selection of 
antibiotics against Bacteroides species. Secondly, it sought to 
provide susceptibility data for strains of known plasmid composition 
with the ultimate aim of determining any correlation between the 
plasmid presence and antibiotic susceptibility. 
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MATERIALS AND METHODS 
Test Strains 
All strains in the Bacteroides collection (Appendix 1) were 
tested together with the following reference strains: B. fragilis 
NCTC 9343, NTCC 9344 and NCTC 11870; E. coli NCTC 10418; 
P. aeruginosa NCTC 10662; Staph. aureus (Oxford) NCTC 6571; 
C. perfringens NCTC 8237 (Table 4.1). 
Antimicrobial Agents 
Antimicrobial agents were supplied as standard powders of known 
potency: benzylpenicillin and cefuroxime sodium (Glaxo), cefotaxime 
(claforan) Roussel Laboratories Ltd.), moxalactam [(latamoxef 
disodium) Eli Lilly and Company Ltd.]; cefoxitin sodium and imipenem 
[(N- formimidoyl thienamycin monohydrate) Merck, Sharp and Dohme]; 
cefotetan disodium (Imperial Chemical Industries); chloramphenicol 
(Parke Davis and Company); clindamycin (Upjohn Ltd.); metronidazole 
(May and Baker Ltd.); erythromycin [(erythrocin I.V. lactobionate) 
Abbott Laboratories Ltd.] and nalidixic acid (Sigma Chemical 
Company). 
Preparation of Antibiotic Solutions 
Stock solutions of concentration 12.8 g/1 (metronidazole), 20 g/1 
(erythromycin) and 100 g/1 (all other antibiotics except 
chloramphenicol and nalidixic acid) were prepared by the addition of 
130 








































































Dr Georges Eli Lilly and 
Co., Ltd. 
Personal communication 
P.J. Turner, I.C.I. 
Freeman et al. (1968) 
Eley and Greenwood (1986b) 
1 Eli Lilly and Co Ltd, City Wall House, Basing View, Basingstoke, 
Hampshire. 




Stock solutions of 
prepared in ethanol. 
water to weighed quantities of the antibiotics. 
chloramphenicol, concentration 100 g /l, were 
Nalidixic acid stock solution of concentration 
12.8 g/1 was prepared in 2% NaOH. 
aliquots and stored at -70 °C. 
These solutions were divided into 
Before use the concentrations of the stock solutions were 
verified by broth dilution MIC tests against the reference strains. 
Tests were performed in 76 x 12 mm glass tubes with 1 ml volumes of a 
range of doubling dilutions suitable for each strain and each 
antibiotic solution. The range started three dilutions above the 
accepted MIC for the strain (Table 4.2) and ended three below. 
Aliquots of stock solution were first diluted with sterile distilled 
water or with ethanol (ethanol was used as a diluent for 
chloramphenicol until the final concentration required was less than 
2.5 g /l) to a concentratin of 20 g/1 (excepting metronidazole which 
was at a concentration of 12.8 g /l), and then further diluted in 
distilled water by the modified method of Ericsson and Sherris 
(1979) (Table 4.2) to 100 times the highest concentration required 
for the determination of each MIC. Further dilutions were made in 
Mueller- Hinton broth (Difco Laboratories). An inoculum of one drop 
(0.03 ml) of a 1 in 200 dilution of overnight culture of the 
reference strains was added to each tube. Two control tubes, each 
containing 1 ml Mueller- Hinton broth, were also prepared. The first, 
the growth control, was inoculated with the test strain; the second 
tube, the media control, was included as a sterility check. 
Incubation was anaerobically at 37 °C for 24 h except where reference 





























































































































































































































































































































































































































































































































































































































































































































































































































































































incubated under aerobic conditions. The MIC of each strain was 
recorded as the concentration of antibiotic at which there was no 
visible turbidity. 
Determination of MICs 
MICs of the test strains were determined by an agar dilution 
method (F. Brown, personal communication). The medium used was 
diagnostic sensitivity test agar [(D.S.T.) Oxoid] with nine per cent 
horse blood. Antibiotic solutions were diluted in distilled water to 
100 times the required concentration by the modified method of 
Ericsson and Sherris [(1979) Personal communication, Table 4.2]. To 
90 ml molten agar, cooled to 55 °C, 9 ml of horse blood and 1 ml 
antibiotic solution were added. The inoculum was prepared from 24 h 
PPY cultures of the strains. B. fragilis group strains were diluted 
1 in 100 in pre- reduced PPY while non -B. fragilis group strains were 
diluted 1 in 10. Cultures of test strains which grew poorly and gave 
no visible turbidity were not diluted. 
Reference strains (Table 4.1) were included on each plate as 
controls. Where two strains were available both were used. 
Inoculation was with a multipoint inoculator (Mast Laboratories), the 
inoculum size being ca 0.03 ml. Incubation was at 37 °C for 40 h in 
an anaerobic atmosphere (as previously outlined). Plates containing 
cefotaxime and moxalactam were further incubated overnight at 37 °C in 
an aerobic atmosphere to facilitate growth of the standard strain 
P. aeruginosa NCTC 10662. 
4t (ca 105 organisms) 
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The range of final concentrations tested for each antibiotic 
(mg /1) was: imipenem (0.016 - 8); metronidazole, chloramphenicol 
(0.063 - 32); clindamycin (0.016 - 128); cefoxitin, moxalactam, 
cefotaxime, cefuroxime, cefotetan, penicillin, erythromycin and 
nalidixic acid (0.25 - 128). The MIC for each strain was the 
antibiotic concentration at which there was no visible growth or the 
growth was reduced to a faint haze with no distinct colonies visible. 
The recorded MICs of the test strains were adjusted to take account 
of any discrepancies between the experimental and literature values 
of the MICs of reference strains. 
Additional Tests for Metronidazole Resistant Strains 
Further tests were conducted on metronidazole- resistant strains 
to ensure that they were Bacteroides species. 
Growth under microaerophillic conditions 
The strains were streak -plated on to blood agar plates incubated 
anaerobically at 37 °C for 48 h and at 37 °C for seven days in 10% 
carbon dioxide plus air (CO2 incubator). 
Gas -liquid chromatography 
GLC profiles were obtained for each strain using the method 
outlined in Chapter 2. 
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RESULTS 
All strains from the melaninogenicus /oralis and asaccharolytic 
groups were highly sensitive to chloramphenicol and clindamycin 
(Tables 4.3 and 4.4). The MIC90 for both groups was less than 0.25 
mg /1 for clindamycin and less than 2 mg /1 for chloramphenicol. All 
the B. fragilis group strains were sensitive to chloramphenicol but 
8% were resistant to clindamycin (Table 4.5). Resistance to 
erythromycin was found in all three groups. Of the 
melaninogenicus /oralis and asaccharolytic strains, 2.4% and 4.6% 
respectively were resistant, but the MIC90 for these strains, 1 
mg /1, was a third of the maximum achievable serum level for this 
antibiotic. With the B. fragilis group, however, 87.5% of the 
strains were resistant to erythromycin and the MIC90 was 32 mg /1 
(Table 4.6). 
Metronidazole was active against all three groups of 
Bacteroides. However with three strains, one B. melaninogenicus and 
two B. fragilis strains, the MIC was >16 mg /1 the maximum achievable 
serum level of this antibiotic (Tables 4.3 - 4.5). These strains 
grew on blood agar incubated anaerobically at 37 °C but not on blood 
agar incubated in an atmosphere of 10% carbon dioxide in air. Their 
GLC profiles of short chain fatty acid and products of glucose 
metabolism, and results of a range of phenotypic tests confirmed the 
identities of these isolates. All bacteroides strains examined were 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































TABLE 4.6 Comparative susceptibility of Bacteroides groups to non - 
beta- lactam antimicrobial agents 
Bacteroides Group 
(number of isolates) 




fragilis (88) Metronidazole >1.0<2.0 >2.0 <4.0 
Clindamycin <0.25 1.0 
Chloramphenicol >2.0 <4.0 >2.0 <4.0 
Erythromycin >4.0<8.0 32.0 
melaninogenicus/ 
oralis (41) Metronidazole 
Clindamycin <0.25 <0.25 
Chloramphenicol >0.5<1.0 >1.0<2.0 
Erythromycin >0.25<0.5 >1.0<2.0 
asaccharolytic (22) Metronidazole <0.25 1.0 
Clindamycin <0.25 <0.25 
Chloramphenicol 0.5 >1.0 <2.0 
Erythromycin <0.25 >0.25 <1.0 
* Minimum inhibitory concentration 
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The asaccharolytic Bacteroides were sensitive to all the beta - 
lactam antibiotics except cefotetan to which 4.6% of the strains were 
resistant (Table 4.7). Imipenem, moxalactam, cefoxitin and 
cefotaxime and cefuroxime all showed excellent activity against the 
melaninogenicus /oralis strains. Low levels of resistance, 2.4 %, were 
displayed to penicillin (2.4%) and cefotetan (7.3 %) (Table 4.8, Fig. 
4.1). 
Imipenem was the only beta -lactam antibiotic to which all the 
strains of the B. fragilis group were sensitive (Table 4.9). 
Resistance varied from 1.1% to cefoxitin and moxalactam, to 50.0á to 
penicillin. 
Within the Bacteroides fragilis group there was variation in the 
susceptibility to cefotetan (Table 4.10, Fig. 4.2). The MIC90 for 
the B. fragilis species were less than 32 mg /1, the peak serum level 
for cefotetan, and only 8.8% of the strains were resistant to 
cefotetan concentrations above this level. For the other members of 
the B. fragilis group the MIC90 was between 64 mg /1 and 128 mg /l. 
Resistance to cefotetan was found in 84.2% of these strains. This 
wide variation was not observed with the other cefamycins 
investigated, although the B. fragilis species were more sensitive 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































serum levels (20) 
B.melaninogenicLs/ B. fragilis group 
oralis group : 
0 25 0.5 1.0 2.0 4.0 8:0 16.0 32.0 64.0 2128.0 
Penicillin MIC (mg /1) 20.0 
Figure 4.1 
The susceptibility of Bacteroides to penicillin as determined by 
an agar dilution method. 
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group species 
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Cefotetan MIC (mg/1) 
Figure 4.2 
The susceptibility of the Bacteroides fragilis group to cefotetan as 


























































































































































































































































































































































































































































































































































































































































TABLE 4.10 Comparative susceptibility of the Bacteroides fragilis 
group to the cephamycins. 
(number of isolates) 
Antimicrobial Agent MIC* (mg /1) 
MIC50 MIC90 
Bacteroides fragilis Cefotetan >8.0<16.0 >64.0<128.0 
(88) Tout) 
Cefoxitin >2.0<4.0 >8.0<16.0 
Moxalactam >0.25<0.5 >8.0<16.0 
Bacteroides fragilis Cefotetan <8.0 >16.0<32.0 
(57) 
Cefoxitin >2.0<4.0 >4.0<8.0 
Moxalactam <0.25 >2<4 
Other (31) Cefotetan >32.0 <64.0 >64.0 <128.0 
Cefoxitin >4.0<8.0 >8.0 <16.0 
Moxalactam >2.0 <4.0 >8.0 <16.0 
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DISCUSSION 
The agar dilution method used for this study has been shown to 
give reliable and reproducible results (Sutter et al., 1979). This 
method was selected instead of the disk diffusion method because of 
the number of bacterial strains and antibiotics involved. 
A range of beta -lactam and non -beta -lactam antibiotics was 
chosen in order to give a balanced perspective of the action of 
antimicrobial agents against the bacteroides. Chloramphenicol, 
clindamycin and metronidazole are non -beta - lactam antibiotics known 
to have high activity against Bacteroides species (Brown and Waatti, 
1980; Cuchural et al., 1981; Nastro and Finegold, 1972; Snydman 
et al., 1980; Sutter and Finegold, 1976). Erythromycin was studied 
because its resistance is often associated with resistance to 
clindamycin (Guinea et al., 1983). 
Nalidixic acid is a quinolone antibiotic which is mainly active 
against Gram -negative aerobes (Garrod et al., 1981). Bacteroides 
species are resistant to nalidixic acid due to the impermeability of 
the drug (Watt, 1979). Crumplin and Smith (1981) demonstrated that R 
factors (plasmids) in Escherichia coli may increase the 
susceptibility of their bacterial host strain to the bactericidal 
effects of nalidixic acid. The activity of this antimicrobial agent 
against Bacteroides was studied as no parallel investigation has been 
undertaken with these species. 
The non -B. fragilis groups of Bacteroides are known to be more 
susceptible to antimicrobial agents than the B. fragilis group 
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(Wexler and Finegold, 1987). The results of this study are in 
agreement with these findings. The asaccharolytic group were found 
to be the most sensitive, but due to the varying styles of reporting 
in the literature, it is difficult to make a direct comparison 
(asaccharolytic bacteroides are often grouped with other species as 
in Table 1.3). 
The high activity of chloramphenicol against the Bacteroides was 
expected as resistance to chloramphenicol is very rare (Martinez - 
Suarez et al., 1985; Phillips et al., 1981). Levels of clindamycin 
resistance range from 2 to 20% of all strains reported in the 
literature (Acar et al., 1981; Brown and Waatti, 1980). The results 
of this study are similar to those of Cuchural et al. (1981) who 
found clindamycin resistance in 7% of all strains examined. 
Erythromycin, though mainly active against Gram -positive species, has 
been shown to have some activity against Bacteroides spp. However, 
the emergence of resistant strains has greatly resitricted its use 
(Finegold et al., 1972) and in this study over 80% of B. fragilis 
group isolates were resistant to erythromycin. 
Low level resistance to erythromycin and clindamycin (resistance 
to 5 - 20 mg /1) has been described as less prevalent among 
Bacteroides than high level resistance (resistance to greater than 64 
mg /1) (Guiney et al., 1983). While only one strain displayed low 
level resistance to clindamycin, this type of resistance to 
erythromycin was the only one displayed by the melaninogenicus / 
oralis and asaccharolytic groups of Bacteroides. Among the 
B. fragilis group, of 87.5% of strains resistant to erythromycin, 
62.5% showed low level resistance, 9% high level resistance and 
15.9% 
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resistance between the two. These results indicate a greater 
incidence of low level resistance to erythromycin than previously 
reported. 
Although high level resistance to erythromycin is usually 
accompanied by resistance to clindamycin and the streptogrammins 
(MLS resistance) (Guiney et al., 1983; Privatera et al., 1981) only 
seven of nine strains showing high level resistance to erythromycin 
showed high level resistance to clindamycin. This indicates the 
existence of another mechanism of resistance to erythromycin besides 
MLS resistance. All strains with high level resistance to 
clindamycin showed high level resistance to erythromycin. Low level 
resistance to erythromycin is accompanied by varying levels of 
resistance to clindamycin and the streptogrammins. None of the 
strains resistant to low levels of erythromycin showed cross - 
resistance to clindamycin. 
Despite reports from other countries of resistance to 
metronidazole (Acar et al., 1981; Appelbaum and Chatterton, 1978; 
Chow et al., 1975) such reports are rare within the United Kingdom. 
Apparent resistance in sensitive strains may be due to inoculum size 
or inadequate conditions of anaerobiosis (Rahimi et al., 1974; Tally 
et al., 1978). In the method used in this study, the inoculum size 
was standardised for all the strains and the anaerobic techniques 
were the well established methods of Collee et al. (1972). These 
factors were therefore unlikely to be the reason 
to metronidazole found in three strains. Growth 
an anaerobic atmosphere but not in an atmosphere 
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for the resistance 
of these strains in 
of carbon dioxide 
plus air indicated that the strains were anaerobes, and other tests 
confirmed that they were Bacteroides. 
Within the UK there have been no confirmed reports of resistance 
in non -fragilis groups. Such reports outside the UK appear also to 
lack independent corroboration (Acar et al., 1981). Ingham et al., 
(1978) showed the development of resistance to metronidazole, in a 
strain of B. fragilis following prolonged treatment with this 
antimicrobial agent. All three strains were originally supplied by 
clinicians and while background information is limited it is known 
that the resistant strain B. melaninogenicus MPRL 528 was isolated 
from an undrained brain abscess following metronidazole treatment. 
It is impossible to state whether this resistance is similar to that 
observed by Ingham et al. (1978) as the duration of treatment is 
unknown. 
The effect of penicillin and the cephalosporins against 
Bacteroides is known to be limited and to vary between the groups. 
The B. fragilis group show intrinsic resistance to penicillin (Tally 
et al., 1979; Acar et al., 1981) possibly by a non -beta- lactamase 
mechanism as the beta -lactamases of this group are predominantly 
cephalosporinase in nature (Anderson and Sykes, 1973; Britz and 
Wilkinson, 1978; Timewell et al., 1981b; Maskell et al., 1984). 
High levels of resistance such as that observed in this study have 
been reported by other workers (Tally et al., 1979; Acar et al., 
1981). It is, however, difficult to assess from the literature 
the 
percentage of isolates resistant to penicillin due to differences 
in 
styles of reporting and MIC breakpoint (4 - 20 mg /1) 
(Watt, 1979; 
Brown and Waatti, 1980; Wexler and Finegold, 1987). 
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Sensitivity among the non -fragilis groups has been widely 
reported (Sutter and Finegold, 1976; Finegold, 1977; Watt, 1979) 
but the MIC90 reported in the literature for these strains (Table 
1.3) was higher than that observed in this study (Table 4.3). The 
beta -lactamase enzymes of the non -fragilis groups have mainly 
penicillinase activity and resistance to penicillin has been known to 
occur (Murray and Rosenblatt, 1977; Salyers et al., 1977; Timewell 
et al., 1981a). All asaccharolytic strains examined were sensitive 
to penicillin but a small percentage of the melaninogenicus /oralis 
group were resistant. Resistance by a small proportion of 
melaninogenicus /oralis strains has been similarly observed by Ohm - 
Smith et al. (1982). While all resistant non -fragilis group strains 
were of the B. bivius species, this study did not confirm the results 
of Snyderman et al. (1980) who found that approximately 50% of 
B. bivius and B. disiens strains were resistant to penicillin. 
Darland and Birnbaum (1977) found that more than 50% of 
B. fragilis isolates were resistant to cefuroxime and 20 - 50% of the 
B. fragilis isolates reported in the literature were resistant to 
cefotaxime (Cuchural et al., 1981; Fu and Neu, 1981; Phillips 
et al., 1981; Wexler and Finegold, 1987). Among the non -fragilis 
group 4% resistance to cefotaxime was observed by Wexler et al. 
(1987). The results of this study are low by comparison and no 
significant difference was found in the activity of cefuroxime, a 
second generation cephalosporin and cefotaxime, a third generation 
cephalosporin. This absence of increased activity of 
cefotaxime 
relative to cefuroxime was also shown by Jorgensen 
et al. (1980). 
While this may indicate continued susceptibility 
of the third 
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generation cephalosporins to the beta -lactamase enzymes of the 
B. fragilis group, other factors could also be involved. The 
relative hydrolysis rate of cefotaxime (28 - 54%) is less than that 
of cefuroxime (58 - 75%) (Fu and Neu, 1981; King et al., 1980; 
Schrinner et al., 1980). If beta -lactamase activity was the only 
factor involved then cefotaxime should have been more active than 
cefuroxime. This was shown to be the case with the non -fragilis 
groups - but since the beta -lactamases of these groups have mainly 
penicillinase activity, beta -lactamase resistance may not be the sole 
factor responsible. 
Reports vary on the level of activity of the cefamycins. The 
literature data summarised in Table 1.3 show that the results vary 
both within and between groups. All cefamycins have been shown to be 
inhibitors of beta -lactamse enzymes (Darland and Birnbaum, 1977; 
Fu and Neu, 1981; Grassi et al., 1983). 
Moxalactam has been shown by Fu and Neu (1981) to be superior to 
cefoxitin in beta -lactamase inhibition. This was thought to be due 
to the carboxyl group at position 10 since this group in 
carbenicillin appeared to confer beta -lactamase stability and 
inhibitory activity. 
Investigations have shown that of the three cefamycins examined 
during this study, moxalactam is the most active compound (Clarke and 
Zemcou, 1983; Moosdeen et al;, 1983) although there is some evidence 
that cefoxitin has superior activity against some species of the 
B. fragilis group (Eley and Greenwood, 1984; Ruckdeschel, 1983). 
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The activity of cefotetan was shown in general to be less than that 
of cefoxitin (Clarke and Zemcou, 1983; Watt and Brown, 1985; Werner 
1983) . 
In this study, cefoxitin and moxalactam had identical levels of 
activity while cefotetan was much less active. While only 1.1% of 
the B. fragilis group strains were resistant to cefoxitin and 
moxalactam, 31.8% of these strains were resistant to cefotetan. 
Resistance to cefotetan was also observed among a small percentage of 
the melaninogenicus /oralis and asaccharolytic strains. Reports of 
resistance in non -fragilis groups are rare. The MIC90 of these 
strains reported in the literature is less than 32 mg /1 (Table 1.3). 
However, Watt and Brown (1985) similarly observed resistance in non - 
fragilis strains. 
Variable results of activity of cefotetan in Bacteroides have 
been reported in the literature. Grassi et al. (1983) showed that 
approximately 50% of B. fragilis strains were resistant to cefotetan. 
This is in contrast to the results of Watt and Brown (1985) who 
showed that 90% of B. fragilis strains were inhibited by readily 
available serum concentrations of cefotetan. This discrepancy may be 
due in part to the number of isolates examined. Watt and Brown 
(1985) investigated the susceptibility to cefotetan of 120 strains of 
B. fragilis as opposed to the 11 strains investigated by Grassi 
et al. (1983). 
The bimodal distribution of MICs to cefotetan within the 
B. fragilis groups, reported by Grassi et al. (1983), was not 
observed. The B. fragilis species were found to be far more 
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susceptible than the other members of the group. These results 
confirm those of other workers (Moosdeen et al., 1983; Ruckdeschel, 
1983; Watt and Brown, 1985; Werner, 1983) and re- emphasises the 
need for speciation within the group (Wexler and Finegold, 1987). 
Less than 10% of B. fragilis strains were found to be resistant to 
cefotetan but this species is responsible for more than 60% of all 
anaerobic infections ( Gorbach and Bartlett, 1974 a and b; Mancini 
and Behme, 1977). Despite the fact, therefore, that other 
B. fragilis group strains are resistant to cefotetan, this antibiotic 
can be used effectively in the treatment of bacteroides infections if 
the infecting organisms are B. fragilis and melaninogenicus /oralis 
and asaccharolytic Bacteroides group strains. 
The excellent activity of imipenem (N- formimidoyl thienamycin) 
against Bacteroides spp. is thought to be due to its high resistance 
to beta -lactamase activity (Brown et al., 1981; Hanslo et al., 1981; 
Labia et al., 1986). This antibiotic is not in use in Great Britain 
but was of interest as a prospective therapeutic agent for 
bacteroides infection. These results are in agreement with those of 
other workers and show a high degree of sensitivity even among the 
more resistant B. fragilis group (Hoffler, 1986; Tally and Jacobus, 
1983; Wexler and Finegold, 1987). 
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CHAPTER 5 
CORRELATION STUDIES OF ANTIBIOTIC RESISTANCE, PLASMID PROFILES 
AND OUTER MEMBRANE PROTEIN COMPONENTS OF BACTERIODES 
INTRODUCTION 
Several groups of workers have attempted to correlate the 
presence of plasmids with phenotypic properties important in the 
expression of antibiotic resistance and virulence (Beul et al., 1985; 
Mays et al., 1982; Riley and Mee, 1984; Stiffler et al., 1974; 
Tinnell and Macrina, 1976; Wallace et al., 1981). While most of 
these attempts have failed, a correlation has been established 
between plasmid presence and resistance to the macrolide- lincosamide- 
streptogramin (MLS) antibiotics and to tetracycline. 
Much evidence indicates the existence of a single, high -level 
resistance (resistance to > 64mg /1) determinant to MLS antibiotics 
which is widely disseminated among Bacteroides species (Guiney 
et al., 1984; Privatera et al., 1979; Rotimi et al., 1981; Smith 
and Macrina, 1984; Tally et al., 1979; Welch et al., 1979). This 
study was designed to investigate the relationship of plasmid DNA to 
observed macrolide - licosamide resistance and to determine possible 
homology between a high -level resistance determinant described in the 
literature and the determinants on the DNA of our resistant isolates. 
Cefoxitin has been widely used in the treatment of mixed 
surgical and gynaecological infections as it is active against both 
facultative organisms and strict anaerobes. While some reports show 
that cefoxitin resistant strains of the B. fragilis group appear only 
sporadically and in low frequencies (Cuchural et al., 1983; Olsson 
et al., 1977) other reports show an incidence of cefoxitin resistance 
varying between 8 - 30% (Bieluch et al., 1987; Cuchural et al., 
1984; Tally et al., 1983). Several mechanisms of resistance have 
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been postulated. These include hydrolysis by beta -lactamases 
(Cuchural et al., 1986a, 1986b; Yotsuji et al., 1983) and 
alterations in cell wall structure (Cuchural et al., 1983; Dornbusch 
et al., 1980). 
Piddock and Wise (1987) induced mutation in a sensitive strain 
of B. fragilis, B1 (MIC of 4 mg /1 to cefoxitin) by the use of the 
mutagen N- methyl -N - nitro -N- nitrosoguanidine (NTG). They isolated 
four mutants, B265, B266, B269 (MIC of 16 mg /1 to cefoxitin) and B271 
(MIC of 32 mg /1 to cefoxitin). The mechanism of cefoxitin resistance 
in these five strains as well as a number of naturally occurring 
resistant strains isolated by Dornbusch et al. (1980) and Dr Francis 
Tally (Tufts University School of Medicine, New England Medical 
Centre, Boston, Mass, USA) was investigated. 
A comparison was made of the outer membrane protein (OMP) 
profile of the mutants and parent strains with that of a standard 
strain, B. fragilis NCTC 9343. NCTC 9343 had been previously 
determined by Piddock and Wise (1986) to be identical to B. fragilis 
B1 in penicillin binding protein (PBP) competition assay against 34 
beta -lactam antibiotics. Piddock and Wise (1987) found that the OMP 
profiles of the mutants were identical to that of the parent strain 
and to that of NCTC 9343 and concluded that resistance to cefoxitin 
in these strains was attributable to altered expression of outer 
membrane proteins. 
Correlations were found between changes in the affinity of PBP1 
and PBP2 of three of the mutants (B265, B269 and B271) and decreased 
susceptibility to cefoxitin. The mechanism of resistance in the 
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fourth mutant remained unknown. Differences in the OMP profile of 
NCTC reference strains compared with some of the naturally resistant 
strains were demonstrated. Alterations in relative PBP profiles were 
in some cases also observed. Based on these findings Piddock and 
Wise (1987) postulated that there were two additional mechanisms of 
cefoxitin resistance in bacteroides; alteration in PBP profile and 
alteration in porin proteins. 
The genetic basis of resistance in the strains was not examined. 
Despite the fact that the use of NTG can result in multiple mutations 
(Guerola et al., 1971), in the absence of significant cross - 
resistance to other antibiotics Piddock and Wise (1987) assumed that 
mutation was in a single gene conferring cefoxitin resistance. A 
number of the strains were obtained and the role of plasmid DNA in 
cefoxitin resistance examined. 
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MATERIALS AND METHODS 
(i) Curing of Clindamycin and Erythromycin Resistant Strains 
Bacterial Strains 
Curing of twelve Bacteroides strains resistant to clindamycin 
and /or erythromycin was attempted (Table 5.1 and Fig 5.1). 
Curing Experiments 
Curing experiments were conducted by the modified method 
Rotimi and Duerden (1982) with the curing agent eithidium bromide. 
Determination of subinhibitory concentration of ethidium 
bromide 
The subinhibitory concentration of ethidium bromide was 
determined in a preliminary study using B. fragilis strain V479. The 
number of cells per ml was determined by direct counting of cells 
from overnight cultures using a Thoma ruled cell count chamber with 
0.1 mm depth (Hawksley, England). Bacterial cells (200 - 400) were 
counted and the average number calculated using the formula: 
Number of = Number of cells x dilution x 4 x 106 
cells /ml per square factor 
Seven determinations were made and based on these results a 
standard procedure for the dilution of overnight cultures to a final 
concentration of ca 105 cells /ml was devised. 
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TABLE 5.1 Minimum Inhibitory Concentrations (MIC) of Bacterial Strains 
Resistant to Clindamycin and /or Erythromycin 
Strains 
MIC MIC 
Clindamycin Erythromycin Plasmid 
mg/1 mg/1 
B. fragilis V479 >64 >64 + 
B. fragilis MH2 >64 >64 + 
B. fragilis MH11 16 8 + 
B. fragilis MH12 >64 >64 + 
B. fragilis MH48 <0.25 64 
B. fragilis MH67 0.50 16 
B. fragilis MH68 16 >64 + 
B. uniformis MH29 >64 >64 
B. uniformis MH58 16 >64 
B. uniformis M59 16 >64 









Agarose gel (0.6 %) showing plasmid profile of bacteroides 






Ethidium bromide was added to PPY complete in universal bottles 
to give final concentrations of 8, 16, 20, 24 and 32 mg /1 and the 
media autoclaved at 121 °C for 15 min. Cells of V479 were pelleted 
by centrifugation at 2,500 g for 20 min at room temperature. They 
were washed and resuspended in PBS (pH 7.2) to a final density of ca 
105 organisms /ml. An inoculum of 0.01 ml was added to each bottle 
and also to PPY without ethidium bromide (control). The final volume 
in all cases was 20 ml. Incubation was at 37 °C in an anaerobic 
atmosphere (as previously described). Growth was observed after 24 
and 48 h. The procedure was repeated using filter -sterilised 
ethidium bromide. 
Curing of test strains 
Cells of the test strains were pelleted by centrifugation at 
2,500 g for 20 min at room temperature. They were washed and 
resuspended in PBS (pH 7.2) to a final concentration of ca 105 
organisms /ml. An inoculum of 0.01 ml was added to a universal bottle 
of PPY (control) and PPY containing filter- sterilized ethidium 
bromide 20 mg /l. Incubation was in an anaerobic atmosphere for 5 
days at 37 °C. Serial dilutions of broth culture (0.1 ml) of up to 
10 
-8 
dilution were spread -plated on to blood agar and blood agar 
containing clindamycin 8 mg /1 or erythromycin 8 mg /l. Growth was 
examined after incubation in an anaerobic atmosphere for 40 h at 
37 °C. Curing was determined by a comparison of growth on the 
non- selective (blood agar) and selective (blood agar with antibiotic) 
media. Organisms which grew on the non- selective but not on the 
selective media were considered cured. 
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(ii) DNA Homology Studies 
Bacterial Strains 
Plasmid DNA from E. coli strain V1476 (supplied by Professor 
Francis Macrina, Virgina Commonwealth University) containing the 
pVA1476 plasmid with, the Hind III -Taq I fragment of erm f (the MLS 
resistance determinant of the 27 MDa pBF4 plasmid from strain V479) 
was used as the genetic probe. All bacterial strains resistant to 
clindamycin and erythromycin were investigated. 
Preparation of Purified DNA 
Purified plasmid and chromosomal DNA were prepared by the method 
previously described for the preparation of purified plasmid DNA 
(Chapter 3). Strains without plasmids had only one DNA band and this 
was harvested. Hybridization studies were with plasmid DNA in 
plasmid- containing strains and with chromosomal DNA in plasmid -free 
strains. 
DNA Hybridization 
The BluGENETM Nonradioactive Nucleic Acid Detection System for 
the detection of DNA sequences in Southern -blot hybridization was 
used. The method was that outlined by the Bethesda Research 
Laboratories and involved the following: incorporation of 
biotinylated mucleotide into a DNA probe; hybridization of the 
biotin -labelled DNA probe to nucleic acid target sequences 
immobilized on a nitrocellulose membrane and colorimetric 
determination of the probe- target hybrid with the B1uGENETM 
streptavidin- alkaline phosphatase conjugate and dyes. 
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Transfer of DNA from Agarose Gels to Nitrocellulose Filters 
Purified DNA separated on agarose gels was observed and 
photographed under ultra -violet as outlined in Chapter 3. Each gel 
contained DNA from three test strains plus DNA from B. fragilis V479 
or E. coli V1476 which acted as the positive controls. Transfer to 
nitrocellulose filters was by the modified method of Maniatis et al. 
(1982) (Fig 5.2). The gel was transferred to a glass plate and 
unused areas trimmed away with a sterile scalpel. The plate was 
placed in a shallow plastic tray. DNA was denatured by soaking the 
gel in 0.25 M HC1 for 30 min followed by soaking the gel twice for 30 
min in 1.5 M NaC1 and 0.5 M NaOH. The gel was neutralized by soaking 
twice in several volumes of a solution of 1 M Tris HC1 (pH 8.0) and 
1.5 M NaC1 for 30 min. Denaturation and neutralization were at 4 °C. 
Whatman 3MM filter paper, paper towels and a piece of 
nitrocellulose filter paper were cut to the same dimensions of the 
gel. The nitrocellulose filter was soaked in 2 x SSC buffer 
(Appendix 4) until it was completely wet and layered carefully on top 
of the gel. All air bubbles trapped between the nitrocellulose and 
the gel were removed. A piece of Whatman 3MM paper was moistened and 
placed on top of the nitrocellulose with care again being taken to 
remove all air bubbles. A stack of Whatman 3 MM paper and a stack 
of paper towels was placed on top of them. A glass plate was put on 
top of the stacks and it was weighed down with a 500 g weight (Fig 
5.2). 
The transfer of DNA was allowed to proceed for 24 h and the 
filter then soaked in 6 x SSC at room temperature for 5 min. Excess 
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weight 
1 1--- glass plate 
paper towels 





Method of transfer of DNA from agarose gels to nitrocellulose filter 
paper (modified from Maniatis et al., 1982). 
164 
fluid was allowed to drain and the filter dried at room temperature 
on a sheet of 3MM paper. The dried filter was then placed between 
two sheets of 3MM paper, baked for 2 h at 80 °C under vacuum and then 
stored at room temperature, under vacuum between sheets of 3MM paper, 
until required. 
(iii) Transfer of antibiotic resistance 
Bacterial Strains 
The bacterial strains investigated are shown in Table 5.2. 
Donor strains were B. fragilis V479; B. fragilis MH2; B. fragilis 
MH11 and B. uniformis MH29. Recipient strains were B. fragilis MH 43 
and B. fragilis MH47, E. coli SA6 and E. coli SA128. 
Selective Media 
A combination of two antibiotics, one to which the donor strain 
was resistant and one to which the recipient strain was resistant, 
was used in the selective media. Antibiotic concentrations were as 
follows: penicillin, 32 mg /1; cefotaxime, 32 mg /1; clindamycin and 
erythromycin, 32 mg /l. 
Transfer Experiments 
The mating procedure was the modified method of Rotimi et al., 
(1981). Twenty -four hour PPY cultures (5 ml) of donor and recipient 
strains were mixed and centrifuged at 2,500 g for 20 min at room 
temperature. The supernatant was decanted and 1 ml of prereduced PPY 
was carefully layered on top of the cell pellet. The mixture was 
incubated anaerobically at 37 °C for 24 h and the cell pellet was then 
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Phenotype* Plasmid Size 
(MDal) 
1 
B. fragilis V479 Ccr, Ermr, PENS, CTXs, CXMs 27 
B. fragilis MH2 Ccr, Ermr, CTXS 3.3 
B. fragilis MH11 Ccr, Ermr, CTXS, CXMS 3.2 
B. fragilis MH12 Ccr, Ermr, PENS, CTXS, CXMS 3.3, 1.5 
B. fragilis MH47 CcS, ErmS, PENr, CTXr, CXMr None present 
B. uniformis MH43 CcS, ErmS, PENr, CXMr None present 
E. coli SA6 Erm, MIC, 32 mg/1, Rifr, Amps None present 
E. coli SA128 Erm, MIC, 32 mg/1, Rifr, Amps None present 
1 
Cc - clindamycin 
Erm - erythromycin 
PEN - penicillin 
CTX - cefotaxime 
CXM - cefuroxime 
Rif - rifampicin 
Amp - ampicillin 
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2 s - sensitive to antibiotic 
r - resistant to antibiotic 
resuspended. A sample (0.1 ml) was plated on selective media and 
incubated anaerobically for 24 - 48 h. 
The inability of both donor and recipient strains to grow on the 
selective media was also tested. Broth cultures (10 ml) of donor and 
recipient strains were treated similarly to the mating mixtures and 
included as negative controls. 
Further tests for E. coli strains resistant to Erythromycin 
32mg /1 
E. coli isolates resistant to 32 mg /1 erythromycin were streak - 
plated on to blood agar containing doubling concentrations of 
erythromycin from 32 mg /1 to 512 mg /l. 
(iv) Genetic analysis of cefoxitin resistant strains 
Bacterial Strains 
B. fragilis strains B1, B265, B266, B269 and B271 were the 
parent strain and laboratory induced mutants isolated in the 
laboratories of LJV Piddock and R Wise (Dudley Road Hospital, 
Birmingham, England). B. fragilis NCTC 9343 (designated B108) was 
originally obtained from the National Collection of Type Culture 
(Colindale Road, London). B. fragilis B165 and B. thetaiotaomicron 
B171 were originally supplied by Dr B. Olsson -Liljequist (The 
National Bacteriology Laboratory, Stockholm, Sweden) while 
B. fragilis B264 and B. ovatus B263 were supplied by Dr Francis Tally 
(Tufts University School of Medicine). All strains (Table 5.3) were 
































































































































































































































































































































































































































































































































































































Plasmid Isolation and Detection 
Plasmids were isolated and detected by the modified method of 
Tinnell and Macrina (1976) as outlined in Chapter 2. 
Preparation of Polyacrylamide Gels 
SDS polyacrylamide (10%) slab gels were made with the buffer 
system of Laemmli (1970) as described by Poxton and Brown (1979). 
Table 5.4 shows gel recipe. 
EDTA Extraction of Outer Membrane Proteins 
Broth culture (50 ml) of each test strain was grown as 
previously described. Cells were harvested and washed twice in PAGE 
cell washing buffer [(pH 7.4) Appendix 4] by centrifugation at 10,000 
g for 10 min at 4 °C. The pellet was resuspended in 2 ml of PAGE EDTA 
buffer (Appendix 4) and placed in a 45 °C waterbath for 30 min. The 
cells were placed in an ultrasonic bath (Dawe, Sonicleaner) for 10 
min. The pellet was discarded and the preparation stored at -20° 
until required. 
Sarkosyl Extraction of Outer Membrane Proteins 
Broth culture (50 ml) of each strain was grown in PPY as 
previously described. Cells were harvested and washed once in 50 ml 
PBS (pH 7.2) by centrifugation at 10,000 g, for 10 min at 4 °C. The 
cells were suspended in 5 ml distilled water and disrupted by 
sonication (using a Soniprep 150) at an amplitude of 6 - 10 u. Six 
one -minute bursts with a 30 second rest in between were sufficient to 
give more than 90% breakage. One volume of Sarkosyl was added to 9 
volumes of broken cells and unbroken cells removed by centrifugation 
169 








Distilled water 6.95 3.5 
Double -strength separating 
buffer 
17.5 
Double- strength stacking 
buffer 
- 5.0 
Acrylamide stock solution 8.75 1.0 
(40%) 
TEMED 50 ul 20 ul 
Ammonium persulphate 1.75 0.5 
(15 mg /ml) 
* Percentage acrylamide in gel 
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at 10,000 g for 10 minutes at 4 °C. The supernatant was centrifuged 
at 50,000 g for 1 h at 4 °C to pellet insoluble outer membrane and 
washed once in 5 ml distilled water using a syringe and 26 g needle. 
Storage was at -20 °C until required. 
Protein Estimation (Folin) 
Distilled water (350 ul) was added to protein sample (50 ul) to 
give a final volume of 0.4 ml. Sodium carbonate [12.5% (1.2 ml)] and 
copper sulphate [CuSO4.5H20 (0.1 ml)] were added and the mixture was 
allowed to stand for 1 h at room temperature. Folin reagent was 
diluted 1 in 3 with distilled water and 0.2 ml was added to the 
mixture in each test tube. The contents of each tube were mixed and 
left to stand at room temperature for 25 min. Protein concentration 
was read at 750 mu against a reagent blank of distilled water taken 
through the assay. 
Loading of Samples and Gel Electrophoresis 
Protein solution (20 - 25 ug protein in 50 ul) was mixed with an 
equal volume of double- strength sample buffer (Appendix 4) and the 
protein washed once in 5 ml distilled water by similar 
centrifugation. The protein was denatured by heating for 3 min in a 
boiling water -bath. Samples (100 ul) were loaded into each cell. 
Electrophoresis was at 50 V (ca 25 mA) until samples had entered the 
separating gel (ca 1.5 h) and then at 150 V until samples had run ca 
11 cm (approximately 3 h). The gel was then removed from the 
cassette and stained. 
171 
Staining Procedures for Proteins in Polyacrylamide Gels 
Two staining methods were employed: 
(i) Coomassie blue staining 
Coomassie blue staining was by the method of Poxton and 
Sutherland (1976) using the solutions outlined in Appendix 4. The 
gel was fixed by overnight soaking in solution 1 and stained by 
immersion in solutions 2 - 5 for 1 h each with shaking. 
(ii) Silver staining 
Silver staining was by the modified method of Oakley 
(1980). The gel was fixed by overnight soaking in an aqueous 
solution of ethanol (25% v /v) and acetic acid (10% v /v) and then 
soaked in unbuffered glutaraldehyde (10% v /v) for 30 min. It was 
rinsed in 500 ml.water for 10 min. The rinsing step was repeated and 
in 1,000 ml distilled water for 2 h followed by 
soaking in dithiothreitol (5 mg /ml) for 30 min. 
The gel was drained of dithiothreitol solution and freshly 
prepared ammoniacal silver nitrate solution [1.4 ml ammonia solution 
(SG 0.88) was added to 21 ml 0.36% NaOH. Silver nitrate solution (4 
ml of a 19.4% solution) was added slowly with vigorous agitation and 
the volume of liquid made up to 100 ml.] The gel was stained for 15 
min, removed from the silver solution and washed in four changes of 
distilled water (200 ml) over 40 min. It was transferred to fresh 
citric acid (0.005%) in formaldehyde (0.019%) and allowed to develop 
for 10 min then washed four times in 1,000 ml distilled water. The 
whole staining procedure, with the exception of fixing, was conducted 




The subinhibitory concentration of ethidium bromide 
The number of organisms per ml of overnight culture of V479 was 
found to vary between 108 and 109. The results obtained for the 
seven determinations were 8.6 x 108, 1.51 x 109, 1.34 x 109, 2.20 x 
109, 1.7 x 109, 2.4 x 109 and 2.97 x 109 cells per ml. The average 
value was 1.85 x 109. In all subsequent curing experiments overnight 
cultures were diluted by a factor of 104. 
After 24 h incubation in the presence of ethidium bromide growth 
was visible at concentrations of 8 and 16 mg /1 and after 48 h growth 
was additionally visible at concentrations of 20 and 24 mg /1. At an 
ethidium bromide concentration of 20 mg /1 there was a marked 
reduction in growth but the growth was just barely visible at 24 
ug /ml. There was no growth in the presence of ethidium bromide 32 
ug /ml. The subinhibitory concentration of ethidium bromide was taken 
as 20 mg /1 and this concentration used for all curing experiments 
with the test strains. 
The effect of ethidium bromide on curing of resistance 
Clindamycin and erythromycin resistance were not cured in any of 
the strains tested. 
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The Transfer of Clindamycin and Erythromycin Resistance 
Bacteroides to . Bacteroides transfer was observed from 
B. fragilis V479 to B. fragilis MH47 (Table 5.5). The transfer 
frequency, calculated as the number of transcipients per donor cell 
per ml of mating mixture, was 2.5 x 10 -7. The plasmid profile of the 
donor, recipient and transcipient strains are shown in Fig 5.3. The 
plasmid content of the donor (V479) and transcipient strains were 
identical. The recipient strain (MH47) was a plasmid -free strain. 
Resistance to clindamycin and erythromycin were transferred together 
as transcipient strains acquired resistance to both of these 
antibiotics. Transfer was not observed in any other mating 
experiment. 
The E. coli strains had MICs to erythromycin of 32 mg /l. During 
mating experiments with MH2 and MH12 it was possible to isolate 
mutants with MICs of 64 mg /l. However after mating experiments with 
B. fragilis MH11 it was possible to isolate mutants with resistance 
to 512 mg /1 of erythromycin. These mutants arose at low frequency, 
approximately 1.1 x 10 -6 and high level resistance was stable through 
several sub -cultures. 
DNA Hybridization Studies 
DNA hybridization was not observed between the plasmid and 
chromosomal DNA of the test strains and the resistance determinant 












































































































































































































































































































































































































































































































































































































































































Figure 5.3 Agarose gel (0.6%) showing the plasmid profiles of strains 
from the mating of a clindamycin resistant (Ccr) donor 
V479 and a clindamycin sensitive recipient MH47 to produce 
Ccr transconjugant strains T1 and T2 with identical plasmid 
profiles to the donor. 
176 
Genetic Analysis of Cefoxitin Resistant Strains 
Plasmids were not detected in any of the naturally resistant 
strains. The cefoxitin sensitive parent strain B. fragilis BL had 
three plasmids of molecular mass 2.9, 1.5 and 1.1 MDa while strain 
B108 (NCTC 9343) had one large plasmid of molecular mass 44 MDa (Fig 
5.4). Three of the mutant strains B265, B266 and B271 had similar 
plasmid content to the parent strain while the mutant B269 had only 
one plasmid (ca 1.1 MDa) with the 1.5 and 2.9 MDa plasmids absent. 
The plasmid profile of the strains shows that in two mutants 
B265 and B266 the 1.5 and 1.1 MDa plasmids migrated further from the 
wells than the corresponding plasmids in the parent strain. In the 
mutant B269 the 1.1 MDa plasmid migrated a shorter distance from the 
wells than the corresponding plasmid in the parent. The plasmid 
profile of the mutant B271 was identical to that of the parent strain 
B1. 
The outer membrane protein profiles of the strains are shown in 
Figs 5.5 and 5.6. Those of the laboratory mutants obtained by both 
methods of extraction and straining were identical to the parent 





Figure 5. 4 
6 7 
Agarose gel (0.67) showing plasmid profiles of 
(1) standard strain MH44; (2) B108 (NCTC 9343) (4) cefoxitin; 
sensitive parent strain, B1; (4) mutant strain B266 




















Coomassie blue stained SDS -PAGE of sarkosyl extracts of outer membrane 
proteins of B. fragilis strains B108 (NCTC 9343 reference strain) B1 
(cefoxitin sensitive parent strain) B265, B266, B269, B271 (cefoxitin 










Mr B1 B266 Mr 
ST DARD (PARENT) (MUTANT) STANDARD 
Figure 5.6 
Silver stained SDS -PAGE of EDTA extracts of the outer membrane proteins 
of B. fragilis strains B108 (NCTC 9343, reference strain), B1 (cefoxitin 
sensitive parent strain) and B265, B266, B269, B271 (cefoxitin resistant 
mutants of B1) and of' the molecular ms(Mr) standard. 
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DISCUSSION 
Correlation of the presence of a plasmid with the expression of 
a phenotypic trait can be accomplished by curing of the plasmid 
involved or the transfer of its genetic determinants into strains 
lacking the characteristic under investigation. In cases of plasmid- 
mediated antibiotic resistance, sensitive strains may arise from the 
loss of plasmids due to errors in replication and segregation and to 
deletions. There is variation in the loss of plasmid DNA but the 
rate of spontaneous loss can be increased by exposure to various 
physical and chemical agents which are known as curing agents. 
Curing agents include acriflavine, acridine orange and 
ethidium bromide but eithidium bromide was chosen for this study as 
it was shown by Rotimi and Duerden (1982) to be the most effective 
with Bacteroides species. While some strains which displayed 
resistance to clindamycin and erythromycin did not have plasmids, 
resistance was not cured in any of the eleven resistant strains. 
Failure to cure a phenotypic trait is not however absolute proof that 
the trait is chromosomally mediated. 
Problems have resulted from the isolation of uncharacterised 
plasmids due to current investigation. There is no standard curing 
agent and curing agents are individually effective only against some 
plasmids (Grinstead et al., 1984). The plasmids involved may 
therefore be refractory to ethidium bromide. In addition the plasmid 
may also encode functions vital to the viability of the cell, 
resulting in the death of cured cells. 
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Clindamycin- erythromycin resistance in B. fragilis V479 is known 
to be encoded by a transposon Tn4351 located on a 27 MDa plasmid 
designated pBF4 (Welch et al., 1979; Shoemaker et al., 1985). 
Attempts to transfer this plasmid into the recipient strain 
B. uniformis MH43 were unsuccessful. Resistance was however 
transferred to B. fragilis MH47. This transfer confirmed the fact 
that failure in other mating experiments was not due to the transfer 
technique. Welch et al. (1979) postulated that there may be 
interstrain differences in surface receptors required for plasmid 
transmission or differences in the ability of plasmids to replicate 
or be expressed in a given host strain. Alternatively, lack of 
resistance transfer in strains with uncharacterised plasmids could 
indicate that the genes conferring clindamycin and erythromycin 
resistance are chromosomally located or that the plasmids on which 
they occur lack mobilization factors. 
The occurrence of high level resistance mutants following mating 
experiments between E. coli and Bacteroides has not been previously 
reported. Mutations to erythromycin in E. coli usually gives rise to 
strains which are resistant to one dilution above the MIC. However 
these strains were resistant to five times the normal MIC and 
resistance was stable. Plasmid DNA was not detected in these 
isolates and the genetic basis remains uncertain. This may indicate 
a role of Bacteroides in increasing resistance in facultative 
anaerobes when present together in concentrated culture. In the gut 
where the number of organisms is high the Bacteroides may exert this 
effect on E. coli. This observation may have therapeutic 
implications for mixed infections. 
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High level resistance in Bacteroides is usually accompanied by 
cross -resistance to erythromycin and the streptogramins (MLS 
resistance) and has been shown in several strains to be plasmid- 
mediated (Privatera et al., 1981; Tally et al., 1979; Welch et al., 
1979). However only three of the ten strains showing high level 
resistance to clindamycin and /or erythromycin had plasmids. In a 
fourth strain MH79 plasmids could not be consistently isolated and 
the plasmid DNA involved was possibly unstable. These results 
indicate that high level resistance to clindamycin and erythromycin 
can be chromosomally encoded. Callihan et al. (1984) found that in 
some plasmid containing strains a resistant determinant which 
hybridizes with the determinant from pBF4 was carried on the 
chromosome. It is possible therefore that in the plasmid- containing 
strains MH2, MH12 and MH11 the resistant determinant carried on pBF4 
resides on the chromosome. 
Four self -transmissible plasmids conferring high level 
resistance to clindamycin and erythromycin have been described in the 
Bacteroides (Guiney et al., 1984; Smith and Macrina, 1984; Tally 
et al., 1979, 1982; Welch et al., 1979). These plasmids vary in 
size and restriction endonuclease patterns but DNA hybridization 
studies have shown the existence of homology between the MLS 
determinants (Guiney et al., 1984; Marsh et al., 1983; Shimell 
et al., 1982; Smith, 1985). This homology has resulted in the 
theory of widespread dissemination of an MLS resistance determinant 
in Bacteroides (Rasmussen et al., 1987). Investigations of low - 
level, chromosomally encoded resistance to clindamycin has shown an 
absence of homology indicating the existence of two different 
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determinants. The absence of homology between the determinant of the 
TN4351 transposon carried by E. coli V1476 and the plasmid or 
chromosomal DNA of the test strains indicate the existence of another 
resistance determinant encoding high level resistance to clindamycin 
and erythromycin. 
It has been postulated that cefoxitin resistance to beta - 
lactamase is a major factor in its superior activity, compared to the 
cephalosporins, against the bacteroides (Darland and Birnbaum, 1977; 
Neu, 1983; Sweet et al., 1979; Tally et al., 1979; Weinrich and 
Del Bene, 1973). Several groups of investigators have demonstrated 
hydrolysis of cefoxitin by novel beta -lactamases produced by some 
cefoxitin- resistant B. fragilis strains (Cuchural et al., 1986a; 
Yotsuji et al., 1983). However, although the association between 
betá- lactamase susceptibility and antibacterial action is very 
significant statistically, the relationship is not absolute. Several 
B. fragilis isolates have been found to be resistant to cefoxitin 
though no beta -lactamase hydrolysis could be detected (Darland and 
Birnbaum, 1977; Olsson et al., 1980; Piddock and Wise, 1987). 
Darland and Birnbaum (1977) demonstrated the absence of a major 
permeability barrier but Dornbusch et al. (1980), in the absence- of 
beta -lactamase activity, deduced that cefoxitin resistance was due to 
an intrinsic factor which was possibly alterations in the cell wall. 
The observation that the OMP profile of the parent strain 
B. fragilis B1 was identical to that of the B. fragilis strain NCTC 
9343 led Piddock and Wise (1987) to postulate a correlation between 
outer membrane proteins and cefoxitin resistance. However, in our 
hands the OMP profile of NCTC 9343 differed from that of B1 despite 
184 
its identical PBP profile to 34 beta -lactam antibiotics. This 
suggests that OMP profiles may be strain specific and differences 
observed by Piddock and Wise (1987) may bear no relationship to 
cefoxitin resistance. 
Similarly, the plasmid profile of NCTC 9343 differed from that 
of B1 despite the identical MIC value to cefoxitin. It is possible 
that homology existed between the genetic material carried on the 
plasmid DNA of both strains but DNA hybridization studies were not 
conducted due to time restraints. The differences in plasmid profile 
of the parent and mutant strains indicate plasmid involvement in 
cefoxitin sensitivity. 
A limitation of the method of agarose gel electrophoresis for 
the determination of the molecular mass of plasmid DNA is that small 
differences in plasmid size such as those observed in Fig 5.1 
(strains B265 and B266) cannot be accurately determined using a 
logarithmic plot. In two mutants, strain B266, for which Piddock and 
Wise (1987) could find no mechanism of cefoxitin resistance, and 
strain B265, two plasmids (molecular mass 2.9 and 1.5 MDa) showed 
slight alterations in size which could be due to insertion or 
deletion of base pairs. In mutant strain B269.a four -fold increase 
in MIC to cefoxitin was accompanied by the loss of two plasmids (the 
2.9 and 1.5 MDa plasmids) and an alteration of molecular mass of the 
third plasmid (the 1.1 MDa plasmid). The plasmid profile of B271 was 
identical to that of the parent strain B1 despite the eight -fold 
decrease in cefoxitin sensitivity. 
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Four mutant strains with distinct differences in plasmid DNA and 
PBP competition assay profiles were isolated from a single parent. 
This would indicate that the mutagen NTG did in fact produce multiple 
mutations of the parent strain. The results of this study have shown 
that these genetic mutations involved plasmid DNA. Crumplin and 
Smith (1981) provided evidence that R factors in facultative 
anaerobes may increase their susceptibility to antimicrobial agents. 
It is possible therefore that the observed alterations of plasmid DNA 
may have resulted in the decreased sensitivity to cefoxitin. 
Piddock and Wise (1987) deduced that for three of the strains 
(B265, B269 and B271) decreased sensitivity to cefoxitin was due to 
alterations in PBP profile during binding assays with cefoxitin. The 
PBP profile of the mutant strains may be related to the plasmid 
profile. An examination of the PBP profile of the strains (Table 
5.1) shows that of all four mutants, B269, the strain with two 
missing plasmids, had the greatest alteration in PBP profile relative 
to the parent strain. In B271 where no changes in plasmid profile 
were observed the effect of the mutagen on the plasmid DNA may have 
been a functional rather than a structural one. However, the absence 
of plasmids in naturally occurring cefoxitin- resistant strains may 
have indicated that in those strains resistance was chromosomally 
mediated. It is possible that the four to eight -fold increase in the 
MIC to cefoxitin of mutant strains of B. fragilis B1 may also be due 
to alterations in chromosomal DNA. This is contrary to the 
observations of Raschtchian et al. (1982) who deduced that cefoxitin- 
resistance genes may be carried on plasmid DNA or on an episome. 
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CHAPTER 6 
PLASMID DNA AND CAPSULE VARIATION IN BACTEROIDES FRAGILIS 
INTRODUCTION 
The observation that Bacteroides fragilis, a minor component of 
the faecal flora, is more frequently associated with infection than 
other members of the Bacteroides fragilis group, implies the 
existence of unique virulence factors associated with its 
pathogenicity. Studies with the capsule of this species, a putative 
virulence factor, have shown that there is variation in capsule size 
(Babb and Cummins, 1978; Patrick et al., 1986). Capsules ranging 
from a half to four times the cell diameter have been described by 
Babb and Cummins (1978). 
Two extracellular layers, a narrow electron dense layer and a 
fibrous metwork, have been observed by electron microscopy (Lambe 
et al., 1984; Patrick et al., 1986). It was suggested that these 
structures were identical, with differences in appearance due to 
condensation during preparations for viewing (Lambe et al., 1984). 
However, Patrick et al. (1986) showed that they may, in fact, be 
different in nature. This group separated bacteria with different 
capsule sizes from a single population by the use of four step (20, 
40, 60, 80%) Percoll density gradients (Table 6.1, Figs. 6.1 - 6.4). 
Patrick (1986) extended this work to determine the ability of 
cells from the two extreme interfaces (0 - 20% and 60 - 80%) to 
agglutinate erythrocytes (Table 6.2). She showed that cells from the 
60 - 80% interface gave strong haemagglutination with both the rocked 
tile and static settling tests. No agglutination was observed with 
cells from the 0 - 20% interface. 
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TABLE 6.1 Incidence of fibrous network and electron dense layer in 
Bacteroides fragilis (NCTC 9343) after density gradient separations* 
Structure 
Gradient position 
0 - 20% 20 - 40% 40 - 60% 60 - 80% 
interface interface interface interface 
Fibrous network ++ + + - 
Electron dense 
layer 
+ + + + 
Figure b.\ 6.2. b.3 6.h 
++ Extensive fibrous network 
+ Presence of structure 
- Absence of structure 
* Results of Patrick et al. (1986) 
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Figures 6.1 - 6.4 
Electron micrographs of B. fragilis 9343 to show surface structures 
of cells harvested from the interface layers of a four -step Percoll 
density gradient. (courtesy of S. Patrick) 
Figure 6.1 
Cells from the 0 - 20% interface showing the fibrous network 
(arrowed) surrounding the outer membrane (0M). 
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Figures 6.2 and 6.3 
(6.2) 
(6.3) 
Cells from the 20 - 40% interface (6.2) and the 40 - 60% interface 
(6.3) showing a narrow eledtron dense layer (EDL) adjacent to the 
outer membrane (0M) or a small fibrous network (arrowed). 
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Figure 6.4 
Cells from the 60 - 80% intérface showing the absence of a fibrous 
network but the presence of the electron dense layer (EDL). 
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TABLE 6.2 Comparison of haemagglutination of a number of erythrocyte 
species by B. fragilis subcultured from the 0 - 20% and 60 - 






0 A B 
Horse Guinea 
pig 
Rabbit Sheep Chicken Mouse 
NCTC 9343 0 - 20% 
60 - 80% 
- 
+ + + + + + + + + 
NCTC 9344 0 - 20% - 
60 - 80% + + + + + + + + 
GNAB4 0 - 207 - 
60 - 80% + + + + + + + + + 
+ = haemagglutination within 5 minutes 
- = no haemagglutination 
* Data of Patrick (1986) 
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The proportion of encapsulated cells and the stability of 
segregation are also subject to variation (Babb and Cummins, 1978; 
Burt et al., 1978; Patrick et al., 1986). Babb and Cummins (1978) 
showed that the chemical, serological and possibly biological 
properties of capsule -producing strains, may be altered by growth 
conditions. No work has been done on the genetic basis of capsule 
production. A study of three of the strains was conducted to extend 
the work of Patrick (1986) and Patrick et al. (1986), and to 





Three of the six strains examined by Patrick (1986) were 
investigated. B. fragilis strains 9343 and 9344 were obtained from 
the National Collection of Type Cultures (NCTC). B. fragilis strain 
GNAB4 was obtained from the culture collection of the Microbial 
Pathogenicity Research Laboratory of the Bacteriology Department, 
University of Edinburgh. 
Bacterial Culture Methods 
Bacteria were grown to late log phase in PPY broth as previously 
described (Chapter 2). 
Separation of Bacteria 
Bacteria were separated on Percoll (polyvinylpyrrolidone (PVP -) 
coated colloidal silica) gradients by the modified method of Kurnick 
et al. (1979). Two step discontinuous gradients were generated in 4 
ml sterile culture tubes (12 mm x 75 mm). The tubes were wetted with 
a small amount of new born calf serum (NBCS) to allow even flow of 
the Percoll. A stock solution of Percoll isotonic with physiological 
saline (PBS) was prepared by diluting nine volumes of Percoll with 
one volume of ten -fold PBS (pH 7.2). This stock was referred to as 
100% Percoll. Less dense solutions of Percoll were prepared by the 
addition of suitable volumes of the growth medium (PPY). 
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Percoll (2 ml of 20% or 80%) was added to each tube. Cells from 
5 ml of broth culture were pelleted by centrifugation in a bench -top 
centrifuge for 20 min at 2600 g. The cells were resuspended in 5 ml 
pre- reduced PPY and 2 ml was layered on to the Percoll. The 
gradients were centrifuged for 20 min at 2,500 1. Cells were 
harvested from the 0 - 20% interface and from the bottom of the tubes 
containing 80% Percoll. Harvesting was from above by means of a 
Pasteur pipette. 
Unwashed cells from the gradient were used as a direct inoculum 
for 10 ml of pre- reduced PPY. This was grown to late log phase to 
produce cultures enriched for cells harvested from the gradient. 
Cells from the enriched cultures were pelleted, resuspended in PPY 
and the separation procedure repeated two to three times. Finally 
cells harvested from the gradient.were used as the inoculum of broth 
cultures used for plasmid analysis. 
Preparation of Plasmid DNA 
Broth cultures (50 ml) were grown and plasmid DNA isolated and 
visualised as previously described (Chapter 3). 
Observation of Capsules 
The presence and sizes of capsules was determined by light 
microscopy with India ink and basic fuchsin (Cruickshank et al., 





It was impossible to obtain cultures of cells with uniform 
capsule size despite repeated separation and enrichment, (Fig 6.5 and 
6.6). Prior to enrichment the proportion of cells with capsules was 
<1% for B. fragilis NCTA 9343, <10% for B. fragilis NCTC 9344 and 
between 10 and 20% for B. fragilis GNAB 4. This was increased to 
approximately 10% for B. fragilis NCTC 9343, 25% for B. fragilis NCTC 
9344 and 50% for B. fragilis GNAB 4 by repeated enrichment. The 
effect of enrichment on cells which produced an electron dense layer 
was less marked. During separation, before and after enrichment, the 
majority of cells collected at the 0 - 80% Percoll interface, with 
only a small proportion of cells (increased slightly by enrichment) 
sedimenting to the bottom of the 60% Percoll layer. 
The plasmid profile of cells enriched for large capsules and 
electron dense layers were identical (Fig 6.7). A large plasmid of 
molecular mass 44 MDa was isolated from NCTC 9343 but plasmids were 
not detected in strains NCTC 9344 and GNAB4. 
*as claimed by Patrick et al.(1986). 
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Figure 6.5 
Enrichment on Percoll gradients of capsulate cells of three strains 
of bacteroides 
0 - 20% Percoll 
interface before 
enrichment 
(i) NCTC 9343 
0 - 20% Percoli 
interface before 
enrichment 
(ii) NCTC 9344 
a b 
ppy broth 











0 - 20% Percoll 
interface after 
enrichment 
(iii) GNAB 4 
197a 
ppy broth 











Encapsulated cells of Bacteroides fragilis as visualised in India ink 
films under light microscopy (magnification 4300x) 







Agarose gel (0.6%) showing plasmids isolated from (1) the standard strain 
B. Fragilis MH44, (2) cells of B. Fragilis NCTC 9343 harvested from the 0 -20% 
interface of a Percoll gradient-and enriched for fibrous capsule, and (3) cells 
of B. Fragilis NCTC 9343 harvested from the bottom of a two -step Percoll gradient 
(containing 0% and 80% Percoll) enriched for an electron dense layer (EDL). 
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DISCUSSION 
Adherence of pathogenic bacteria to different kinds of 
substances is important in successful colonisation of the host 
tissue. Mechanisms of adherence therefore constitute virulence 
factors. The genetic determinants for certain virulence factors can 
be carried on plasmids. Enterotoxin and adhesin production in 
E. coli and antibiotic resistance in Gram -negative and Gram -positive 
bacteria, for example, have been shown in some cases to be plasmid 
mediated (Helinski, 1973; Gyles et al., 1974; Welch et al., 1979; 
Elwell and Shipley, 1980). These plasmids are sometimes unstable and 
in such cases changes in the virulence of an organism can be 
correlated with the loss of plasmids. Re- introduction of the 
plasmids into the wild -type strains lacking the relevant plasmid or 
transfer of the plasmid to other recipient strains can then confirm 
that genes coding for a particular character are carried on the 
plasmid. 
The bacteroides subpopulations examined, displayed phenotypic 
variation in haemagglutinating activity which was correlated with 
differences in extracellular structures. The haemagglutinating 
activity of bacteria is related to its adherence properties. 
Adhesins can confer on cells the ability to adhere to a large number 
of cellular substrates within the host, including erythrocytes (Old, 
1985). It was considered possible that this variation could be due 
to the presence of extrachromosomal DNA which was being transferred 
through a population of cells. The identical nature of the plasmid 
profile of each strain when cells enriched for large capsules were 
xt by Patrick (1986) 
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compared with those enriched for electron dense layers indicated that 
differences were due to gene expression rather than the presence or 
absence of plasmid DNA. Further evidence for this was provided by 
the fact that in two of the strains in which capsule variation was 
observed no plasmids were present. 
Despite repeated enrichment attempts it was impossible to obtain 
a culture with uniform capsule size. This was in agreement with the 
findings of Patrick et al. (1986). These results indicate that 
incomplete segregation of capsules did not result from the transfer 
of plasmid DNA within a population of cells. However, the inability 
to produce pure cultures of cells with the fibrous capsule may have 
altered the plasmid profile of the strains. Low copy number plasmids 
present in these strains could have remained undetected. Enrichment 
for cells with an electron dense layer in the absence of a fibrous 
network, was from an inoculum harvested from the bottom of a 0 - 80% 
Percoll gradient. Despite the fact that Patrick et al. (1986) 
harvested cells with the EDL from the 60 - 80% interface of a Percoll 
gradient, this modified method has been shown to give good results 
(S. Patrick, personal communication). 
The presence of several capsule sizes within a given population 
of cells may increase the virulence of strains. Bacteroides cells 
producing the fibrous capsule, when present in concentrations greater 
than 107 /ml, have been shown to inhibit phagocytic and serum killing 
of both capsule producing cells and concomitant facultative anaerobes 
(Connolly et al., 1984). However, the work of Patrick (1986) has 
provided evidence that these cells lack haemagglutinating activity. 
200 
Babb and Cummins (1978) observed that on average approximately 
10% of cells of Bacteroides strains produced a fibrous capsule. In 
our hands, 24 h cultures of bacteroides contained ca 109 cells /ml 
(Chapter 4). Therefore, if on average 10% of the cells possess a 
fibrous capsule, then these capsule -producing cells would be present 
in 108 cells /ml, a concentration exceeding that required for the 
inhibition of phagocytosis. A possible function of the capsule of 
Bacteroides species may, therefore, be to facilitate the colonisation 





As the study progressed the complexity of each section of the 
work was daunting. The characterization of the test strains proved a 
major assignment. Storage at -70 °C was by far superior to storage 
on agar plates as it removed the need for frequent sub -culture to 
maintain viability. The method of White and Sands (1985) was an 
efficient one which facilitated frequent use of the stored cultures. 
It was possible to sub -culture without thawing thereby reducing the 
time involved and destruction of bacterial cells caused by frequent 
freezing and thawing. 
The mini -test system was found to be an effective way of 
characterizing Bacteriodes. However tests had to be repeated several 
times on atypical members of the three groups to confirm the results. 
Reading of the results was very time consuming as estimates of 
turbitity were required for all fermention tests. Fast -growing 
strains often produced equivocal results for fermentation tests and 
use of a pH meter was therefore required to confirm the results. It 
was convenient to investigate 10 - 15 strains at the same time with a 
mixture of fast and slow -growing strains to spread out the reading of 
the results. 
The development of an effective method of plasmid analysis was 
by far the most challenging section of the study. It was developed 
over several months with every effort being made to improve and 
perfect the selected technique. The final method was suitable for 
the isolation and detection of plasmids covering an extensive size 
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range as plasmids less than 10 MDa and greater than 100 MDa were 
isolated. This study served to emphasize the need for the use of 
methods developed for the specific organisms under investigation. 
Established methods which gave good results with aerobes and 
facultative anaerobes failed to give satisfactory results with 
Bacteroides. 
Werner et al. (1981) determined that the B. fragilis group were 
resistant to the effects of lysozyme but it has been used 
successfully by other workers (Guerry et al., 1973; Tinnell and 
Macrina, 1976) and this study has shown that it can be effectively 
used in the lysis of Bacteroides (a finding welcomed since it removed 
the need for unpleasant phenol extractions) The increased incidence 
of plasmid presence observed for the B. fragilis group may reflect 
strain variations. Alternatively it may be reminiscent of the 
increased frequency of isolation of anaerobes from sites of infection 
which resulted from the use of improved methods of isolation. 
Antimicrobial susceptibility tests required particular care in 
performance and interpretation. The main problem encountered was the 
sheer amount of work involved, with agar dilution tests supplemented 
with broth dilution tests to ensure accuracy. Use of the agar 
dilution method, as opposed to the disk diffusion method, increased 
the number of strains which could be investigated at any one time. 
The multipoint inoculator was a very effective labour -saving device 
and a maximum of 18 strains could be tested per plate along with the 
two reference strains. It was found to be convenient to test strains 
in batches of 36 on four antibiotics. Preparation of dilutions for 
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use was the most tedious procedure but once prepared the work flowed 
smoothly. 
The interpretation of results was in general straightforward. 
With the exception of erythromycin there was a definite cut -off point 
at the MICs (i.e. no visible growth). However, with erythromycin 
there was a tailing off effect and the end -point was set as the 
concentration at which there was significant reduction in growth. 
Comparative Efficacy of Antimicrobial Agents 
Chloramphenicol, clindamycin and metronidazole were all found to 
be very active against the Bacteroides. Of the non -beta -lactam 
antibiotics chloramphenicol had the highest activity as no resistant 
strains were observed. Resistance to clindamycin was found to be 
confined to the B. fragilis group. The percentage of resistant 
strains was sufficiently low to allow continued use of this 
antimicrobial agent in the treatment of bacteroides infections. 
These results are in agreement with those of other workers (Sutter 
and Finegold, 1976; Appelbaum and Chatterton, 1978; Brown and 
Waati, 1980;' Phillips et al., 1981). 
Reports of metronidazole resistance within the UK are 
significantly less than those from other countries. However, 
resistance to metronidazole, though rare, may occur with some strains 
(Ingham et al., 1978; Rotimi et al., 1979; Eme et al., 1983). This 
study has shown that resistance is not confined to the B. fragilis 
group. Despite the observation of Ingham et al. (1978) that 
metronidazole resistance may develop after long -term therapy, Willis 
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et al. (1978) noted that if the clinical use of metronidazole 
continued to be controlled then metronidazole resistance should not 
be a problem. The low incidence of metronidazole resistance confirm 
its continued effectiveness against the Bacteroides. 
Imipenem was the most active of all the beta -lactam antibiotics 
tested. Resistant strains were not observed in any group The use of 
this agent within the United Kingdom as an anti -bacteroides drug is 
therefore recommended. The activity of the cephalosporins varied 
between the groups. They were found to be more active against the 
non -fragilis groups, due possibly in part to the substrate profile of 
the beta -lactamase enzymes of these groups (minimal cephalosporinase 
activity). 
The therapeutic efficacy of the cefamycins has been associated 
with their resistance to hydrolysis by bacteroides beta -lactamases. 
Cefoxitin and moxalactam have been shown to have high activity 
against bacteroides but cefotetan was the least active beta -lactam 
antibiotic against the non -fragilis groups. Its activity against the 
B. fragilis groups as a whole was also poor. However the activity of 
cefotetan against the B. fragilis species was found to be high. This 
antimicrobial agent may therefore find clinical application in the 
treatment of some bacteroides infections. 
While the B. fragilis groups possess intrinsic resistance to 
penicillin, resistance among the non -fragilis groups, as has been 
observed in this study, is emerging. This has been attributed to the 
production of beta -lactamases of mainly penicillinase activity. 
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The Role of Bacteroides Plasmid DNA 
Four mechanisms of cefoxitin resistance have been suggested for 
the Bacteroides. They are beta -lactamase hydrolysis (Cuchural 
et al., 1983), alterations in an intrinsic character [possibly cell 
wall change] (Dornbusch et al., 1980)] and alterations of outer 
membrane proteins and PBP affinities to the antimicrobial agent 
(Piddock and Wise, 1987). The results of this study have indicated a 
possible role of plasmid DNA in cefoxitin sensitivity. 
Differences in the plasmid profile of resistant mutant strains 
compared to that of the sensitive parent strain have indicated that 
genes carried on plasmid DNA may make bacteroides host cells more 
susceptible to the effects of cefoxitin. An examination of the PBP 
competition assays of Piddock and Wise (1987) have shown that a 
possible mechanism of sensitivity is the alteration of access to the 
penicillin binding proteins or alteration of the affinity of proteins 
to cefoxitin by plasmid encoded genes. 
Despite the established correlation of MLS resistance and 
plasmid DNA in Bacteroides (Guiney et al., 1984; Rotimi et al., 
1981; Tally et al., 1979, 1982; Welch et al., 1979) conclusive 
results of such plasmid involvement in the strains examined were not 
made. However, the incidence of low -level resistance among the 
isolates was found to be higher than previously reported. The nature 
of the genetic determinants were also found to be different. While 
this study confirmed that low -level resistance is carried on the 
chromosome, the observations suggest that there may be more than one 
plasmid -borne high level clindamycin- resistance determinants, and 
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such determinants may be carried on the Bacteroides chromosome. 
Plasmids in Bacteroides, have not been shown to increase the 
sensitivity of the strains to nalidixic acid. All strains, 
regardless of their plasmid content, were resistant. 
The Bacteroides are a suspected reservoir of antibiotic 
resistance plasmids (Del Bene et al., 1976; Guiney and Davis, 1975; 
Stiffler et al., 1974; Tinnell and Macrina, 1976; Shoemaker and 
Salyers, 1987). The inability to demonstrate the transfer of 
antibiotic resistance genes from Bacteroides to E. coli does not rule 
out this possibility. There are no known antibiotic resistance 
determinants which are expressed in both E. coli and Bacteroides, a 
factor which may reflect differences in plasmid replication and gene 
expression (Guiney et al., 1984; Shoemaker et al., 1985; 1986a; 
1986b). However, determinants on transposons from Bacteroides which 
are expressed in E. coli are not expressed in Bacteroides and vice 
versa (Guiney et al., 1984; Robillard et al., 1985; Shoemaker 
et al., 1985; 1986). It is possible therefore that Bacteroides do in 
fact act as a source of resistance genes which may, due to lack of 
expression in the donor organisms, be difficult to identify and 
relate to the Bacteroides. In addition, this study has provided 
evidence that other mechanisms of increasing the resistance of 
facultative anaerobes may exist in the Bacteroides. 
The observations of other workers support the theory that 
encapsulated strains of Bacteroides may have a protective function 
towards unencapsulated strains of Bacteroides and facultative 
anaerobes (Connolly et al., 1984; Reid and Patrick, 1984). This 
study has provided no evidence of an involvement between plasmid DNA 
207 
and capsule variation in Bacteroides. However, due to the small 
number of strains examined and the simplicity of the plasmid profiles 
obtained, further work is required in this area. It is possible that 
if capsule variation in strains with large numbers of plasmids was 
examined, differences in plasmid profiles may be obtained. As with 
other areas requiring further work, a decision had to be made to 
limit experimental procedures to facilitate the completion of other 
aspects of this study, and to prevent its indefinite extension. 
The high incidence of plasmids in Bacteroides, especially among 
the clinically important B. fragilis group, indicates an as yet 
undisclosed function of this type of DNA. It is hoped that the 
material in this study has made a contribution towards the 
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APPENDIX I 
APPENDIX I The identity of bacterial strains used throughout the 
study. 
Strain Bacteroides Strain Bacteroides 
number species number species 
MH 1 B. uniformis 
MH 2 B. fragilis 
MH 3 " 
MH 4 " 
MH 5 " 
MH 6 " 
MH 7 'r 
MH 8 " 
MH 9 " 
MH 10 It 
MH 11 " 
MH 12 " 
MH 13 " 
MH 14 " 
MH 15 
MH 16 B. ovatus 
MH 17 B. fragilis 
MH 18 " 
MH 19 " 
MH 20 " 
MH 21 " 
MH 22 B. thetaiotaomicron 
MH 23 B. fragilis 
MH 24 B. distasonis 
MH 25 B. fragilis 
MH 26 B. uniformis 
MH 27 B. fragilis 
MH 28 " 
MH 29 B. uniformis 
MH 30 B. fragilis 
MH 31 " 
MH 32 " 
MH 33 B. uniformis 
MH 34 B. fragilis 
MH 35 " 
MH 36 " 
MH 37 B. uniformis 
MH 38 B. fragilis 
MH 39 " 
MH 40 " 
MH 41 It 
MH 42 " 
MH 43 B. uniformis 





Strain Bacteroides Strain Bacteroides 
number species number species 
ME 49 B. fragilis 
MH 50 
MH 51 B. bivius 
MH 52 B. fragilis 
MH 53 
MH 54 
MH 55 B. species 
MH 56 B. disiens 
MH 57 B. capillosis 
MH 58 B. uniformis 
MH 59 B. uniformis 
MH 60 B. bivius 
MH 61 
MH 62 B. species 
MH 63 B. species 








MH 72 B. bivius 
MH 74 B. species 
MH 75 B. capillosus 
MH 76 B. ovatus 
MH 77 B. fragilis 
MH 78 
MH 79 B. thetaiotaomicron 
MH 80 B. fragilis 
MW 1 B. bivius 
MW 2 " 





MW 8 B. disiens 
MW 9 
MW 10 B. bivius 







MH 73 B. corporis MW 18 B. disiens 
Strain Bacteroides Strain Bacteroides 
number species number species 
MW 19 B. disiens 
MW 20 
MW 21 
MW 22 B. bivius 
MW 23 B. disiens 




MW 28 B. oralis 
MW 29 






MW 36 B. vulgatus 
MW 37 
MW 38 B. uniformis 
MW 39 B. ovatus 
MW 40 
MW 41 B. oralis 
MW 41 B. ruminicola 
MW 42 B. distasonis 
MW 43 B. distasonis 
MPRL 528 B. melaninogenicus 












































Appendix 2 Molecular Masses of Plasmids Detected in Bacteroides Species 
Strain number Number of plasmids 
detected 
Molecular masses of plasmids 
(MDa) 
MH1 2 3, 2.8, 1.7, 1.3 
2 1 3.3 
3 7 33, 15, 3, 2.4, 1.75, 1.15 
4 7 42, 19, 5.7, 3.8, 2.5, 1.4, 2.2 
5 1 1.35 
6 2 3, 1.7 
7 4 3.2, 2.5, 1.65, 1.35 
8 2 2.5, 1.3 
9 2 2.2, 1.35 
10 - 
11 1 3.2 
12 2 3.2, 1.5 
13 5 39, 3.2, 2.35, 1.6, 1.34 
14 1 1.35 
15 2 3.4, 1.65 
16 1 59 
17 5 42, 3, 2.8, 2.45, 1.45 
18 1 1.4 
19 5 19, 3.3, 2.3 
20 - 
21 4 3.4, 2.3, 1.6, 1.35 
22 4 2.8, 2.4, 2.2, 1.1 
23 3 3.3, 1.6, 1.4 
(continued) 
Strain number Number of plasmids Molecular masses of plasmids 
detected (MDa) 
MH24 - 
25 1 2.4 




30 2 3.3, 1.65 
31 3 2.3, 1.7, 1.45 
32 3 24.7, 10.4, 2.4, 2.0 
33 - 
34 1 2.5 
35 1 108 
36 2 5.4, 3.1 
37 4 5.4, 3.1, 3.0, 2.2 
38 6 19.4, 10.5, 2.5, 2.3, 1.7, 1.45 






45 1 1.7 
46 1 1.7 
(continued) 











4.3, 3.9, 3.0, 1.95, 1.8, 1.7 
52 5 16, 4.6, 3.8, 1.6, 1.1 
53 - 

























76 2 1.75, 1.1 
77 
78 2 2.4, 1.65 
79 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































APPENDIX 4 Reagents used for polyacrylamide gel electrophoresis 
(PAGE) 
Electrode Buffer (Final strength) 
0.025 M Tris 
0.192 M glycine 
0.1% sodium dodecyl sulphate (SDS) 
Separating Gel Buffer (Double strength) 
0.75 M Tris -HC1 pH 8.8 
0.2% SDS 
Stacking Gel Buffer (Double Strength) 
0.25 M Tris -HC1 pH 6.8 
0.2% SDS 
Sample Buffer (single strength) 
0.0625 M Tris -HC1 pH 6.8 
2% SDS 
10% glycerol 
1% 2- mercaptoethanol 
0.001% bromophenol blue 
Acrylamide Stock Solution 
40% acrylamide 
1.08% methylenebisacrylamide 
PAGE Cell Washing Buffer 
0.05 M sodium phosphate buffer pH 7.4 
0.15 M NaC1 
PAGE EDTA Buffer 
0.05 M sodium phosphate buffer pH 7.4 
0.15 M NaCl 
0.01 M EDTA di- sodium salt 
SDS -PAGE 
Coomassie blue stain 
Solution 1 
500 mg Coomassie blue (Bio -rad R -250 or Gurr Brilliant blue R) 
250 ml Propan -2 -ol (BDH GPR) 
100 ml Glacial acetic acid (BDH Analar) 
650 ml Distilled water 
Solution 2 
50 mg Coomassie blue (Bio -Rad R -250 or Gurr Brilliant.blue R) 
100 ml Propan -2 -ol (BDH GPR) 
100 ml Glacial acetic acid (BDH Analar) 
800 ml Distilled water 
Solution 3 
24 mg Coomassie blue (Bio -Rad R -250 or Gurr Brilliant blue R) 
100 ml Glacial acetic acid (BDH Analar) 
900 ml Distilled water 
Solution 4 
100 ml Glacial acetic acid (BDH Analar) 
400 ml Methanol (BDH GPR) 
500 ml Distilled water 
Solution 5 
200 ml Glacial acetic acid (BDH Analar) 
1800 ml Distilled water 
